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Abstract 
 
This thesis has investigated the role of neutrophil extracellular traps (NETs) in the 
pathogenesis of periodontitis.  A fluorometric assay was developed for the in vitro 
quantification of NET release and used to assess relative levels in chronic periodontitis 
patients, indicating elevated release under several stimulatory conditions compared with 
controls.  Studies also demonstrated that challenge with periodontitis-associated bacteria 
evoked differential NET release.  In addition, an extensive panel of periodontal pathogens was 
screened for two potential virulence traits that may confer a survival advantage when 
challenged with NETs.  Deoxyribonuclease (DNase) secretion, capable of degrading NETs, 
and resistance to killing by histone, a core structural and antimicrobial protein within NETs, 
were both shown to be relatively common characteristics possessed by pathogens associated 
with severe disease.  Additionally, an in vivo study demonstrated DNase activity in plaque 
and GCF during the development of experimental gingivitis.  Further studies examined the 
association between neutrophil reactive oxygen species production and NET release 
implicating a regulatory role for myeloperoxidase generated hypochlorous acid in NET 
production.  In conclusion, the results contained within this thesis indicate a putative role for 
NETs in the pathogenesis of periodontitis and highlight a high prevalence of potential 
counter-NET mechanisms in certain periodontal organisms. 
 
 
 
 
 3 
Acknowledgements 
 
I would like to thank Dr Helen Wright, Dr Paul Cooper and Professor Iain Chapple for their 
endless support, guidance and patience.  Thanks also go to all my fellow tea drinkers in the 
postgraduate office who have made this time a pleasure, particularly my desk-neighbours Jen 
and Erum.  Most importantly I would like to thank all those willing to role up their sleeve in 
the name of science, without their blood this thesis would not have been possible.  Equally 
vital are the nurses of the Periodontology Unit whose venepuncture skills meant my 
volunteers kept coming back for more. 
 
In addition I would like to thank Iru at Aston University for her time spared in providing me 
with HL60 cells on more than one occassion, and also Rachel Sammons for allowing me use 
of her microbiology lab. 
 
I would also like to acknowledge the University of Birmingham, School of Dentistry for their 
financial support. 
 4 
Table of Contents: 
 
 
 
List of figures 
 
List of tables 
 
Abbreviations 
 
CHAPTER 1 INTRODUCTION ................................................................................ 1 
1.1 Periodontal diseases ............................................................................................... 2 
1.1.1 The prevalence of periodontitis ................................................................... 4 
1.1.2 Risk factors for periodontitis ....................................................................... 5 
1.1.3 The progression of periodontitis .................................................................. 5 
1.2 The role of bacteria in periodontal disease ......................................................... 6 
1.3 The role of the host in periodontal disease .......................................................... 9 
1.4 Neutrophils and disease ...................................................................................... 12 
1.4.1 Neutrophil activation ................................................................................. 13 
1.4.2 Neutrophil killing mechanisms - Non-oxidative and oxidative................. 14 
1.4.3 Extracellular neutrophil killing mechanisms ............................................. 17 
1.4.4 Microbial mechanisms for evading killing by neutrophils ........................ 18 
1.5 Neutrophil extracellular traps (NETs) .............................................................. 19 
1.5.1 Dependence on ROS .................................................................................. 22 
1.5.2 The function of NETs ................................................................................ 26 
1.5.2.1 Aiding other immune processes .......................................................... 28 
1.5.2.2 Extracellular antimicrobial activity ..................................................... 30 
1.5.2.3 NETs in non-infectious diseases ......................................................... 32 
1.5.3 Stimuli for NET production ....................................................................... 37 
1.5.4 Non-neutrophil derived extracellular traps ................................................ 40 
1.6 HL60 cells as a model for neutrophils ............................................................... 41 
1.7 Microbial mechanisms for the evasion of NETs ............................................... 44 
1.7.1 Inhibition of antimicrobial peptides (AMPs)............................................. 44 
1.7.2 Charge modifications of the bacterial surface ........................................... 45 
1.7.3 Expression of bacterial capsules ................................................................ 47 
1.7.4 Bacterial DNases ....................................................................................... 48 
1.8 The role of NETs in the pathogenesis of periodontal disease .......................... 52 
1.9 Summary and aims .............................................................................................. 56 
 
CHAPTER 2 MATERIALS AND METHODS ...................................................... 58 
2.1 NET production in vitro ...................................................................................... 59 
2.1.1 Isolation of neutrophils .............................................................................. 59 
2.1.1.1 Percoll density gradient ....................................................................... 59 
2.1.1.2 Lysis buffer .......................................................................................... 60 
2.1.1.3 Phosphate buffered saline (PBS) ......................................................... 60 
2.1.1.4 Method for isolation of neutrophils ..................................................... 60 
2.1.2 Culture and differentiation of HL60 cells.................................................. 61 
2.1.3 NET staining .............................................................................................. 62 
 5 
2.1.3.1 Paraformaldehyde (PFA) 8% .............................................................. 62 
2.1.3.2 NET staining ........................................................................................ 62 
2.1.3.3 Image capture and processing ............................................................. 63 
2.1.4 Fluorometric analysis of NET release ....................................................... 64 
2.1.5 Micrococcal nuclease (MNase) assay of NET release .............................. 64 
2.1.6 SEM of NETs ............................................................................................ 65 
2.1.7 Enhanced chemiluminescence assay for ROS ........................................... 65 
2.1.7.1 GPBSS (glucose supplemented PBS) .................................................. 66 
2.1.7.2 Blocking buffer (PBS BSA) ................................................................ 66 
2.1.7.3 Luminol and isoluminol....................................................................... 66 
2.1.7.4 Lucigenin ............................................................................................. 66 
2.1.7.5 Method for enhanced chemiluminescent assay for ROS ..................... 66 
2.1.8 Stimuli used to induce NETs ..................................................................... 67 
2.1.8.1 Preparation of bacterial stimuli ........................................................... 68 
2.1.8.2 Opsonisation of S. aureus .................................................................... 69 
2.1.9 Modulators of neutrophil function used in NET assays ............................ 69 
2.2 Comparison of NET production between periodontal patients and healthy 
individuals .................................................................................................................. 71 
2.2.1 Selection of volunteers .............................................................................. 71 
2.2.2 Assay of peripheral blood neutrophils ....................................................... 71 
2.3 HL60 cell characterisation .................................................................................. 72 
2.3.1 Gene expression analysis by RT-PCR in HL60 cells and primary 
neutrophils .......................................................................................................... 72 
2.3.1.1 mRNA extraction ................................................................................. 75 
2.3.1.2 Reverse transcription ........................................................................... 76 
2.3.1.3 PCR amplification of selected transcripts ........................................... 76 
2.3.1.4 Gel electrophoresis and image capture ................................................ 77 
2.3.2 Staining of HL60 cells ............................................................................... 78 
2.3.2.1 Haematoxylin and Eosin staining ........................................................ 78 
2.3.2.2 Immunocytochemical staining ............................................................. 78 
2.4 Culture of bacteria .............................................................................................. 79 
2.4.1 Storage of bacteria ..................................................................................... 81 
2.4.2 Culture conditions ..................................................................................... 81 
2.4.3 Blood agar ................................................................................................. 81 
2.4.3.1 Enriched blood agar ............................................................................. 82 
2.4.3.2 Hemin (100x concentration) ................................................................ 82 
2.4.3.3 N-acetylmuramic acid (NAM; 100x concentrated solution) ............... 82 
2.4.3.4 Vitamin K (100x concentrated solution) ............................................. 82 
2.4.3.5 Preparation of enriched blood agar ...................................................... 83 
2.4.4 Planktonic growth of bacteria .................................................................... 83 
2.4.4.1 Tryptone soya broth ............................................................................. 83 
2.4.4.2 Enriched tryptone soya broth ............................................................... 84 
2.5 Identification of bacteria ..................................................................................... 84 
2.5.1 Gram stain ................................................................................................. 84 
2.5.1.1 Crystal violet solution .......................................................................... 85 
2.5.1.2 Carbol fuchsin ..................................................................................... 85 
2.5.1.3 Method for Gram stain ........................................................................ 85 
2.5.2 Catalase test ............................................................................................... 86 
 6 
2.5.3 PCR identification ..................................................................................... 86 
2.5.3.1 PCR primers ........................................................................................ 86 
2.5.3.2 Bacterial PCR ...................................................................................... 92 
2.6 Antimicrobial susceptibility testing using histone proteins ............................. 92 
2.6.1 Microtitre plate analysis for antimicrobial susceptibility testing .............. 93 
2.6.2 Determination of bacterial growth by spectrophotometry ......................... 93 
2.6.3 Determination of bacterial growth by colony count .................................. 95 
2.6.4 Determination of bacterial growth by fluorescence .................................. 95 
2.7 Deoxyribonuclease (DNase) activity assays ....................................................... 95 
2.7.1 Plate flooding method ................................................................................ 95 
2.7.1.1 Preparation of DNase test plates .......................................................... 96 
2.7.1.2 Toludine blue O (TBO) 0.05% ............................................................ 96 
2.7.1.3 Innoculation of DNase test plates ........................................................ 96 
2.7.1.4 Plate flooding method .......................................................................... 97 
2.7.1.5 Image analysis ..................................................................................... 97 
2.7.2 Agarose gel method ................................................................................... 98 
2.7.2.1 Preparation of test samples .................................................................. 98 
2.7.2.2 Reaction mixture for agarose gel method of DNase assay .................. 99 
2.8 Detection of DNase in plaque and GCF samples ............................................ 100 
2.8.1 Clinical study period ................................................................................ 100 
2.8.2 Clinical measures of gingival inflammation ............................................ 101 
2.8.3 Plaque sampling ....................................................................................... 101 
2.8.4 GCF sampling .......................................................................................... 101 
2.8.4.1 PBS-BSA ........................................................................................... 102 
2.8.4.2 GCF sampling .................................................................................... 102 
2.8.5 Assay of samples for DNase activity ....................................................... 102 
2.9 Statistical analysis .............................................................................................. 102 
 
CHAPTER 3 RESULTS                                                                                                    
Assay of NET release ............................................................................................... 103 
3.1 Fluorometric quantification of NET release ................................................... 106 
3.1.1 Sensitivity of fluorometric detection of DNA ......................................... 106 
3.1.2 Determination of optimal concentrations of cells.................................... 107 
3.1.3 Correlation analysis of real-time fluorometric assay and visualisation of 
NET formation .................................................................................................. 110 
3.1.4 Quantification of NET production following MNase digestion .............. 112 
3.1.5 Comparison of quantitative NET production data obtained by end-point 
fluorescence and MNase assay ......................................................................... 115 
3.2 Determination of optimal concentration of serum for NET release ............. 118 
3.2.1 Effect of foetal calf serum (FCS) on NET release................................... 118 
3.2.2 Effect of BSA concentrations on NET release ........................................ 121 
3.2.3 Effect of BSA and FCS on NET release using fluorometric quantification124 
3.3 Determination of optimal concentration of stimuli ........................................ 128 
3.3.1 Dose-response analysis following PMA stimulation .............................. 128 
3.3.2 Dose-response analysis following stimulation with opsonised S. aureus130 
Discussion ................................................................................................................. 132 
 
 
 7 
CHAPTER 4 RESULTS                                                                                          
Modulation of NET release ..................................................................................... 138 
4.1 ROS inhibitor, diphenyleneiodonium (DPI) ................................................... 139 
4.1.1 Effect of DPI on cell viability ................................................................. 141 
4.2 Phagocytosis inhibitor, cytochalasin B (cytoB) ............................................... 144 
4.3 Effect of combination of ROS and phagocytosis inhibitors on NET release 147 
4.4 Superoxide dismutase (SOD) ............................................................................ 152 
4.5 Antioxidant/radical scavenger, curcumin ....................................................... 154 
4.6 Myeloperoxidase inhibitor, sodium azide ........................................................ 156 
Discussion ................................................................................................................. 160 
 
CHAPTER 5 RESULTS                                                                                                    
HL60 cells as a model system for NET release ..................................................... 167 
5.1 Differentiation of HL60 cells by DMSO .......................................................... 168 
5.2 PCR characterisation of dHL60 cells............................................................... 170 
5.3 Cytological analysis of dHL60 cells .................................................................. 177 
5.4 NET production in dHL60 cells ....................................................................... 179 
5.4.1 Visualisation of NETs in dHL60 cells ..................................................... 180 
5.4.2 Fluorometric quantification of NET release from dHL60 cells .............. 181 
5.4.3 MNase assay of dHL60 cell NET production ......................................... 183 
5.5 ROS production by dHL60 cells ...................................................................... 185 
Discussion ................................................................................................................. 188 
 
CHAPTER 6 RESULTS                                                                                                                
Comparison between NET release in periodontitis patients and healthy controls                                           
and the NET responses to periodontal pathogens ................................................ 191 
6.1 Comparison between NET release in periodontitis patients and self-reported 
healthy controls ........................................................................................................ 193 
6.1.1 Selection of test subjects.......................................................................... 193 
6.1.2 ROS production ....................................................................................... 194 
6.1.3 NET release ............................................................................................. 198 
6.1.4 NADPH oxidase-dependant NET release................................................ 200 
6.1.5 Comparison between ROS production and NADPH oxidase-dependant 
NET release ...................................................................................................... 202 
6.2 NET production by stimulation with periodontal pathogens and comparison 
with ROS production .............................................................................................. 204 
6.2.1 SEM of periodontal pathogens interacting with NETs ............................ 204 
6.2.2 MNase assay of periodontal pathogen stimulated-NET release .............. 208 
6.2.3 ROS production in response to periodontal pathogens ........................... 209 
6.2.4 Correlation analysis between NET release and ROS generation in response 
to periodontal pathogens ................................................................................... 211 
Discussion ................................................................................................................. 213 
 
CHAPTER 7 RESULTS                                                                                    
Characterisation of periodontal pathogens and their susceptibility to killing by 
histone ....................................................................................................................... 218 
7.1 Characterisation of periodontal pathogens ..................................................... 219 
7.1.1 PCR identification of bacteria ................................................................. 219 
 8 
7.1.2 Gram stain and cell morphology analysis................................................ 226 
7.1.3 Haemolysis and colony morphology ....................................................... 230 
7.1.4 Catalase testing ........................................................................................ 231 
7.1.5 Summary of identification ....................................................................... 232 
7.2 Susceptibility of periodontal pathogens to killing by histones ...................... 234 
7.2.1 Spectrophotometric analysis .................................................................... 234 
7.2.2 Plating method (colony count) ................................................................ 236 
7.2.3 Fluorometric quantification of bacterial growth ...................................... 238 
Discussion ................................................................................................................. 243 
 
CHAPTER 8 RESULTS                                                                                                   
DNase expression by periodontal pathogens and in dental plaque ..................... 247 
8.1 DNase expression by periodontal pathogens ................................................... 248 
8.1.1 DNase test plate assay ............................................................................. 248 
8.1.1.1 Duration of incubation of test plates.................................................. 249 
8.1.1.2 Plate-based assay of periodontal pathogens ...................................... 250 
8.1.2 ‘Gel-based assay’ of DNase activity in bacterial broth culture ............... 252 
8.1.2.1 Optimum duration of ‘gel-based assay’ ............................................ 252 
8.1.2.2 DNase standards ................................................................................ 253 
8.1.2.3 Stability of DNase ............................................................................. 256 
8.1.2.4 Gel-based assay of periodontal pathogen DNase activity ................. 257 
8.1.3 Summary of DNase expression by periodontal pathogens by both methods261 
8.2 In vivo DNase activity in gingival inflammation ............................................. 263 
8.2.1 Clinical measure of inflammation ........................................................... 263 
8.2.2 DNase activity within biological samples ............................................... 265 
Discussion ................................................................................................................. 267 
 
CHAPTER 9 CONCLUDING REMARKS .......................................................... 271 
9.1 Mechanism of NET release ............................................................................... 272 
9.2 Microbial interactions with NETs .................................................................... 274 
9.3 NETs in periodontitis ........................................................................................ 277 
 
References................................................................................................................. 281 
 
APPENDIX .............................................................................................................. 299 
 
 9 
List of Figures 
 
Figure                     Page 
1 The periodontium in health and disease 3 
2 Clinical presentation of periodontitis 4 
3 Proportion of teeth affected by different levels of loss of attachment 5 
4 Diagrammatic representation of microbial complexes 8 
5 Transmission electron micrograph of a neutrophil 12 
6 Blood smear stained with the Romanowsky stain 12 
7 Electron micrograph of a neutrophil phagocytosing a bacterium 13 
8 Schematic of the generation of reactive oxygen species 15 
9 Immunostaining of IL-8 stimulated NETs 19 
10 SEM of NETs showing smooth and globular domains 20 
11 Immunofluorescent staining of PMA-stimulated NETs 21 
12 Immunostaining of neutrophils stimulated with TNFα 25 
13 Immunostaining of pneumococci trapped in NETs 27 
14 SEM of NET capturing the yeast C. albicans 27 
15 SEM of parasite L. amazonensis captured in NET 27 
16 Serum inhibits NET formation 38 
17 NETs trapping S. pneumoniae 48 
18 Toluidine blue staining of NETs in purulent crevicular exudate 54 
19 TEM of pocket epithelium 54 
20 Immunofluorescent staining of gingival tissue sections 55 
21 Variation in NET production between donors 56 
22 DNase test plate flooded with TBO 97 
23 Binarised image of Figure 22 98 
24 Fluorometric detection of SYTOX
®
 stained calf thymus DNA 107 
25 Fluorescent time course analysis using a range of cell concentrations 109 
26 Time course fluorescence and visualisation of PMA stimulated NET 
production 
111 
27 MNase assay of NET release from PMA stimulated cells 113 
28 Microscopic images of cells used for assay in Figure 27   114 
29 MNase assay of NET release from F. nucleatum stimulated cells 115 
30 End-point fluorescence and MNase values of various cell 
concentrations 
116 
31 Validity of inferring one assay value from the other based on equation 
of trend line 
117 
32 SYTOX
® 
stained NETs produced in FCS supplemented media 120 
33 Effect of FCS supplementation on MNase detection of NETs 121 
34 SYTOX
®
 stained neutrophils in BSA supplemented RPMI 123 
 10 
Figure  Page 
35 Effect of BSA and FCS on real-time fluorescence 125 
36 Effect of BSA plate blocking and/or FCS supplementation of media 127 
37 Effect of PMA concentrations on NET release. 129 
38 Dose response of opsonised S. aureus on NET release 131 
39 Effect of DPI on ROS production 140 
40 Effect of DPI on MNase assay of NET production 141 
41 Time course analysis of the effect of DPI on cell viability 142 
42 Effect of DPI on cell viability detected by SYTOX
®
 fluorescence and 
MNase assay 
144 
43 Analysis of cytochalasin B on peak ROS production 146 
44 Analysis of cytochalasin B on NET production 147 
45 Effect of DPI and/or cytochalasin B on real-time fluorescence 149 
46 Effect of DPI and/or cytochalasin B on MNase assay 151 
47 Effect of SOD on peak ROS production 153 
48 Effect of SOD on MNase assay of NET production 154 
49 Effect of curcumin on peak ROS production 155 
50 Effect of curcumin on NET release 156 
51 Effect of sodium azide on peak ROS production 158 
52 Effect of sodium azide on NET production 159 
53 Peak ROS production in dHL60 cells 170 
54 RT-PCR analysis HL60 cells compared to primary neutrophils 173 
55 Densitometric profiles of transcript levels in HL60 cells 175 
56 Haematoxylin and eosin staining of HL60 cells 178 
57 Immunocytochemical staining of HL60 cells 179 
58 SYTOX
®
 stained DNA in dHL60 cells 181 
59 Real time fluorescence of dHL60 cells with and without DPI 183 
60 MNase assay of dHL60 cells with and without DPI 184 
61 Peak ROS production by dHL60 cells  186 
62 Time course of ROS production by dHL60 cells 187 
63 Luminol detected ROS production by patient-control pairs 195 
64 Isoluminol detected ROS production by patient-control pairs 196 
65 Lucigenin detected ROS production by patient-control pairs 197 
66 NET release from peripheral neutrophils of patient-control pairs 199 
67 NADPH oxidase-dependant NET release from patient-control pairs 201 
68 Comparison between luminol-dependant ROS and NADPH oxidase-
dependant NET release 
203 
69 SEM of neutrophils stimulated with periodontal pathogens 206 
70 MNase assay of neutrophils in response to periodontal pathogens 208 
71 ROS production in response to periodontal pathogens 210 
72 Correlation between MNase assay and ROS detection 212 
 11 
Figure  Page 
73 PCR amplification of species specific genes in bacterial mixes 222 
74 Gram stains of bacterial cultures 227 
75 Haemolysis by periodontal pathogens 231 
76 Spectrophotometric analysis of bacteria with pen-strep 235 
77 Spectrophotometric analysis of histone 236 
78 Colony count analysis of bacteria exposed to pen-strep 237 
79 Percentage growth of periodontal pathogens with mixed histone 
measured by plating out method 
238 
80 Standard curve of SYTOX
®
 detection of F. nucleatum subsp. 
polymorphum 
239 
81 Fluorometric quantification of the antimicrobial activity against 
periodontal pathogens 
241 
82 Time-course analysis of  DNase test agar plates  250 
83 Zone ratio of DNA hydrolysis on DNase test agar plates 251 
84 Time-course analysis of DNA degradation 253 
85 DNA degradation by bovine pancreatic DNase standards in PBS or 
culture media 
255 
86 Degradation of bovine pancreatic DNase at 37°C 257 
87 Gel based assay of membrane bound DNase activity in periodontal 
pathogens 
259 
88 Gel based assay of secreted DNase activity in periodontal pathogens 260 
89 Clinical measures of inflammation during the 21 day experimental 
model of gingivitis 
264 
90 Gel based assay of DNase activity in biological samples 266 
91 Schematic of relationship that may exist between NET production and 
DNase production 
279 
  
Appendix 
 
92 Gene alignments for design of primers 300 
93 Effect of low PMA concentrations on NET release 304 
94 Time course analysis of the effect of DPI on cell viability 305 
95 Effect of DPI on cell viability detected by SYTOX
®
 fluorescence 306 
96 Kinetics of PMA stimulated ROS production 306 
97 Primer specificity for A. naeslundii and A. viscosus 307 
 12 
List of Tables 
 
Table                                Page 
1 Publications reporting extracellular traps 36 
2 Stimuli used to induce NETs 68 
3 Modulators of NET release 70 
4 Primers and conditions used for gene expression analysis in HL60 
cells 
73 
5 Antibodies and dilutions used for immunocytochemical staining 79 
6 Oral microorganisms used in this study 80 
7 Primers and PCR conditions used for bacterial identification 88 
8 OD values of bacteria 94 
9 Ages of volunteers 193 
10 Bacterial mixes used for PCR analysis 220 
11 Catalase production by periodontal bacteria 232 
12 Summary of bacterial identification tests 233 
13 Summary of detected bacterial DNase expression 262 
 
 
 
 13 
Abbreviations 
 
AFU  arbitrary fluorescent units 
AMP  antimicrobial peptide 
ANCA  antineutrophil cytoplasm autoantibody 
ATCC  American type culture collection 
BSA  bovine serum albumin 
bp  base pairs 
CAL  clinical attachment loss 
cDNA  complementary DNA 
CDT  cytolethal distending toxin 
CEJ  cemento-enamel junction 
CGD  chronic granulomatous disease 
cytoB  cytochalasin B 
dHL60  differentiated HL60 
DMSO  dimethysulphoxide 
DNase  deoxyribonuclease 
DPI  diphenylene iodonium 
FCS  foetal calf serum 
FeLV  feline leukemia virus 
fMLP  N-formyl-methionyl-leucyl-phenylalanine 
GAS  group A streptococci 
GCF  gingival crevicular fluid 
GM-CSF granulocyte-macrophage colony stimulating factor 
GO  glucose oxidase 
HET  heterophil extracellular trap 
HK  high molecular weight kininogen 
HNK  hemin, NAM, vitamin K 
IL  interleukin 
IFN  interferon 
Ig  immunoglobulin 
Ipa  invasion plasmid antigen 
ISG  interferon stimulated genes 
kV  kilovolt 
LOA  loss of attachment 
LPS  lipopolysaccharide 
M  molar 
MCET  mast cell extracellular trap 
MMP  matrix metalloproteinase 
MNase  micrococcal  nuclease 
MOI  multiplicity of infection 
MPO  myeloperoxidase 
mRNA  messenger ribonucleic acid 
NADPH nicotinamide adenine dinucleotide phosphate 
NAM  N-acetylmuramic acid 
NET  neutrophil extracellular trap 
 14 
OD600nm optical density at 600 nanometres 
PAD4  peptidylarginine deiminase 4 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PDL  periodontal ligament 
PFA  paraformaldehyde 
PKC  protein kinase C 
PMA  phorbol 12-myristate 13-acetate 
PMNL  polymorphonuclear leukocyte 
PR3  proteinase 3 
PS  phosphatidylserine 
PTX3  pentraxin 3 
RANKL receptor activator of NFκB ligand 
rcf  relative centrifugal force 
RLU  relative light units 
RNase  ribonuclease 
ROS  reactive oxygen species 
rRNA  ribosomal RNA 
RT-PCR reverse transcriptase polymerase chain reaction 
SD  standard deviation 
SEM  scanning electron microscopy 
SLE  systemic lupus erythamatosis 
SOD  superoxide dismutase 
STBM  syncitiotrophoblast microparticles 
SVV  small vessel vasculitis 
TBO  toluidine blue O 
TIMP  tissue inhibitors of matrix metalloproteinases  
TEM   transmission electron microscopy 
TLR  toll-like receptor 
TNF  tumour necrosis factor 
  
 
 
 
 
 
 
 
 
CHAPTER 1 INTRODUCTION 
 
 2 
1.1 Periodontal diseases 
Periodontitis is an inflammatory lesion mediated by host-bacterial interactions which results 
in a non-resolving inflammation that leads to local connective tissue attachment loss from the 
tooth surface, loss of alveolar bone and ultimately tooth loss (Gaffen et al. 2008).  Indeed, 
periodontal disease is the leading  cause of tooth loss in the western world (Papapanou 1999). 
Over 1200 bacterial phylotypes have been identified within the subgingival biofilm (Paster et 
al. 2009) and they have been classified by cluster analysis into complexes associated with 
varying degrees of health and disease (Socransky et al. 1998).  Outward signs of infection 
occur in periodontitis with the destruction of the supporting structures arising through 
dysregulated inflammatory processes.  Indeed, the bacteria themselves are estimated to 
account only for 20% of disease prevalence (Grossi et al. 1994), the remainder of host tissue 
damage being attributed to the host response.  
 
Pathogenic bacteria within the dental plaque biofilm which colonise the gingival crevice 
initiate an inflammatory response, the initial signal being through a microbial-epithelial 
interaction (Dale 2002; Milward et al. 2007).  When the inflammation is restricted to the 
gingiva the condition is known as gingivitis (Figure 2a).  The disease becomes periodontitis 
when the inflammatory lesion progresses to include the supporting periodontal tissues i.e. the 
periodontal ligament (PDL), alveolar bone and root cementum.  It is the host-bacterial cellular 
and molecular interactions that ultimately results in the destruction of the periodontal tissues 
(Page et al. 1997).  Tissue destruction begins within the gingival connective tissues and leads 
to apical migration of the junctional epithelium, resulting in gingival recession, the formation 
of periodontal pockets, and the exposure of the cementum or root dentine (Figure 1).  The 
 3 
cemento-enamel junction provides a point of reference against which to measure the extent of 
periodontal destruction, the so called ‘clinical attachment level’.   
 
   
Figure 1. The periodontium in a) health and b) disease. Courtesy of M.R. Milward. 
 
Attachment loss continues when the PDL is progressively damaged and since the PDL 
anchors the tooth to the alveolar bone, bone loss follows resulting from host-mediated enzyme 
and oxygen radical release.  In addition to the direct bone destruction by immune cells, the 
osteoclast-osteoblast balance can become modified, favouring osteoclastic bone resorption.  
This can result from increased osteoclastogenesis which is primarily stimulated by receptor 
activator of NFκB ligand (RANKL) expressed on the surface of osteoblasts and from 
activated T lymphocytes.  In addition, cytokine expression such as high interleukin-1 can 
promote osteoclastogenesis (Assuma et al. 1998).  Alternatively, bone formation can be down 
regulated via tumour necrosis factor α (TNFα) expression from macrophages and T 
lymphocytes (Baker 2000).  As bone resorption progresses the tooth becomes mobile within 
its socket and is eventually lost unless treatment is initiated.  Destruction of the alveolar bone 
itself is detectable radiographically (Figure 2b).   
a) b) 
 4 
       
 
Clinically, the severity of periodontitis can be defined by the formation of pockets measurable 
by probing.  A normal probing pocket depth is approximately 0.5-3.0 mm (Chapple et al. 
2002).  Alternatively, clinical attachment loss (CAL) can be measured from the level of the 
cemento-enamel junction (CEJ) to the base of the clinical pocket.  This has the advantage of 
using a fixed reference point (the CEJ), thus eliminating false results caused by gingival 
recession and gingival inflammation or swelling.  CAL measures are the most reliable for 
determining cumulative tissue loss. 
 
1.1.1 The prevalence of periodontitis 
Epidemiological studies have shown that chronic gingivitis is found in the majority of the 
population (Morris et al. 2001).  Indeed, the mouth is inhabited by a multitude of commensal 
microorganisms whose accumulation reportedly initiate gingivitis (Loe et al. 1965).  The most 
recent assessment of the prevalence of periodontal disease in the UK population was provided 
by the 1998 Adult Dental Health Survey (Morris et al. 2001).  This was the fourth decennial 
survey to assess oral health in UK adults and involved the examination 3817 individuals.  
Data demonstrated that 72% of the population surveyed had evidence of visible plaque on 
their teeth and 43% of the population had developed CAL on at least one tooth, which in this 
survey was defined as a loss of attachment (LOA) of 3.5 mm or more.  When analysing each 
Figure 2. Clinical 
presentation of periodontitis 
a) bleeding on probing, 
gingival inflammation and 
gingival   recession, b) x-ray 
showing bone resorption. 
Courtesy of Prof I. Chapple. 
a)                                           b) 
 5 
tooth individually only 10% of those examined showed attachment loss of greater than 
3.5mm.  Figure 3 shows the distribution of attachment loss in those individuals with severe 
attachment loss of 5.5mm and greater.   
 
 
 
1.1.2 Risk factors for periodontitis 
Putative risk factors for periodontitis include genetic predisposition (Michalowicz et al. 
1991), smoking (Baharin et al. 2006), diabetes mellitus (Mealey et al. 2006), poor oral 
hygiene, post menopausal hormonal changes (Baltacioglu et al. 2006) and the more recently 
demonstrated low plasma micro-nutrient levels (Chapple et al. 2007c).  Some may be ‘risk 
indictors’ i.e. share common risk factors so present together, rather than be true risk factors in 
which the risk factor itself increases the chance of developing periodontal disease and its 
removal will trigger disease resolution (Beck et al. 1995). 
 
1.1.3 The progression of periodontitis 
Periodontitis is always preceded by gingivitis (Kinane et al. 2005).  Gingivitis may be seen at 
almost any age and does not always progress to periodontitis with approximately 10% of the 
population appearing to be resistant to periodontitis (Loe et al. 1986).  The early lesion of 
chronic marginal gingivitis develops after 4 days of plaque accumulation and is histologically 
Figure 3. Proportion of 
teeth affected by 
different levels of loss of 
attachment (LOA; 
measured from CEJ) in 
people with some LOA in 
excess of 5.5 mm (Morris 
et al. 2001) 
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detectable after 7 days (Page et al. 1976).  Periodontitis patients may have had gingivitis for 
several years before the disease progressed to periodontitis (Page et al. 1976).  The transition 
may be triggered by impairment of host defences, introduction of a new pathogen into the 
biofilm, or activation of a destructive immune-inflammatory process in susceptible patients 
(Samaranayke 2002).    
 
Periodontitis, like most inflammatory diseases, shows discontinuous progression meaning it is 
subject to episodes of disease progression interspersed with periods of quiescence.  This 
hypothesis was first described as the random burst theory (Socransky et al. 1984).   Chronic 
periodontitis, unlike other forms of periodontitis such as juvenile periodontitis, is not seen 
before early adolescence in patients who are otherwise systemically healthy, but is believed to 
develop from adolescence (Clerehugh et al. 1990; Clerehugh et al. 1995) and increases in 
prevalence with increasing age, to 85% of patients over 65 years of age (Morris et al. 2001).  
 
1.2 The role of bacteria in periodontal disease 
The sub-gingival flora is complex so a single causative pathogen for periodontal disease 
cannot be identified (Socransky et al. 1984).  The theory that a limited number of specific 
species of bacteria trigger periodontal inflammation is known as the ‘specific plaque 
hypothesis’ (Loesche 1976; Slots 1999).  In support of this theory are the findings that in 
‘necrotising ulcerative gingivitis’ the prime causative pathogens are Fusobacteria sp. and 
spirochaetes, and in aggressive periodontitis Aggregatibacter actinomycetemcomitans appears 
to be closely involved (Slots 1999).  The opposing hypothesis, known as the ‘non-specific 
plaque hypothesis’ (Theilade 1986) proposes that a combination of non-specific bacteria are 
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responsible and will be pathogenic when a threshold volume of plaque is reached.  It has been 
reported that the diversity of bacterial species within periodontal pockets is substantial and 
varies between different samples from different patients and also within the same patient.  The 
non-specific plaque theory implies that any plaque will cause periodontal disease.  Current 
thinking however supports the ‘environmental’ or ‘ecological’ plaque hypothesis (Haffajee et 
al. 1991; Marsh et al. 2009).  In this case, Marsh argues that a change in the microbial 
environment can initiate a shift in the balance of bacteria within the plaque biofilm which may 
confer pathogenicity.  However, if the change in the microbial environment results in reduced 
growth of certain commensals, for example S. sanguis, pathogenic bacteria may not 
necessarily benefit because they rely upon mutual support to survive.  This theory has 
potential therapeutic implications i.e. that periodontal disease could be prevented by improved 
oral hygiene measures which aim to create a shift in biofilm composition from a pathogenic to 
a health-associated microflora.  The plaque stimulates an inflammatory response within the 
host tissues, part of which creates an increase in the flow of gingival crevicular fluid (GCF).  
This provides an abundance of host molecules some of which can be metabolised by the Gram 
negative anaerobic bacteria normally present in the plaque biofilm.  The relative number of 
Gram negative anaerobic species increases in the microbial plaque, suppressing the growth of 
other species found in a healthy flora.  The bacteria then express virulence factors to avoid or 
combat the host defence strategy and establish an infection.  As periodontal disease 
progresses and the gingival crevice deepens to become a periodontal pocket, the micro-
environmental conditions become more anaerobic, further aiding the growth of obligate 
anaerobic bacteria.  Whilst numerous studies have investigated the composition of plaque, 
Socransky et al. (1998) employed cluster analysis on large numbers of plaque samples from 
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healthy and diseased sites and defined 5 bacterial complexes ranked by the strength of the 
groups relationship with clinical measures of periodontitis (Figure 4). 
 
P. intermedia
P. nigrescens
P. micros
F. nuc. vincetii
F. nuc. polymorphum
F. nuc. nucleatum
F. periodonticum
P. gingivalis
B. forsythus
T. denticola
V. parvula
A. odontolyticus
Streptococcus sp.
S. gordonii
S. intermedius
S. oralis
S. mitis
S. sanguis
E. corrodens
C. gingivalis
C. sputigena
C. ochracis
C. concicus
A. actino. a
E. nodatum
C. rectus
C. gracilis
S. constellatus
C. showae
A. actino b
S. noxia
A. naeslundii 2
(A. viscosus)
 
Figure 4. Diagrammatic representation of the relationship of species within microbial 
complexes and between microbial complexes.  Coloured groups represent bacteria found 
together in pathogenic plaque and their relationship to the clinical parameters of periodontitis, 
the red complex showing the highest association with disease. (Socransky et al. 1998) 
 
The normal subgingival flora consists of mainly facultative (both aerobic or anaerobic 
capabilities) anaerobic Gram positive bacteria, and only 5% spirochaetes and motile rods.  
Generally speaking, as periodontal disease progresses the proportion of anaerobic, Gram 
negative, spirochaetes and other motile bacteria increases.  In chronic periodontitis 
approximately 75% of cells are Gram negative of which 90% are strict anaerobes 
(Samaranayke 2002).  This shift in microbial composition is represented by a change from 
mainly purple complex bacteria through to a large proportion of red complex bacteria in sites 
of active disease. 
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1.3 The role of the host in periodontal disease 
The destruction of the periodontal tissues that constitutes ‘inflammatory periodontitis’ results 
from the interaction between the host and the pathogenic bacteria.  An inflammatory response 
is mounted within the host tissues at the site of infection primarily consisting of an innate 
immune response and ultimately resulting in the activation of the acquired immune response 
and a subsequent increase in antibodies in the GCF against bacteria found in the gingival 
crevice or periodontal pocket (Tew et al. 1985).  These responses initially have a protective 
function and aid the phagocytosis of pathogens and prevent their spread.  Indeed, the 
importance of neutrophils for the maintenance of periodontal health can be observed in 
patients with cyclic neutropenia in which periodontal inflammation and destruction are 
associated with decreased peripheral neutrophil numbers (Matarasso et al. 2009).  However, 
the host inflammatory response can also lead to a damaging ‘hypersensitivity reaction’.  The 
innate immune system is the first line of defence and consists of cells such as monocytes 
which then differentiate into phagocytic macrophages and antigen presenting dendritic cells 
(Alberts et al. 2002), and also neutrophils which are thought to be the main cause of damage 
to host tissues.  This occurs through the release of reactive oxygen species (ROS) and 
degradative proteolytic agents such as matrix metalloproteinases (MMPs) and serine proteases 
especially neutrophil elastase.  In addition, ROS produced by neutrophils can inactivate 
protease inhibitors such as alpha-1 antitrypsin, a serine proteinase inhibitor (serpin) produced 
to protect the host tissue from the same fate as the microorganism at the hands of serine 
proteinases (Henson et al. 1987).  Indeed, it has been shown in vivo that GCF levels of free 
neutrophil elastase, i.e. not bound by serpins, is increased in periodontitis sites compared to 
gingivitis sites (Figueredo et al. 2005).  Neutrophils are recruited to the periodontal tissues 
from the blood stream in a process requiring margination, tethering and rolling, adhesion and 
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finally transmigration.  This occurs in response to bacterial products themselves such as LPS 
and formyl peptides or by cytokines secreted by other host cells in response to the bacterial 
challenge.  For example monocytes secrete IL-1 which up-regulates endothelial expression of 
adhesion molecules such as ICAM-1 thereby facilitating adhesion of neutrophils via β2 
integrin.  Complement C5a and leukotriene B4 then facilitate the endothelial transmigration 
(diapedesis) by increasing vascular permeability, and cytokines such as IL-8 with a high 
specificity for neutrophils create a chemotactic gradient across the endothelium to direct the 
neutrophils to the site of inflammation.  Although these cytokines are essential for 
homeostasis of the healthy periodontium, in diseased tissue cytokine expression is increased.  
In chronic periodontitis it has been shown that patients have elevated plasma levels of 
interferon-α (IFN-α) compared to healthy controls (Wright et al. 2008).  Elevated levels of 
IFN-α affect neutrophil function, potentially by priming, as microarray analysis of messenger 
RNA (mRNA) derived from hyperactive peripheral blood neutrophils in periodontitis patients 
demonstrated a panel of interferon stimulated genes (ISGs) to be up-regulated relative to those 
from healthy control individuals.  This up-regulation of ISGs was reduced to the levels of 
healthy controls by successful periodontal treatment indicating that the increased plasma IFN-
α levels were associated with the active state of periodontal disease.  The up-regulation of 
ISGs could be reproduced in peripheral neutrophils of healthy controls by priming with IFN-
α, which resulted in enhanced neutrophil ROS production (Wright et al. 2008).  ROS 
production has previously been found to be both hyperactive (i.e. in resting cells) and hyper-
reactive (i.e. in stimulated cells) in the peripheral neutrophils of patients compared to controls 
(Matthews et al. 2007a; Matthews et al. 2007b).  The hyper-reactive neutrophil phenotype 
was also demonstrated in vivo by Figueredo et al. (2005).  The ratio of lactoferrin (released 
normally from neutrophils) to elastase (released only upon activation) was used to assess the 
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activity of neutrophils in vivo in the gingival crevice independently of neutrophil number.  It 
was found that the ratio of elastase:lactoferrin and therefore neutrophil activity was increased 
in GCF samples from periodontal patients compared to those with chronic gingivitis.  This 
was true not only when deep inflamed pockets were sampled from the patients with 
periodontitis, but also when shallow pockets were sampled with a similar level of 
inflammation to the pockets of patients with gingivitis.  It was also found that lactoferrin 
levels, used as a surrogate marker of total neutrophil number, were in fact higher in gingivitis 
patients than in periodontitis patients.  This suggests that although gingival inflammation is 
associated with increased neutrophil recruitment compared to healthy sites, it is the activity of 
those neutrophils that determines whether the inflammation is mild or severe.  To date, 
peripheral neutrophils from periodontitis patients have been found to be hyper-reactive with 
regards to ROS generation primarily in response to Fcγ receptor stimulation (i.e. with 
opsonised S. aureus), and unstimulated neutrophils have also been shown to express higher 
levels of active elastase and IL-1β (an inducer of bone resorption) (Figueredo et al. 2000) and 
produce higher levels of ROS (Matthews et al. 2007a)than peripheral neutrophils from 
healthy individuals. 
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1.4 Neutrophils and disease 
 
                               
 
 
 
 
Neutrophils are also known as polymorphonuclear leukocytes (PMNL) due to their 
multilobed nucleus (Figures 5 and 6).  Their function is to phagocytose and kill 
microorganisms, particularly bacteria.  For this purpose they contain abundant granules 
containing hydrolytic enzymes, proteolytic enzymes and other antimicrobial peptides (AMPs) 
such as defensins, to degrade the internalised microorganism (Borregaard et al. 1997).  
 
Neutrophils, are fundamental cells of the innate immune system.  The innate immune system 
mounts an immediate and low specificity defence against invading microorganisms regardless 
of whether the pathogen has been encountered previously.  The adaptive immune system acts 
later in the infection with a response highly specific to the pathogen (Alberts et al. 2002). 
Figure 5. Transmission electron 
micrograph (TEM) of a neutrophil. The 
single nucleus is multilobed, however in 
this view connections are out of plane 
(Nichols et al. 1971) (Alberts et al. 2002) 
Figure 6. Light micrograph of a blood 
smear stained with the Romanowsky 
stain.  A neutrophil with multilobed 
nucleus is visible along with other 
immune cells (Alberts et al. 2002). 
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1.4.1 Neutrophil activation 
Neutrophils originate from the bone marrow and differentiate from granulocyte/macrophage 
progenitor cells prior to entering the blood circulatory system.  Here, their half life is 
approximately 6.7 hours, and up to 1-2 days when they have infiltrated tissues (Squier et al. 
1995).  The neutrophil targets the pathogen for phagocytosis via a variety of cell-surface 
receptors, such as, pattern recognition receptors e.g. toll-like receptors (TLRs), Fcγ receptors 
for the Fc region of antibodies, and receptors for C3b, an opsonising molecule of the 
complement system (Garcia-Garcia 2005).  Binding of the pathogen to any of these receptors 
triggers the neutrophil to engulf the microorganism (Figure 7) and internalise it within a 
vacuole called a phagosome.  The contents of the neutrophil granules (lysosomes) are then 
released as it fuses with the phagosome to create a phagolysosome (Tapper 1996). 
pseudopod
phagocytic
white blood cell 1m
plasma 
membrane
bacterium
 
 
 
Figure 7. Electron micrograph of a 
neutrophil phagocytosing a 
bacterium that is currently 
undergoing division. (Williams and 
Fudenberg, Phagocytic Mechanisms 
in Health and Disease. New York: 
Intercontinental Book Corporation, 
1971; (Alberts et al. 2002) 
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1.4.2 Neutrophil killing mechanisms - Non-oxidative and oxidative 
The non-oxidative killing mechanisms of neutrophils involve the release of proteases and 
AMPs contained within neutrophil granules.  There are three types of neutrophil granule 
released in the following order (Faurschou et al. 2003),  
- specific (secondary) 
- gelatinase (tertiary)  
- azurophilic (primary)  
The specific and gelatinase granules contain lysozyme, lactoferrin, gelatinase and 
metalloproteases.  Their granule membranes also contain 95% of the cells cytochrome b558 
which makes up the NADPH oxidase (nicotinamide adenine dinucleotide phosphate-oxidase) 
enzyme. The azurophilic granules are so called because they stain with the dye azure A, and 
are the only granules that contain myeloperoxidase (MPO) required to enzymatically convert 
H2O2 (a secondary product of NADPH oxidase, Figure 8) to hypochlorous acid (HOCl).  They 
also contain neutrophil elastase, and AMPs such as defensins.  Defensins are small positively 
charged peptides which make up 15% of a neutrophils protein content (Borregaard et al. 
1997).  The mechanism of their anti-microbial activity is uncertain but the defensin may insert 
into the microbial membrane to disrupt its integrity (Lichtenstein 1991), as well as that of the 
bacteria’s DNA (Gera et al. 1991).   
 
The oxidative killing mechanism employed by neutrophils is via the non-mitochondrial 
generation of ROS through a process known as the respiratory burst.  Assembly of the 
NADPH oxidase responsible for ROS generation requires phosphorylation of the four 
cytosolic subunits (p47-phox, p40-phox, p67-phox and Rac) to enable combination with 
cytochrome b558 (comprised of gp91phox and p22phox) (Figure 8).  Once the NADPH 
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oxidase is assembled in the vacuole membrane, it reduces oxygen to superoxide anions (O2·
-
) 
which form H2O2, either spontaneously or via superoxide dismutase (SOD), and ultimately 
with the help of MPO, form hypochlorous acid.  HOCl chlorinates bacterial targets such as, 
the origin of replication site for DNA synthesis and membrane proteins, to bring about 
bacterial death.     
                    
Figure 8. Schematic of the generation of reactive oxygen species (Robinson 2008) 
 
ROS also have an indirect bactericidal action as they can activate granule proteases.  
Potassium ions (K
+
) enter the phagosome via Ca
2+
 channels to compensate for the charge 
difference created by the transfer, across the vacuole membrane, of electrons when O2·
-
 is 
released into the vacuole via NADPH oxidase (Ahluwalia et al. 2004).  The high K
+
 
concentration within the vacuole activates latent proteases released from the anionic sulphated 
proteoglycan granule matrix (Ahluwalia et al. 2004).  The importance of ROS to the function 
NADPH + O2 
NADP+ + H+ + O2
.-  (superoxide anion) 
SOD (superoxide dismutase) 
NADPH oxidase 
MPO (myeloperoxidase) 
H2O 
+ Cl- 
H2O2 (hydrogen peroxide) + O2 
HOCl  
(hypochlorous acid) 
OH. 
(hydroxyl radical) 
catalase 
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of neutrophils is demonstrated in chronic granulomatosis disease (CGD).  This is a disorder in 
which genetic defects results in dysfunctional NADPH oxidase, and thus a failure to generate 
ROS.  Individuals with this disorder are susceptible to frequent and life-threatening bacterial 
and fungal infections (Dinauer 2005). 
 
ROS can also act extracellularly to cause damage to the surrounding tissues.  One particular 
cell type that ROS acts upon are osteoclasts, with ROS activation culminating in increased 
bone resorption.  Evidence shows ROS are capable of both increasing osteoclast numbers 
(Garrett et al. 1990) and activating osteoclasts (Bax et al. 1992).  In addition, ROS can 
damage various components of the connective tissues as they have been found to degrade 
proteoglycans of alveolar bone and the periodontium (Moseley et al. 1997).  This yields 
glycosaminoglycans which can be further degraded, although the sulphated 
glycosaminoglycans are more resistant to ROS degradation than the unsulphated forms.  Type 
I collagen has also been shown to be susceptible to degradation by ROS  in vitro (Nguyen et 
al. 2005).  ROS can act directly to cause fragmentation and polymerisation or indirectly by 
modifying the collagen and making it more susceptible to proteolysis.  In tissues such as in 
blood vessels, high levels of extracellular superoxide dismutase enzyme is normally present 
which protects the type I collagen from the damaging effects of ROS (Petersen et al. 2004).  
Aside from the obvious destructive effect that collagen degradation will have on the 
connective tissues, it has also been found in vitro to increase neutrophil adhesion and 
chemotaxis (Monboisse et al. 2000).  This process occurs when the collagen is in a glycated 
state, a modification facilitated by the oxidative processes of ROS.  ROS can also disrupt the 
protective function of tissue inhibitors of matrix metalloproteinases (TIMPs) either by directly 
modifying the molecules or indirectly by preventing TIMP expression (Hadjigogos 2003).   
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Neutrophil apoptosis is vital to the resolution of bacterial infection.  The size and duration of 
the neutrophil response must be appropriate to fight the infection but must also be confined 
within the neutrophil membrane in order to limit collateral host tissue damage.  It is important 
that neutrophils undergo apoptosis and not necrosis, which would result in their toxic contents 
being uncontrollably released externally and subsequently causing substantial damage to the 
surrounding tissues.  It is thought that the phagocytic event may alter gene expression to 
trigger apoptosis (Kobayashi et al. 2003).  A further theory is that the respiratory burst acts as 
an apoptosis trigger so the neutrophil undergoes apoptosis shortly following phagocytosis 
(Watson et al. 1996). 
 
1.4.3 Extracellular neutrophil killing mechanisms 
Neutrophil anti-microbial granules can be released into the extracellular space via 
degranulation with the aim of degrading microorganisms within the extracellular 
environment.  This may be a more rapid method of killing, however it is also less discriminate 
and is associated with a higher risk of damage to the host tissues.  Tissue damage is primarily 
caused by serine proteinases such as elastase and cathepsin G (Forsyth et al. 1994).  
Endogenous soluble inhibitors of serine proteinases (serpins), such as alpha-1 antitrypsin and 
alpha1-antichymotrypsin, may constrain the range of action of these enzymes (Forsyth et al. 
1994).  Recently, neutrophils have been seen to release webs of DNA which physically trap 
and immobilise microorganisms, preventing their spread within tissues.  In addition, this 
process may also act to localise neutrophils AMPs, limiting the extent of damage caused to 
otherwise healthy tissue or conversely may serve to concentrate damaging proteases within 
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the locality and increase local tissue damage. These webs are known as neutrophil 
extracellular traps (NETs; (Brinkmann et al. 2004) and are discussed below (1.5).  
 
1.4.4 Microbial mechanisms for evading killing by neutrophils 
Neutrophils are a primary line of defence against infection enabling time for an adaptive 
immune response to be mounted.  Without them, as in conditions of neutropenia such as those 
induced by chemotherapy, an individual is left immuno-compromised.  However, infections 
can become established even when the innate immune system is functioning correctly.  This is 
because the more virulent bacteria possess strategies for, amongst other things, evading host 
defences.  The strategies for evading neutrophil killing include, 
 i) Launching a general survival response such as in group A streptococci (GAS) 
 (Voyich et al. 2003). 
 ii) Avoiding contact by secretion of chemotaxis inhibitory protein (S. aureus; de Haas 
 et al. 2004).  
 ii) Preventing phagocytosis by secretion of actin polymerisation inhibitors (Yersinia 
 enterocolitica) (Grosdent et al. 2002).  
 iv) Release of exotoxins e.g. leukotoxin from A. actinomycetemcomitans (Baehni et al. 
 1979). 
 v) Surviving intracellularly e.g. P. gingivalis within oral epithelial cells (Lamont et al. 
 1995). 
 vi) Inducing cell death such as GAS which produce streptolysin O (Sierig et al. 2003). 
 vii) Avoiding killing by NETs such as deoxyribonuclease (DNase) expression by 
 Streptococcus pyogenes (Buchanan et al. 2006). 
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1.5 Neutrophil extracellular traps (NETs) 
Neutrophil extracellular traps are strand-like webs of decondensed chromatin, which also 
contain granule proteins (Brinkmann et al. 2004).  The granule proteins present are derived 
from all three types of neutrophil granule.  Azurophilic granule proteins such as neutrophil 
elastase (Figure 9 A), cathepsin G and MPO; specific granule proteins e.g. lactoferrin; and 
tertiary granule proteins e.g. gelatinase.  In addition, LL37, a cleaved form of the granule 
protein cathelicidin has been identified in NETs (in vitro and in vivo) (Kessenbrock et al. 
2009), as has the innate immune receptor pentraxin 3 (PTX3) found to originate from specific 
granules (Jaillon et al. 2007).  The DNA component of NETs has been shown to be more vital 
to NET structure than the protein component.  When treated with DNase NETs are degraded, 
but when treated with proteases, NETs remains intact (Brinkmann et al. 2004).  The exception 
to this is the parasite L. amazonensis which was still killed although at a reduced level, by 
NETs after digestion with DNase (Guimaraes-Costa et al. 2009).  This finding however, 
appears to be exclusive to the killing of parasites. 
 
 
 
 
Figure 9. Immunostaining of neutrophils stimulated with IL-8 to produce NETs. A 
neutrophil elastase, B DNA, C histone (H2A-H2B)-DNA complex. (Brinkmann et al. 
2004) 
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The structure of NETs can be observed by high resolution scanning electron microscopy 
(SEM) and this approach demonstrates that they consist of relatively smooth regions of 15-  
17 nm diameter with globular domains of approximately 25-50 nm diameter (Brinkmann et 
al. 2004; Figure 10).  Ermert et al. (2009) claimed to have observed that murine and human 
NETs differ in their structure, observing that the globular domains of murine NETs were 
tightly packed and covered the entire surface.  However, the cells used were bone marrow 
derived mature neutrophils, not peripheral neutrophils as employed in human studies. 
 
          
 
Research indicates that NETs are formed by controlled extrusion, rather than random spilling 
of granule and nuclear contents during necrosis or apoptosis, but NET release does precede 
apoptosis.  Preliminary evidence for this is that NETs form in as little as 10 minutes after 
cellular activation, a process more rapid than apoptosis (Brinkmann et al. 2004).  
Furthermore, NET production was not accompanied by the release of the cytoplasmic marker 
lactate dehydrogenase and vital dyes did not enter the cell for at least 2 hours post stimulation, 
indicating that necrosis is not involved as the cell membrane remained intact (Brinkmann et 
al. 2004).  Other findings contrary to apoptotic or necrotic theories of NET release are that IL-
8 and lipopolysaccharide (LPS), which prolong the life of neutrophils (Sabroe et al. 2003), 
also induce NET formation.  Furthermore, cells have been observed to retain motility during 
Figure 10. High resolution SEM 
of NETs showing smooth 
(arrow heads) and globular 
(arrows) domains. Bar represents 
500µm (Brinkmann et al. 2004). 
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NET release, and DNA intercalating dyes. which prevent the formation of NETs, do not affect 
the induction of apoptosis (Brinkmann 2004).  In 2007 Fuchs et al. used live cell imaging to 
follow the production of NETs whilst simultaneously monitoring cell viability.  They 
observed that upon stimulation with phorbol 12-myristate 13-acetate (PMA) neutrophils 
flattened (Figure 11b) and their nuclei lost their characteristic lobular morphology, and filled 
the majority of the intracellular cytoplasmic space.  During this time the chromatin began to 
decondense so the distinction between euchromatin and heterochromatin was lost.  The space 
between the inner and outer nuclear membrane increased to eventually form distinct vesicles.  
Neutrophil granule membranes were lost which allowed the release of granule proteins, 
specifically neutrophil elastase, which then co-localised with chromatin (Figure 11c).  A 
single report by Vitkov et al. (2009) contradicts this data by claiming that in vivo neutrophil 
activation lacked this co-localisation step previously observed in vitro. 
 
 
 
 
After mixing of the nuclear and granule contents, cells began to lose the vital dye calcein 
blue, indicating loss of membrane integrity and subsequent loss of cytoplasm.  At the same 
time, NETs are first visualised and the cells became Annexin V-positive by binding to 
phosphatidylserine (PS) on the inner leaflet of the cell membrane.  As the cells became 
Figure 11. Neutrophils stimulated with PMA and immunofluorescently stained 
for neutrophil elastase (green), chromatin (red). (a) 0 minutes stimulation – naïve 
cells have lobulated nucleus (b) 60 minutes - cells have flattened and neutrophil 
elastase granules are individually visible (c) 120 minutes - granules disintegrated so 
neutrophil elastase and chromatin are colocalised (yellow) (d) 180 minutes – NETs 
start to form (Fuchs et al. 2007). 
a) b) c) d) 
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Annexin V-positive and lost vital dye simultaneously, this indicates a rupture of the 
neutrophil cell membrane.  Notably, if the cells had been apoptotic they would have become 
Annexin V-positive prior to calcein release.  Fuchs et al. (2007) concluded that NETs were 
formed during a novel cell death programme that was proven distinct from apoptosis and 
necrosis.  The differences from necrosis were observed visually in that the stimuli used to 
induce necrosis (secreted pore-forming toxins from S. aureus) did not result in extracellular 
DNA release and, although similar in the loss of nuclear lobules and loss of differentiation 
between eu- and hetero-chromatin, the nuclear and granule membranes remained intact only 
during necrosis.  It has previously been shown that PMA can exert a cytotoxic effect on 
neutrophils that is distinct from apoptosis and dependant on ROS (Takei et al. 1996) so recent 
advances in the understanding of NETs may provide an explanation (1.5.1).   
 
1.5.1 Dependence on ROS 
A further conclusion from the work of Fuchs et al. (2007) was that NET production is 
dependant on ROS production via the NADPH oxidase.  It is known that the neutrophils from 
patients with CGD are unable to generate ROS due to a deficiency in the NADPH oxidase 
enzyme responsible for its production.  Notably, neutrophils from these patients were also 
found to be incapable of producing NETs.  However, the ability to produce NETs could be 
induced in the neutrophils of CGD patients by the addition of glucose oxidase (GO), as this 
enzyme can substitute for the dysfunctional NADPH oxidase to generate hydrogen peroxide.  
GO was also used with neutrophils from healthy subjects and was shown to significantly 
increase NET production and restore NET production following application of the NADPH 
oxidase inhibitor, diphenylene iodonium (DPI).  In further investigations catalase was used to 
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remove H2O2 from the system and a reduction in NETs was observed.  Conversely the 
introduction of 3-amino-1,2,4-triazole (AT) to inhibit endogenous catalase activity caused an 
increase in NET production.  This work demonstrated that NET production was not just 
dependant on ROS production but specifically H2O2,  which has since been used directly as a 
stimulus to induce NET release (Neeli et al. 2009).  The use of DPI has also since been used 
by multiple research groups as a negative control for NET release (von Kockritz-Blickwede et 
al. 2008; Yousefi et al. 2008; Behrendt et al. 2010).  Significantly, a study utilising 
neutrophils derived from patients with x-linked gp91
phox
-deficient CGD was able to 
demonstrate that using gene therapy, replacement of the absent gp91
phox
 subunit could restore 
the capacity for NET production (Bianchi et al. 2009).  After 6 weeks the percentage of 
neutrophils expressing gp91
phox
 had reached 26-29% and the yeast infections patients had 
been suffering from, caused by Aspergillus nidulans conidia, were resolved.  This correlated 
with the ability of patient neutrophils to produce NETs when challenged with A. nidulans and 
PMA which were subsequently effective in inhibiting growth of conidia and its hyphae.  This 
effect was abrogated when micrococcal nuclease (MNase) was introduced indicating that the 
fungicidal activity was due to NET-DNA release and not due to another killing mechanism 
such as phagocytosis.  In studies utilising murine NETs, a gp91 knockout mouse (gp91-/-) 
was used as a model of CGD (Ermert et al. 2009).  Upon stimulation with 100nM PMA the 
bone marrow derived mature neutrophils from these mice were incapable of producing ROS 
or NETs, although the cells exhibited a flattened appearance, as observed in the early stages 
of NET production.  In fact, PMA stimulation promoted cell survival over the 16 hour 
observation period in this knock-out strain. 
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Although these data demonstrate that the generation of ROS is involved in the process 
culminating in NET release, the precise signalling mechanisms linking the two processes are 
unclear.  For example in the case of bovine mastitis it was found that although the proteins in 
the milk inhibited the respiratory burst in neutrophils (Mehrzad et al. 2001), NET production 
could still occur (Lippolis et al. 2006).  These data indicate that there is either i) an alternative 
pathway not requiring ROS capable of regulating NET production, or, ii) that the step of the 
ROS generation pathway that is inhibited by milk proteins is downstream of the point at 
which the ROS pathway and NET pathway cease to be common.  Moreover, research by Yost 
et al. (2009) analysing the immune function in human neonates found that although their 
neutrophils were capable of ROS production, they were unable to form NETs.  They 
concluded that although ROS was required, it was not alone sufficient for NET production 
indicating a dis-connect in the subsequent downstream signalling events.   
 
Later studies by Wang et al. (2009) and Neeli et al. (2008) have shown NET release to be 
dependant upon histone citrullination by PAD4 (peptidylarginine deiminase 4).  This enzyme, 
present in neutrophils and other cell types, converts arginine and methylarginine residues on 
histones to citrulline, enabling decondensation of the chromatin and subsequent extrusion in 
the form of NETs.  This process was shown to be essential for NET release in calcium 
ionophore (CI) stimulated neutrophil-like HL60 cells, as pre-treatment with Cl-amidine, a 
PAD4 inhibitor, eradicated all NET production (Wang et al. 2009).  NETs released from 
human neutrophils in response to TNFα were also shown to be composed of highly 
decondensed chromatin containing citrullinated histones (Figure 12).  
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Recent investigations have examined the role of actin and microtubules in NET release (Neeli 
et al. 2009).  Pre-treatment with the tubulin polymerisation inhibitor nocodazole resulted in a 
reduction in LPS stimulated NET release from 30% to 5%.  Pre-treatment with the actin 
polymerisation inhibitor cytochalasin D did not inhibit the disintegration and mixing of the 
nuclear and granule compartments but only 9% of cells extruded NETs.  Notably some of the 
remaining cells swelled to twice their normal diameter, indicating that actin may be necessary 
for NET extrusion.  As integrins are receptors responsible for transmitting extracellular 
signals to the cytoskeleton, the Mac-1 integrin was also inhibited using a monoclonal 
antibody.  Data indicated that this inhibition resulted in a significant decrease in NET 
production and a 51% reduction in histone citrullination (Neeli et al. 2009).   
 
Viral infection may also be capable of modifying the NET response in neutrophils.  Feline 
leukemia virus (FeLV) is naturally occurring in cats and can cause modulation of immune 
cells including neutrophil responses and give rise to opportunistic infections.  Work by 
Wardini et al. (2010) found that neutrophils from symptomatic FeLV infected cats had a 
higher unstimulated level of NET production compared to asymptomatic infected or 
uninfected cats.  However, these neutrophils were unable to increase NET production in 
Figure 12. Immunostaining 
of neutrophils stimulated 
with TNFα. DNA (blue), 
citrullinated histone H4 
(pink). Bar represents 20µm. 
(Wang et al. 2009) 
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response to protozoal or PMA stimulation, suggesting an exacerbated NET response in FeLV 
infected neutrophils. 
 
1.5.2 The function of NETs 
NET formation has so far been observed in humans (Brinkmann et al. 2004; Gupta et al. 
2005; Jaillon et al. 2007), mice (Beiter et al. 2006; Buchanan et al. 2006; Wartha et al. 2007), 
rabbits (Brinkmann et al. 2004), horses (Alghamdi et al. 2005), cows (Lippolis et al. 2006); 
(Behrendt et al. 2010), fish (Palic et al. 2007), chickens (Chuammitri et al. 2009), chinchillas 
(Hong et al. 2009; Reid et al. 2009) and cats (Wardini et al. 2010).  NETs function to 
immobilise microorganisms (Gram negative, Gram positive bacteria, yeast and parasites, see 
Figures 13, 14 and 15), to augment the bactericidal action of neutrophils, and to prevent the 
spread of infection.  Even the intracellular bacterium Mycobacterium tuberculosis has been 
shown to be trapped in NETs although not killed (Ramos-Kichik et al. 2009).  NET formation 
is also reportedly induced by parasites, including Leishmania amazonensis and enhanced by 
the addition of PMA (Guimaraes-Costa et al. 2009).  In this study NET killing of L. 
amazonensis was largely attributed to the histone component of the NET complex as in this 
case DNase treatment of the NETs did not inhibit killing of the parasite.  NET formation 
induced in bovine neutrophils by live Eimeria bovis sporozoites was increased compared to 
PMA-induced NETs, however, dead and homogenised E. bovis sporozoites were less efficient 
at inducing NETs than the live form or PMA (Behrendt et al. 2010).  These NETs were 
thought to act primarily by immobilising the sporozoites as subsequent in vitro incubation 
with host epithelial cells resulted in a reduction in infection rate from 43.9% to 15.5%.  
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DNase treatment allowed a similar infection rate of host epithelial cells as if the parasites had 
not previously been exposed to NETs.   
 
             
    
 
 
 
 
 
Figure 15. SEM of parasite L. 
amazonensis (P) captured in NET 
(Guimaraes-Costa et al. 2009) arrow 
indicates neutrophil granules. 
Figure 13. Immunostaining of 
pneumococci (FITC-labelled, green) 
trapped in NETs (neutrophil elastase 
stained red) produced by neutrophils 
(DNA stained blue) (Beiter et al. 2006). 
Figure 14. SEM of NET 
capturing the yeast C. albicans 
(Volker Brinkmann) (Urban et al. 
2006a). 
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1.5.2.1 Aiding other immune processes 
The primary function of neutrophils is phagocytosis, for which they are highly specialised 
with their characteristic lobulated nuclei which enables flexible movement.  Although a 
parasite is physically too large to be phagocytosed, and the primary cells responsible for 
combating parasitic infection are eosinophils, it appears that neutrophils can also aid the 
attack and destruction of a parasitic infection by NET release, a strategy also displayed by 
eosinophils themselves (Yousefi et al. 2008).   
 
There is evidence that the AMPs associated with NETs cause local tissue damage (Clark et al. 
2007).  However, NETs may function to limit the diffusion of the degradative agents released 
from neutrophils to the site of infection, thus limiting the extent of tissue damage to otherwise 
healthy tissue.  Research by Lippolis et al. (2006) on bovine mastitis, in which phagocytosis 
and the respiratory burst are hindered by milk fat and proteins, has suggested that NETs can 
be formed as an alternative to phagocytosis.  Although these two antimicrobial mechanisms 
were inhibited, the neutrophils were still able to produce NETs even following 6 hours 
incubation with milk.  Fuchs et al. (2007) also demonstrated that in the absence of PMA and 
therefore NETs, S. aureus was killed exclusively by phagocytosis (DNase independent 
killing).  However, as the cells were pre-incubated with PMA for increasing amounts of time 
the capacity for phagocytosis was almost completely lost by 3 hours and the killing of S. 
aureus by NETs (DNase sensitive killing) increased.  This also suggests that phagocytosis is 
the preferred method of bacterial killing by neutrophils but that NETs can take over as a 
secondary killing approach.  However, the mechanisms that decide which killing processes 
are employed by a neutrophil are as yet unclear.  In another study regarding the pathogenesis 
of bovine mastitis by Grinberg et al. (2008) β-hydroxybutyrate was found to inhibit neutrophil 
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responses to the mammary pathogenic E. coli strain P4.  β-hydroxybutyrate, a ketoacid, is 
known to be elevated in the blood and milk of cows with ketosis, a state also seen in diabetics, 
and associated with immune impairment and susceptibility to infection.  Purified β-
hydroxybutyrate caused not only a reduction in phagocytosis of E. coli (90% down to 20%) 
but also a reduction in the number of cells releasing NETs (29% down to 3.5%), whilst 
intracellular killing was unaffected.  There is a possibility that this effect is linked to ROS 
release as β-hydroxybutyrate has previously been found to inhibit ROS production by 
neutrophils (Hoeben et al. 1997). 
 
It has been suggested by Oehmcke et al. (2009) that the DNA strands of NETs may provide a 
base for the adherence and subsequent activation of the human contact system.  This is a 
humoral innate immune response consisting of 3 serine proteases and 1 high molecular weight 
kininogen (HK) which, as the name suggests, needs to contact a surface for activation.  This 
activation results in the release of AMPs, release of the pro-inflammatory mediator bradykinin 
and coagulation factors.  It was demonstrated that when plasma was incubated with NET-
stimulated neutrophils, one of the serine proteases (Factor XII) and HK were able to bind to 
NETs and subsequently activate the contact system measured by the activity of another of the 
serine proteases (plasma kallikrein).  This activation of the contact system was abrogated by 
the addition of DNase and absent in unstimulated neutrophils.  It is suggested that in this way 
NETs may act to further amplify the innate immune response in vivo. 
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1.5.2.2 Extracellular antimicrobial activity 
Even if not completely killed, pathogens can also be disarmed within NETs.  Using Shigella 
flexneri (Gram negative bacteria) the virulence factor IpaB (invasion plasmid antigen) has 
been shown to be degraded by neutrophil elastase extracellularly within NETs (Brinkmann et 
al. 2004) as opposed to intracellularly post-phagocytosis.  Neutrophil elastase (a neutrophil 
granule protein associated with NETs) is a major protein required for the disarming of the Ipa 
virulence factors, which enable bacteria to escape from the phagosome (Weinrauch et al. 
2002).  This is the first example of a neutrophil enzyme specifically targeting bacterial 
virulence factors, in this case acting on Ipa, at a 1000-fold lower concentration than that 
needed to degrade other bacterial proteins (Weinrauch et al. 2002).  The amount of α-toxin, a 
virulence factor of Staphylococcus aureus (Gram positive), was also reduced in NETs 
compared to free bacteria, due to the action of another neutrophil protease (Brinkmann et al. 
2004).  This is evidence that NETs may act as an adjuvant to degranulation, to facilitate the 
extracellular degradation of bacterial virulence factors by a range of neutrophil antimicrobial 
agents, prior to neutrophil engulfment of the microorganism.   
 
Histones H2A and H2B are major components of NETs (Figure 9C) contributing 
approximately 69% of the protein content of NETs (Urban et al. 2009) and exert an 
antibacterial effect presumed to be due to the highly basic residues disrupting the plasma 
membranes of pathogens.  Investigations into the antimicrobial properties of histones has a 
history dating back to 1942 (Miller et al.) although the most commonly cited research is by 
Hirsch et al. (1958) who concluded that histones, rather than just inhibiting bacterial growth 
as previously thought, did indeed have a bactericidal effect similar to protamines.  To date the 
majority of research on histone bioactivity has focussed upon their role in fish immunity.  The 
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isolation of potent AMPs from fish mucosa and gut lumen identified a range of histones and 
histone fragments as having potent activity.  The majority of antimicrobial histones have been 
identified as the linker histone H1, and its related peptides.  However, an AMP, Buforin I 
(isolated from the stomach of an Asian toad), was identified as the first 39 amino acids of 
histone H2A (Park et al. 1996), and Parasin I, an antimicrobial found in catfish was 
determined to represent the first 19 amino acids of histone H2A (Park et al. 1998b).  In 
addition, Hipposin, an antimicrobial found in the Atlantic halibut was identified as the first 50 
residues of H2A (Birkemo et al. 2003).  Histone H2B related anti-microbial peptides have 
been found in trout and bass (Noga et al. 2001) and shrimp hemocytes (Patat et al. 2004).  
Bacteria particularly susceptible to histones are Escherichia sp., Salmonella sp., Pseudomonas 
sp., Micrococcus pyogenes and Shigella sp. (Hirsch 1958).  H2A alone (a subunit of the 
histone complex) was found to destroy Shigella flexneri, Salmonella typhimurium and 
Staphylococcus aureus at concentrations lower than required for other antimicrobial agents 
(Brinkmann et al. 2004).  However, the bactericidal effect of the histone is antagonised by 
acid polysaccharides, including nucleic acids and bacterial lipopolysaccharides (Hirsch 1958).  
Whilst this is not consistent with the antimicrobial action for the histones within NETs, it is 
however hyopthesised that as well as providing a scaffold for the folding and structure of 
NETs, histones may still contribute to the NETs antibacterial effects along with its other 
AMPs such as neutrophil elastase.   It has previously been shown that NETs are destroyed by 
treatment with DNase allowing the pathogen to escape killing, however, treatment of NETs 
with protease did not hinder their function (Brinkmann et al. 2004).  If the AMPs coating the 
NET were removed this would create a greater necessity for histones to contribute as the 
antibacterial agents to maintain NET function.  It has been shown that in intact NETs formed 
in response to L. amazonensis, histones play an active part in NET-mediated parasitic killing 
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as demonstrated by the addition of an anti-histone antibody to neutralise the histones, which 
resulted in a 42% increase in parasite survival (Guimaraes-Costa et al. 2009).  This was 
confirmed by the treatment of L. amazonensis with purified histone H2A (20µg/ml) which 
caused 62% of promastigotes cell death.  However, in this case the neutrophil elastase 
inhibitor, methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone, had no effect on the killing 
efficacy of the NETs implying neutrophil elastase was not active in this process.  It is possible 
that the AMPs found in NETs are microbial specific, with specific AMPs being important for 
killing specific pathogens. 
 
1.5.2.3 NETs in non-infectious diseases 
NETs have also been found to play a role in non-infectious disease such as pre-eclampsia 
(Gupta et al. 2005).  Pre-eclampsia is characterised by hypertension in pregnancy due to an 
immune reaction triggered by the placenta.  It is also thought that circulating peptides released 
from the placenta such as syncitiotrophoblast microparticles (STBM) may contribute to 
triggering the generalised maternal immune response.  Gupta et al. subsequently found that a 
significant number of NETs were present within the intervillous space of pre-eclamptic 
placentae and that NET release was stimulated by, and subsequently trapped STBM.  This is 
particularly notable as STBM are significantly smaller (<200nm) than the bacteria (>2µm) 
that NETs have previously been reported to trap. 
 
Small vessel vasculitis (SVV) is an example of an auto-inflammatory condition in which 
NETs have been found to contribute.  Anti-neutrophil cytoplasm autoantibodies (ANCAs) are 
antibodies directed against neutrophil granule proteins such as proteinase-3 (PR3) and MPO, 
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and are known to be implicated in the pathogenesis of SVV.  It was shown by Kessenbrock et 
al. (2009) that ANCAs could stimulate NET release in vitro from 23% of TNFα primed 
neutrophils.  In addition to ANCAs purified from patient blood, a mouse monoclonal antibody 
against proteinase-3 was able to elicit NET release from ~17% of TNFα primed neutrophils.  
These data also support the link between NET and ROS generation, as binding of ANCA to 
PR3 and MPO on the neutrophil surface has already been found to activate the respiratory 
burst (Falk et al. 1990).  Analysis of NETs both in vitro and in vivo (kidney biopsies) found 
them to contain the autoantigens MPO and PR3 and that they were still available for 
autoantibody (ANCA) binding.  The implication for this is that the NETs could act to ‘mop 
up’ ANCAs by binding them within extracellular traps, or conversely, that the exposure of the 
autoantigens could stimulate further production of ANCAs.  Prior to the discovery of NETs it 
had been found that circulating levels of nucleosomes were raised in a range of autoimmune 
disorders including ANCA-associated vasculitis and also systemic lupus erythmatosus 
(Holdenrieder et al. 2006).  In the light of NETs being associated with SVV, antibodies were 
used to detect serum levels of DNA-MPO complexes i.e. presumed NET fragments.  This 
confirmed a significant increase in circulating DNA-MPO fragments compared to the sera of 
healthy individuals or SVV patients who were in remission. 
 
The level of circulating free DNA has potential use as a therapeutic marker of neutrophil 
activity and levels have been used for this purpose in septic arthritis (Lögters et al. 2009).  
Double stranded DNA was quantified in samples of joint synovial fluid using a fluorescent 
dye, and the likelihood of this DNA originating from NETs rather than general cell death was 
confirmed using an MPO specific antibody.  Results demonstrated a significant increase in the 
levels found in samples from those with septic arthritis compared to non-septic inflammation.  
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A pilot study involving 37 trauma patients also evaluated the levels of circulating free DNA 
in plasma over 10 days and found a correlation with the likelihood of the patients developing 
sepsis, multiple organ failure and death (Margraf et al. 2008). 
 
Apoptosis is a strictly controlled and regulated response which aims to ensure that no cell 
contents are released into the extracellular space.  NETosis on the other hand actually aims to 
release cell contents although this too must be highly regulated and only specific cell contents 
are released.  Molecules normally found intracellularly can have diverse functions on 
neighbouring cells extracellularly.  For example, it has been shown that in the case of 
TNFα/ANCA-stimulated NETs and PMA-stimulated NETs, that the antimicrobial peptide 
LL37 is present.  This peptide is known to convert self-DNA to an active form capable of 
stimulating plasmacytoid dendritic cells to release IFN-α (Lande et al. 2007), the effects of 
which were seen locally at the site of NET accumulation in vivo in kidney biopsies, and, in 
addition were shown to significantly increase serum levels of IFN-α in SVV patients 
(Kessenbrock et al. 2009).  Another example of the potentially more widespread 
consequences of NET release is that extracellular double stranded DNA can stimulate the 
maturation of antigen presenting cells such as bone marrow dendritic cells by up-regulating 
expression of major histocompatability complex class II (MHC II), CD40 and CD54 (Ishii et 
al. 2001).  This suggests that the release of NETs may have an effect on the adaptive immune 
response.   
 
Recently it has been hypothesised (Lee et al. 2004) that excessive NET production is counter-
productive and can contribute to pathological conditions.  Evidence for this is provided by 
examining DNase treatments used in mucolytic therapy for cystic fibrosis.  Cystic fibrosis is 
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characterised by excess mucous containing DNA and elastase in the airways, this milieu 
therefore exhibits a similar composition to NETs.  In a clinical trial examining the daily 
administration of aerosolised recombinant human DNase, a reduction in symptoms was 
observed (Fuchs et al. 1994).  It is thought that the webs formed by NETs impair the ciliary 
clearance of mucous from the airways, and treatment with DNase reduced the viscocity of the 
mucous enabling its removal. 
 
The full range of species, tissues, pathologies and physiologies in which extracellular traps 
have been reported to date is presented in Table 1 below. 
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Table 1. Publications reporting extracellular traps, in chronological order. 
Location/Pathology/Physiology Species Reference 
Experimental dysentery (Shigella) 
Spontaneous human appendicitis 
rabbit, human (Brinkmann et al. 2004) 
Pre-eclampsia human (Gupta et al. 2005) 
Insemination (reproductive tract) equine (in vitro) (Alghamdi et al. 2005) 
Necrotising fasciitis (group A 
streptococci) 
murine (Buchanan et al. 2006) 
Mastitis bovine (Lippolis et al. 2006) 
Blood sepsis human (in vitro) (Clark et al. 2007) 
Kidney zebra fish (Palic et al. 2007) 
Malaria (Plasmodium falciparum) human (Baker et al. 2008) 
Tuberculosis (Mycobacterium 
tuberculosis) 
human (Ramos-Kichik et al. 
2009) 
Septic arthritis (synovial fluid) human (in vivo) (Lögters et al. 2009) 
Leishmania (parasite: Leishmania 
amazonensis) 
human (in vivo and in 
vitro) 
(Guimaraes-Costa et al. 
2009) 
Small vessel vasculitis human (in vivo kidney 
and in vitro) 
(Kessenbrock et al. 2009) 
Periodontitis human (in vivo) (Vitkov et al. 2009) 
Aspergillosis (fungi: Aspergillus 
nidulans conidia)  
human (in vitro) (Bianchi et al. 2009) 
Otitis media (Streptococci 
pneumoniae) 
chinchilla (in vivo) (Reid et al. 2009) 
Otitis media (Haemophilus 
influenza) 
chinchilla (in vivo) (Hong et al. 2009) 
Feline leukaemia virus (L. 
amazonensis) 
feline (in vitro) (Wardini et al. 2010) 
Eimeria bovis parasitosis (E. 
bovis sporozoites) 
bovine (in vitro) (Behrendt et al. 2010) 
Non-neutrophil extracellular traps,  
Mast cells (MCETs; 
Streptococcus pyogenes) 
human (in vitro), murine 
(in vivo) 
(von Kockritz-Blickwede 
et al. 2008) 
Eosinophils (murine cecum) human (in vitro), murine 
(in vivo) 
(Yousefi et al. 2008) 
Heterophils (HETs) chicken (in vitro) (Chuammitri et al. 2009) 
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1.5.3 Stimuli for NET production 
The point at which NETs are released from neutrophils is critical because by their very nature, 
being ‘traps’, they will impede other functions of the neutrophil e.g. migration to the 
pathogen, recruitment of other white blood cells and to a certain extent phagocytosis.  The 
individual neutrophil also dies at the point of NET release so will not be capable of further 
functions itself.  Currently recognised stimuli for NET release are cytokines (Brinkmann et al. 
2004), bacteria (Fuchs et al. 2007), bacterial endotoxins (Brinkmann et al. 2004), parasites 
(Guimaraes-Costa et al. 2009) and yeast (Urban et al. 2006b).  It has been reported that 
approximately one third of PMA-activated neutrophils isolated from human venous blood 
make NETs in vitro (Fuchs et al. 2007).  Brinkmann et al. (2004) exposed neutrophils to the 
cytokine IL-8 for 30-60 minutes, as well as PMA and LPS.  IL-8 is produced by 
macrophages, endothelial and epithelial cells to induce neutrophil chemotaxis, whilst LPS is a 
component of the outer membrane of Gram negative bacteria and acts at TLR4.  PMA is 
known to be a potent activator of neutrophils and its receptor is the intracellular calcium 
dependant signal transduction enzyme, protein kinase C (PKC).  It has been noted that whole 
bacteria induce NETs more efficiently than IL-8 or LPS alone, suggesting that activation of 
multiple receptors is required for optimal NET stimulation (Fuchs et al. 2007).  Guimaraes-
Costa et al. (2009) found that the parasite L. amazonensis was capable of stimulating NET 
release but pre-treatment of the neutrophils with PMA resulted in a 53% increase  in 
promastigote killing.  The purified promastigote membrane component lipophosphoglycan 
(LPG) was also able to elicit NET release but to a lesser extent than the whole organism.  In 
addition, dead sporozoites of the bovine parasite Eimeria bovis were able to elicit NET release 
upon direct contact with neutrophils but the cellular reaction was significantly stronger with 
live sporozoites (Behrendt et al. 2010).   Yeast such as Candida albicans (Urban et al. 2006b) 
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and Aspergillus nidulans (Bianchi et al. 2009) are known to induce NETs although in the case 
of A. nudulans this effect was shown to be greatly increased by the addition of PMA.  It has 
also been shown that in mouse bone marrow-derived neutrophils challenged with C. albicans, 
the hyphal form is more effective at inducing NET release than the yeast form (Ermert et al. 
2009).  In some cases cytokine priming has been necessary before NET release is elicited.  
Yousefi et al. (2009) primed mature peripheral neutrophils with granulocyte-macrophage 
colony stimulating factor  (GM-CSF) for 20 minutes, before stimulation with LPS or 
complement C5a which then caused dramatic NET release within 15 minutes in ~80% of the 
cell population.  In studies by Fuchs et al. (2007), although it was acknowledged that 
microorganisms themselves were capable of stimulating NET release, PMA and glucose 
oxidase (GO) were also used to pre-activate the neutrophils before stimulation by S. aureus.  
Glucose oxidase is an exogenous enzyme which promotes H2O2 synthesis within the cells in 
addition to the endogenous NADPH oxidase.  Notably, high concentrations of serum in the 
culture medium was shown to inhibit NET formation, although the mechanism of this 
inhibition is currently unknown (Figure 16). 
  
Figure 16. Serum inhibits NET 
formation. Neutrophils were 
activated with 10 nM PMA for 
240 minutes in the presence of 
indicated concentration of foetal 
calf serum (FCS), and NET-DNA 
was quantified. The inhibitory 
effect increased in a dose-
dependent manner. At 20% FCS, 
NET formation is almost 
completely suppressed. The data 
shown is a representative 
triplicate experiment and is 
presented as a mean value ± the 
SD. (Fuchs et al. 2007) 
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Unpublished data from our own laboratory have shown that opsonised Gram positive bacteria 
(S. aureus coated in immunoglobulin G) stimulate NET release acting via the Fcγ receptor 
(H.J. Wright, personal communication).  Similarly, others have found that IgG coated beads 
were capable of inducing NETs, although IgG free in solution was not (Fuchs et al. 2007).  
Clark et al. (2007) investigating the role of NETs in severe blood sepsis, found that platelets 
act as mediators to stimulate NET release when they detect the bacterial component, LPS, in 
the circulation.  LPS binding of TLR4 on platelets subsequently binds adherent neutrophils 
inducing NET release within the capillaries.  In a similar way, host fibrinogen has been found 
to form a complex with the M1 protein from the surface of S. pyogenes and stimulate NET 
release even though neither component alone was capable of inducing NETs (Oehmcke et al. 
2009). 
 
It has been suggested that priming may have a significant effect on the nature of the response 
from the neutrophils (Yousefi et al. 2009).  GM-CSF priming for 20 minutes and subsequent 
short-term stimulation with LPS or complement C5a for only 15 minutes resulted in 
extracellular release of mitochondrial DNA only and the cells remained viable.  This is in 
contrast to all previous reports of NETs which consist of nuclear DNA and subsequent cell 
death.  It is unclear as to whether observation for longer than 15 minutes would have resulted 
in the cells undergoing nuclear DNA extrusion as a more advanced stage of NET release.  
Characteristics in common with the more universally described process of NET release are 
that it was dependent on ROS, that granule proteins were present within the NETs, and 
cytoplasmic and membrane markers were absent.  In contrast, histones were also absent but 
nuclear proteins were present.  This description of NET release appears to be highly specific 
to the stimuli used as although both GM-CSF + C5a and GM-CSF + LPS induced NETs in 
 40 
the same way, ethidium bromide detection of cell viability found GM-CSF + C5a extended 
the life of neutrophils whilst GM-CSF + LPS had no effect. 
 
The change in gene expression during neutrophil maturation was investigated by Martinelli et 
al. (2004).  Of 12,599 genes examined, 1049 were found to be differentially expressed in 
immature versus mature neutrophils.  Mature neutrophils were found to have a higher 
expression of genes which transduce signals of type I and type II interferons as well as higher 
expression of genes for apoptosis and inflammatory responses.  As IFN-γ is known to be able 
to enhance the anti-fungal activity of neutrophils, studies investigated whether this may be 
due to NET formation (Martinelli et al. 2004).  It was found that the altered IFN sensitivity of 
mature neutrophils was indeed important for the formation of NETs.  IFN-α or IFN-γ 
appeared to prime neutrophils and when followed by stimulation with C5a, NETs were 
produced.  This occurred in mature but not immature bone marrow derived neutrophils, i.e. 
those receptive to IFN signals.   
 
1.5.4 Non-neutrophil derived extracellular traps 
Neutrophils are not the only immune cell capable of extracellular trap formation.  Mast cells 
have also been shown to be capable of this phenomenon to ensnare S. pyogenes (von 
Kockritz-Blickwede et al. 2008).  A primary function of mast cells is to mediate allergic 
reactions and they are found in tissues exposed to the external environment such as the 
mucosa of the respiratory tract.  Whilst they are capable of phagocytosis they do not perform 
this at a significant level physiologically.  The extracellular traps formed by mast cells 
(termed MCETs) were shown to be similar to NETs in their composition, dependence on ROS 
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production and required stimuli.  A similar NET release process has also been reported in 
eosinophils whose primary function is to combat parasites (Yousefi et al. 2008).  DNA 
extruded into the extracellular space also occurred in a process independent from cell death 
and dependant on ROS generation similar that of NETs.  Unlike NETs, eosinophil derived 
extracellular traps were found to consist of mitochondrial DNA rather than nuclear chromatin 
and required priming by IL-5 or IFN-γ prior to stimulation with LPS. 
 
1.6 HL60 cells as a model for neutrophils 
Owing to the invasive nature of obtaining primary neutrophils for scientific study and in 
consideration of the multitude of influencing factors the cells may be exposed to in the 
peripheral bloodstream before experimentation, the human promyelocytic cell line, HL60,  
has been used, since its discovery in 1977 (Collins et al.), as a model for neutrophil growth 
and differentiation.  These cells were originally isolated from a 36 year old female patient 
with acute promyelocytic leukemia and can be stimulated to differentiate to a monocytic cell 
using vitamin D (Miyaura et al. 1981), a macrophage-like cell using PMA (Rovera et al. 
1979), or a granulocytic cell with retinoic acid (Breitman et al. 1980) or dimethylsulphoxide 
(DMSO) (Gallagher et al. 1979).  DMSO differentiated HL60 cells (dHL60) have been 
described as neutrophil-like with regards to various morphological, biochemical and 
functional characteristics.  Characterisation in 1979 by the group who originally isolated them 
found the cells to test positive for surface Fc receptors by the erythrocyte-antibody test when 
using bovine erythrocytes and positive for complement receptors when using sheep 
erythrocytes (Gallagher et al. 1979).  They also found the cells to be capable of phagocytosing 
Candida albicans.  Subsequently dHL60 were shown to be capable of phagocytosing Ig-
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opsonised paraffin droplets containing albumin, complement-opsonised paraffin droplets 
containing LPS and latex beads (Newburger et al. 1979).  dHL60 cells were found to generate 
superoxide in response to PMA and opsonised zymosan at early stages during their 
differentiation, which occurred prior to morphological changes being observed.  Notably, the 
superoxide response took longer and never reached the levels achieved in primary neutrophils 
(Newburger et al. 1979).  With respect to the components of the NADPH oxidase responsible 
for the respiratory burst, Roberts et al. (1982) described an increase in cytochrome b 
expression during differentiation and Teufelhofer et al. (2003) also observed an upregulation 
of mRNA encoding the NADPH oxidase subunits gp91phox, p47phox and p67phox.  
Although along with a low level expression of NADPH oxidase subunits in undifferentiated 
cells Teufelhofer et al. also claimed to observe PMA-induced superoxide production in 
undifferentiated cells.  Immunoblot analysis for NADPH oxidase sununits by Levy et al. 
(1990) did find a low level of expression of p47, p22 and gp91 in undifferentiated HL60 cells 
but found the cytosolic component p67 to be absent and concluded that undifferentiated HL60 
cells did not generate significant superoxide in response to PMA (100ng/ml).  Newburger et 
al. (1979) examined the granule content of dHL60 and found that as cells differentiated, 
levels of peroxidase (found in primary granules), β-glucuronidase (also found in primary 
granules) and lysozyme (found in tertiary granules) increased, as did the quantities released 
by degranulation in response to opsonised zymosan.  Finally, the same researchers 
demonstrated that dHL60s were capable of bacterial killing when challenged with opsonised 
S. aureus.  However, dHL60 cells appear to be devoid of secondary granules (Harris et al. 
1985) and in comparison to primary neutrophils have been reported to contain only half the 
amount of MPO from primary granules (Stendahl et al. 1986).  dHL60s have been shown by 
Shuto et al. (2007) to i) express IL-8 receptors, ii) exhibit chemotaxis in response to N-
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formyl-methionyl-leucyl-phenylalanine (fMLP),  iii) produce cytokines IL-1β and IL-8 in 
response to TLR2 and TLR4 stimulation by bacterial peptidoglycan / lipoteic acid or LPS 
respectively, iv) produce low levels of cytokines in response to TLR1/2 stimulation by 
Pam3Cys, TLR3 stimulation by poly(I-C) and TLR9 stimulation by bacterial DNA and v) to 
show surface expression of MD-2 (myeloid differential protein-2) and CD14 (components of 
the TLR4 complex).   
 
Notable differences between dHL60 cells and primary neutrophils are that they do not contain 
lactoferrin indicating they do not possess secondary granules (Newburger et al. 1979).  
dHL60s also lack the capacity for ROS production in response to the calcium ionophore 
ionomycin but retain the ability to degranulate to a similar level observed in primary 
neutrophils (Dahlgren 1989).  Ionomycin was however, able to prime dHL60s for enhanced 
ROS release upon subsequent stimulation with fMLP or PMA, an effect also seen in primary 
neutrophils.  It is agreed that the level of ROS produced in dHL60s is significantly reduced 
compared to primary neutrophils, however it is unclear whether this is due to i) a low level of 
expression of the components required for activity, ii) the components being dysfunctional or 
iii) only a certain percentage of the cell population is responsive to the differentiation stimuli 
and therefore become mature cells.  Indeed one study reported that only 65% of cells from a 
day 5 differentiated culture were capable of PMA-induced ROS production (Dahlgren 1989).   
 
Wang et al. (2009) have subsequently analysed the role of PAD4 histone hypercitrullination 
in stimulated HL60s NET release, which is known to be involved in NET release from 
primary neutrophils.  Notably, as HL60s were differentiated with DMSO the expression of 
PAD4 increased.  Subsequent treatment with calcium ionophore resulted in ~36% of cells 
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showing the citrullinated form of histone H3 and this was accompanied by >8% of cells 
releasing NETs.  Using IL-8 and bacterial stimulation (S. flexneri) 9.8% of differentiated cells 
showed citrullinated H3 and 3.2% released NETs after 3 hours.  Spontaneous histone 
citrullination was observed in undifferentiated HL60 cells but this was not a characteristic of 
the cell population as a whole and no NET release was seen under these conditions.   
 
1.7 Microbial mechanisms for the evasion of NETs 
Certain bacteria have been demonstrated to exhibit resistance to NET capture and/or NET 
mediated killing.  Mechanisms described include the production of extracellular DNases to 
degrade NETs (Buchanan et al. 2006), cationic modification of surface proteins to repel like-
charged AMPs (Kristian et al. 2005), and the expression of a capsule to evade NET capture 
(Wartha et al. 2007). 
 
1.7.1 Inhibition of antimicrobial peptides (AMPs) 
Certain bacteria have been reported to be trapped by NETs but not killed.  An example of this 
is the M1 serotype GAS.  The M1 surface protein is already recognised as a virulence factor 
but a novel action has recently been described indicating that it can inhibit the action of 
cathelicidin LL37 within NETs and also MCETs (Lauth et al. 2009).  Although it is the M1 
protein that is largely responsible for inducing neutrophils to release NETs when exposed to 
GAS (as demonstrated by M1 knockouts and re-transfection of the M1 gene), once trapped it 
is the M1 protein (and specifically the N-terminal hypervariable region of the M1 protein) 
which allows bacterial survival within the NET.   
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1.7.2 Charge modifications of the bacterial surface 
In specific cases, modifications of molecules comprising the bacterial cell surface serve to 
alter its charge.  Usually the surfaces of bacteria are anionic and exhibit a net negative charge 
due to a high density of charged phosphate groups.  In Gram positive bacteria these are found 
on teichoic acids of the cell wall, and in Gram negative bacteria they are found on LPS, the 
major component of the outer membrane.  AMPs are cationic, i.e. positively charged, so they 
are electrostatically attracted to their site of action, namely the bacteria.  Modifications which 
provide the bacterial surface with a positive charge subsequently mean harmful cationic 
AMPs are repelled.  This phenomenon may not be specific to NETs although one of the 
functions of NETs is to concentrate AMPs around the bacteria.  Therefore repulsion of these 
peptides becomes all the more vital for bacterial survival in this situation.  Reported examples 
in which bacteria are able to make modifications to their surface charge in response to the 
environmental conditions include the addition of L-lysine to phosphotidylglycerol within the 
cell membrane via the mprF gene loci in Staphylococcus aureus (Peschel et al. 2001; Kristian 
et al. 2003).  Another example is the modulation of cell wall teichoic acids by D-alanylation 
which is catalysed and regulated by 5 genes carried by the dlt operon found in certain Gram 
positive bacteria.  This latter mechanism is a two-step process requiring a D-alanine-D-alanyl 
carrier protein ligase and a D-alanyl carrier protein (Linzer et al. 1973).   
 
Bacterial teichoic acids are either anchored to glycolipids in the cell membrane (lipoteic 
acids), or attached to peptidoglycan in the cell wall.  Studies of dlt mutants have found that 
the dlt operon is important for resistance to AMPs in Bacillus subtilis (Bensaci et al. 2007), 
Staphylococcus aureus (Peschel et al. 1999), Listeria monocytogenes (Abachin et al. 2002), 
Streptococcus agalactiae (group B streptococci, (Poyart et al. 2003) and the virulent M1 
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serotype GAS (Kristian et al. 2005).  In the case of GAS, D-alanylation also promotes 
epithelial cell invasion and resistance to neutrophil killing (Kristian et al. 2005).  With regards 
to oral pathogens, the dlt operon was found to be important in Streptococcus mutans for the 
accumulation of intracellular polysaccharide (IPS) (Spatafora et al. 1999) and acid tolerance 
(Boyd et al. 2000), and also in Streptococcus gordonii for intrageneric coaggregation 
(Clemans et al. 1999).  In Salmonella enterica surface charge is altered by the transcriptional 
activation of two pmr genes, facilitating the addition of aminoarabinose to lipid A of LPS 
(Gunn et al. 2000).  This modification is also made in Proteus mirabilis but in this case 
requiring an acetyltransferase (McCoy et al. 2001).  Lipid A is also modified with 
phosphoethanolamine in addition to, or in place of, aminoarabinose in S. enterica (Zhou et al. 
2001).  Haemophilus influenzae, a common cause of otitis media, is able to escape killing by 
PMA-induced NETs but mutants in lipooligosaccharide (LOS or LPS) surface glycolipids 
were found to be more susceptible (Hong et al. 2009).  Mutants with defects in the core region 
or lipid A region, truncated oligosaccharide region and asialylated forms were found to be 
more susceptible to killing by not only phagocytosis but also NETs. 
 
Modifications of surface charge can work in conjunction to confer virulence to specific 
bacteria.  For example Staphylococcus aureus has the mprF gene for the addition of L-lysine 
into the cell membrane and also the dlt operon for the D-alanylation of teichoic acids in the 
cell wall.  This enables AMPs to be repelled by the cell wall, however if they cross this barrier 
they are then repelled at the cell membrane.  Another example of a bacterium with dual 
mechanisms for charge modification is Bacillus subtilis which has the pssA operon for the 
synthesis of phosphatidylethanolamine which acts at the level of the cell membrane, whilst its 
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dlt operon for D-alanylation of teichoic acids provides further resistance at the cell wall (Cao 
et al. 2004).   
 
1.7.3 Expression of bacterial capsules 
A bacterial capsule is a layer of polysaccharide that conceals the antigenic molecules on the 
surface from being recognised and targeted for phagocytosis by neutrophils and macrophages.  
In light of the relatively recent discovery of NETs as an antibacterial mechanism employed by 
neutrophils, it is thought that the capsule expressed in virulent strains of bacteria also 
functions to enable NET evasion.  In Streptococcus pneumoniae significantly fewer of the 
encapsulated serotypes were captured in NETs than their corresponding non-encapsulated 
serotypes (Figure 17) (Wartha et al. 2007).  Interestingly, in this same study, bacteria 
expressing capsules which exhibited no net charge were equally proficient at evading NET 
capture compared to those with anionic capsules, making electrostatic repulsion an unlikely 
reason for this phenomenon.  The majority of the invasive forms of pneumococci which are 
responsible for causing pneumonia express a capsule, with over 90 serotypes being described.  
Streptococcus mutans, a key coloniser of the oral cavity, secretes a specialised polysaccharide 
capsule that provides an adherent, nutritious and protected environment which enables biofilm 
colonisation.  The polymerisation of glucose to dextran by S. mutans allows adherence to the 
tooth enamel and enables dental plaque formation.  The bacteria can also depolymerise the 
dextran to recover and utilise the glucose as an energy source.  It is this process that yields 
lactic acid responsible for the decalcification of the tooth enamel observed in caries (Hamada 
et al. 1980).  In addition to concealing antigens, the bacterial capsule may express molecules 
that mimic those of the host and are therefore recognised as ‘self’ by immune cells and 
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subsequently therefore do not evoke an immune response.  This process has been described by 
Carlin et al. (2009) using a highly encapsulated group B Streptococci which express a 
sialoglycan as part of the bacterial capsule.  The sialic acid of this molecule is recognised as 
‘self’ by human neutrophil Siglec-9 which has an inhibitory cytoplasmic domain resulting in 
down regulation of the oxidative burst and NET formation and ultimately enabling bacterial 
survival.  This was demonstrated by competitive inhibition of the sialic acid binding site of 
Siglec-9 using an antibody which allowed more ROS and NET production than in the 
presence of an antibody which did not block the binding site.  These data indicate that not 
only does this capsule component avoid recognition and evoking of an immune response by 
the host, it actively down-regulates the immune response.  A secondary action of bacterial 
sialoglycan engagement of Siglec-9 was the upregulation of mRNA expression of the anti-
inflammatory cytokine IL-10 (Carlin et al. 2009). 
 
 
 
1.7.4 Bacterial DNases 
DNases are virulence factors produced by certain bacteria to evade NETs (Beiter et al. 2006; 
Buchanan et al. 2006).  The enzyme degrades the principal component of NETs, DNA, 
Figure 17. NETs trapping 
S. pneumoniae. NETs 
stained for DNA (Draq5, 
blue) and neutrophil elastase 
(AlexaFluor488 labelled 
antibody, red).  Encapsulated 
S. pneumoniae (FITC, green) 
are able to exist free of 
NETs. Non-encapsulated 
pneumococci are mainly 
associated with NETs. 
(Wartha et al. 2007) 
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enabling the microorganism to evade this form of capture and killing and thereby facilitate its 
spread throughout the tissue.  It has been known for decades that many bacteria, particularly 
Gram negative bacteria, produce extracellular DNases although until recently their role and 
benefit to the bacteria had been a mystery.  In 1974 Porschen and Sonntag examined the 
production of DNase in anaerobic bacteria, and found that DNase activity was extremely 
common in Gram negative bacteria and present in all strains of Fusobacterium tested 
(Porschen et al. 1974).  DNase production was found to be less common in Gram positive 
bacteria although certain bacteria, e.g. Clostridium perfringens, did show significant nuclease 
activity.  This is of particular relevance as it is thought that the pathogens predominantly 
responsible for periodontitis are Gram negative anaerobic bacteria.  In 1967 Cuatrecasas et al. 
found that Staphylococcus aureus was able to produce an extracellular nuclease which cleaves 
the 5’-phosphyl ester bond in nucleic acids to produce mono- and di- 3’-phosphonucleotides 
(Cuatrecasas et al. 1967).  This nuclease was capable of cleaving RNA but had a higher 
affinity for DNA and this bacterial property is now used in diagnostic laboratories for the 
identification of S. aureus infections.  One function of DNases may be that they create a wider 
range of available nucleotides conferring a growth advantage (Fox et al. 1968).  However, in 
the light of recent advances in the characterisation of NETs, investigations have been 
undertaken into the potential of streptococcal group A DNases in particular, to degrade NETs 
and subsequently enhance their virulence.  There is now evidence which indicates that 
extracellular DNases are of particular importance to GAS because all strains produce at least 
one type and the majority produce several distinct DNases (Wannamaker 1958; Miyakawa et 
al. 1985).  Significantly, gene expression of prophage encoded DNase can be up regulated by 
exposure to hydrogen peroxide (Banks et al. 2003).   
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Buchanan et al. (2006) examined the DNase Sda1 expressed by the M1 serotype GAS strain.  
An Sda1 mutant which exhibited decreased DNase activity had increased susceptibility to 
neutrophil killing in vitro, and an in vivo mouse model of necrotising fasciitis subsequently 
demonstrated that the Sda1 mutant was also significantly less virulent than the wild type 
strain.  The addition of G-actin to inhibit the DNase also reduced virulence of the bacteria in 
the mouse model.  Significantly, exudates of abscesses from the infected mice showed higher 
levels of NETs remaining in the Sda1 mutant than in infections due to the wild type strain.  
Walker et al. (2007) also studying GAS found that expression of Sda1 paradoxically provided 
a selection pressure for a shift in the bacterial population to a highly invasive phenotype.  
Natural selection meant those bacteria expressing Sda1 were able of escaping NETs and 
increased in number.  In the M1T1 GAS serotype the Sda1 phenotype was only observed 
when accompanied by a mutation in the covRS regulator, causing suppressed SpeB 
expression.  SpeB is a cysteine protease which degrades plasmin, however in its absence, 
plasmin is able to accumulate on the bacterial surface enabling the bacteria to invade from the 
local tissue into the blood causing a systemic infection (Cole et al. 2006).  ‘End A’, another 
DNase found expressed on the surface of Streptococcus pneumoniae, which is the primary 
cause of community-acquired pneumonia, was examined in strain TIGR4 (serotype 4) (Beiter 
et al. 2006).  The EndA mutant strain was able to infect the upper respiratory tract in mice but 
failed to disseminate into the lung and bloodstream indicating that although neutrophils are 
unable to kill S. pneumoniae, NETs are able to limit dissemination. 
 
Sumby et al. (2005) recently hypothesised that the multiple forms of DNases produced by 
GAS may preserve their ability to degrade DNA if the host produces antibodies to inhibit one 
form of the enzyme.  In addition, multiple forms of DNase may enable activity under a range 
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of conditions e.g. pH and cationic requirement.  Multiple DNase genes may also enable 
expression at various stages of infection and may aid the dissemination of phages on which 
many virulence factors, including DNases, are found. 
 
Another group of endonuclease producing bacteria are Gram negative bacteria which secrete 
the bacterial toxin cytolethal distending toxin (CDT).  This group of bacteria include the 
pathogenic strains of E. coli (Johnson et al. 1988b), Aggregatibacter actinomycetemcomitans 
(Sugai et al. 1998) and Campylobacter (Johnson et al. 1988a).  CDT works by creating a nick 
in the DNA of host cells which is recognised by the cell causing cell cycle arrest at G2/M and 
eventually cell death (Elwell et al. 2000; Lara-Tejero et al. 2002).  The name, cytolethal 
distending toxin, refers to its cytotoxic nature and morphological changes seen in cells as the 
toxin targets the nucleus causing it to swell (Johnson et al. 1988b).  The active subunit of the 
toxin, CdtB, is a molecule similar to DNase I.  Investigations into the DNase activity of CDT 
have found it to be generally very low.  This may be due to either the purification process, a 
lack of appropriate co-factors, or simply because this nuclease acts locally only requiring the 
ability to make a single nick in a cell’s DNA to be toxic and, therefore, may only require 
relatively low activity. 
 
Aside from their role in infectious diseases, DNases are expressed by non-bacterial cells, as 
investigated by Alghamdi et al. (2005) who demonstrated their role in fertilisation.  The 
process of insemination evokes the recruitment of neutrophils to the reproductive tract to 
remove excess spermatozoa and bacterial contaminants.  It is thought that if the neutrophil 
response is too early or is exaggerated then the production of NETs may entangle the 
spermatozoa and reduce fertility.  However, the inclusion of seminal plasma with the 
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spermatozoa appeared to greatly increase the chance of successful fertilisation in equine 
artificial insemination.  This is thought to be due to a ‘fertility associated antigen’ found in 
seminal plasma which shares sequence homology with DNase I, which is thought to be able to 
digest NETs and free trapped spermatozoa.   
 
Another area of study regarding eukaryotic DNase I activity includes that of systemic lupus 
erythamatosus (SLE).  SLE is an autoimmune disorder in which antibodies are produced 
against the patients own DNA causing multiple organ inflammation including pleuritis, 
arthritis, rash, myocitis, vasulitis and kidney inflammation.  The pathogenesis of this disorder 
is unclear but recent research suggests that it may be caused by disturbed clearance of nuclear 
DNA after cell death (Napirei et al. 2000).  This may be the result of faulty or reduced levels 
of DNase, and a reduced level of DNase I in the urine of patients with SLE supports this 
hypothesis.  Knock-out mice for the DNase I gene have also been shown to develop 
symptoms of SLE (Napirei et al. 2000).  Replacement therapy involving administration of 
recombinant DNase I in a different mouse model of SLE delayed disease progression and 
prolonged their lifespan (Macanovic et al. 1996).  
 
1.8 The role of NETs in the pathogenesis of periodontal disease 
Evidence suggests that the nature of the inflammatory response and a patient’s innate 
susceptibility determines the destructive nature and progression of periodontal disease.  As 
neutrophils are the major immune cell type involved in the periodontal inflammatory 
response, it is therefore reasonable to speculate that perturbations in their function may 
determine a patient’s periodontal state.   
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To extrapolate this premise to NETs, it is reasonable to hypothesise that the prevalence or 
effectiveness of NETs in diseased periodontal tissue may be reduced.  This could be the result 
of i) hypo-active NET production, or ii) periodontal bacteria rendering the NETs ineffective 
by either complete degradation via DNase activity or evasion of trapping by capsule 
expression or membrane charge modification.  The result of this ineffective NET function, 
would be that bacteria could more freely infiltrate the periodontal tissues, evoking a more 
widespread inflammatory response culminating in neutrophil mediated tissue destruction e.g. 
ROS and protease damage.  As NETs are thought to function to maintain a high local 
concentration of AMPs, DNase digestion of NETs may result in liberation of NET-associated 
AMPs, resulting in more widespread tissue destruction. 
 
Conversely it is conceivable that periodontal disease may associate with an excessive 
production of NETs, consistent with the theory that patients exhibits a ‘hyperreactive 
phenotype’ (Matthews et al. 2007a).  Patient neutrophils could therefore exhibit constitutive 
hyperactivity and a raised baseline level of NET production, or they could be hyper-reactive 
resulting in excessive NET production in response to periodontal bacteria and local pro-
inflammatory mediators.  In either scenario the implication is that both the neutrophils and 
their associated degradative enzymes are concentrated within the abundant NETs for an 
extended duration.  Supporting evidence for this hypothesis is derived from data 
demonstrating that NET release is dependant upon ROS production (Fuchs et al. 2007), which 
is also shown to be increased in periodontal disease (Matthews et al. 2007a).  In addition, 
increased neutrophil ROS production has been associated with elevated type-I IFN levels in 
periodontal disease (Wright et al. 2008) and these molecules are also able to prime for NET 
release (Martinelli et al. 2004).  It is also interesting to speculate that an abundance of NETs 
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within a tissue could trigger a localised autoimmune-like response resulting in elevated 
neutrophil recruitment and tissue destruction (Mayadas et al. 2009).  This hyperactive NET 
hypothesis in periodontitis is also supported by Vitkov et al. (2009) who visualised NETs in 
purulent exudates from the gingiva of chronic periodontitis patients.  These data are 
comparable to those previously presented by Buchanan et al. (2006) in the examination of 
abscess exudates from GAS infections of mice, and in human mixed bacterial infection in vivo 
(appendicitis; Brinkmann et al. 2004).  Vitkov et al. also observed that all 22 of the samples 
collected showed significantly high levels of NETs and that in 7 samples trapped bacteria 
were associated with the NETs (Figure 18).  Notably, transmission electron microscopic 
(TEM) analysis of pocket epithelium biopsies from chronic periodontitis patients also showed 
the presence of NETs (Figure 19).  Additionally, preliminary work relating to this project has 
indicated that the structures comprising NETs are present within the gingival tissues at sites of 
inflammation but less easily seen in healthy gingival tissue when visualised by 
immunofluorescent staining (Figure 20).   
 
         
 
 
 
Figure 18. Toluidine blue staining 
of bacteria (black arrows) 
associated with NETs (white 
arrows) from purulent crevicular 
exudate (Vitkov et al. 2009) scale 
bar represents 20µm. 
 
Figure 19. TEM of pocket 
epithelium (Vitkov et al. 2009) 
Arrows indicate NET fibres. 
 
a) b) 
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Figure 20. Immunofluorescent staining of gingival tissue sections. a) Healthy gingival 
tissue, and b) gingivitis derived tissue. MPO (green) and DNA (red).  Courtesy of Dr S. 
Yousefi, University of Berne, Switzerland. 
 
Unifying the two hypotheses (hyper- and hypo-active NET production) is the possibility that 
the degradation and evasion of NETs by virulent periodontal pathogens may cause neutrophils 
to respond by up-regulating the release of NETs, resulting not in the trapping of bacteria but 
instead the immobilisation and localisation of neutrophils responsible for periodontal tissue 
destruction.   
 
Therefore the factors determining whether one individual develops inflammatory periodontitis 
whilst another does not, may be determined by i) the type of bacteria inhabiting the gingival 
crevice, ii) whether these bacteria possess virulence factors for NET evasion, and iii) the 
individual’s innate ability for NET production.  In support of biological variation with regard 
to NET production, data provided by Fuchs et al. (2007) demonstrate a significant range in 
 
 
 a) Health b) Gingivitis 
 56 
levels of NET production between neutrophils obtained from several healthy individuals 
(Figure 21). 
  
 
1.9 Summary and aims 
Since the first report in 2004 that neutrophils can extrude their own DNA to form extracellular 
traps against microorganism survival and dissemination, their role has been examined in a 
multitude of infectious and non-infectious pathologies as well as physiologies (Table 1).  As a 
disorder mediated by the balance between the innate immune system (namely neutrophils) 
and the plaque bacteria, periodontitis is a likely disease in which NETs may play a significant 
role.  A variety of in vitro and in vivo studies have indicated that there is a hyper-active and 
hyper-reactive neutrophil phenotype with regards to generation of ROS in the active state of 
periodontitis (Matthews et al. 2007a; Matthews et al. 2007b).  As NET release has been found 
to depend in part on ROS generation, specifically hydrogen peroxide (Fuchs et al. 2007), one 
Figure 21. Variation in 
NET production between 
donors. Cells were 
unstimulated, stimulated 
with 10nM PMA or 100 
mU/ml glucose oxidase 
for 180mins. Extracellular 
DNA was quantified by 
micrococcal nuclease 
digestion and expressed as 
a percentage of total 
DNA. Experiments 
repeated in triplicate to 
give mean value ± SD 
(Fuchs et al. 2007). 
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aim of this work was to elucidate weather a hyper-active or hyper-reactive neutrophil 
phenotype existed with regard to NET generation.  
 
The process of NET release has by no means been fully characterised and their function can 
only be implied.  However, examining the mechanisms bacteria possess which can confer 
virulence when challenged with NETs can provide further clues to the function of NETs.  
Although reports of NETs are mixed and often contradictory, characteristics which are 
common to all reports to date are that they comprise DNA and antimicrobial granule proteins.  
Thus an obvious candidate for a bacterial virulence factor is expression of DNase.  DNase 
expression has been reported sporadically through the years and found to be a feature of Gram 
negative anaerobes (Porschen et al. 1974) which is of particular relevance to periodontal 
disease as it is characterised by a high proportion of Gram negative anaerobic bacteria within 
the subgingival biofilm.  In recent years with regards to NETs, S. pneumoniae (Beiter et al. 
2006) and group A streptococci (Buchanan et al. 2006) have been found to express DNase 
which is associated with increased virulence.  However, there are no reports of the frequency 
of DNase expression amongst periodontal pathogens.  The other universal component of 
NETs are the granule peptides suggesting that an antimicrobial property is key to the action of 
NETs.  However, bacteria, particularly the pathogenic varieties responsible for periodontal 
disease possess an arsenal of strategies to resist antimicrobial attack (Kristian et al. 2005; 
Lauth et al. 2009).  Therefore it has been suggested that histones, as a component of the 
chromatin core of NETs, exert a primitive antimicrobial effect.  As such, an aim of this work 
was to examine the susceptibility of periodontal pathogens to the antimicrobial action of 
histones. 
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CHAPTER 2 MATERIALS AND METHODS 
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2.1 NET production in vitro 
Utilising the fact that DNA is a major structural component of NETs (Brinkmann et al. 2004), 
the fluorescent DNA stain, SYTOX
®
 green, was used to both visualise NET release from 
peripheral neutrophils and HL60 cells, and also for fluorometric quantification of NET 
release.  In addition, scanning electron microscopy (SEM) was used to examine the 
interaction of periodontal pathogens with extruded NETs. 
 
2.1.1 Isolation of neutrophils 
The following section details the isolation of peripheral neutrophils from whole blood using a 
discontinuous Percoll density gradient for the study of in vitro NET release.  A Percoll density 
gradient was used, rather than a dextran/ficoll method (Weinrauch et al. 2002), since the latter 
can pre-activate neutrophils (Rebecchi et al. 2000). 
 
2.1.1.1 Percoll density gradient 
8ml of 1.098 Percoll was carefully layered underneath 8ml 1.079 Percoll in a 25ml centrifuge 
tube.  The Percoll composition is documented in the table below. 
Density 1.079 1.098 
Percoll 19.708 ml 24.823 ml 
Water 11.792 ml 6.677 ml 
NaCl 3.5 ml 3.5 ml 
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Materials were obtained as Percoll 1.13g/ml (17-0891-01 GE Healthcare); distilled sterile 
water (Versol); NaCl 1.5M in distilled sterile water (S9625 Sigma).  Percoll densities were 
stored at 4
o
C. 
 
2.1.1.2 Lysis buffer 
1 litre of lysis buffer was made by adding 8.3g NH4Cl (A9434 Sigma), 1g KHCO3 (P9144 
Sigma), 0.04g Na2 EDTA 2H2O (E5134 Sigma) and 2.5g bovine serum albumin (BSA; 
A4530 Sigma) to 1 litre of water (Versol) and stored at 4
o
C until use. 
 
2.1.1.3 Phosphate buffered saline (PBS) 
1 litre of PBS was made by combining 7.75g NaCl (S9625 Sigma), 0.2g KH2PO4 (P5379 
Sigma) and 1.5g K2HPO4 (P8281 Sigma) with 1 litre distilled water.  This solution was 
autoclaved and stored at 4
o
C. 
 
2.1.1.4 Method for isolation of neutrophils 
12ml venous blood was collected in two 7ml lithium heparin Vacutainers (Greiner, Bio-One) 
and layered onto a Percoll density gradient (2.1.1.1) in a 30ml centrifuge tube (63.9922.254PP 
Sarstedt), then centrifuged (IEC Centra CL3R) for 8 minutes at 150 relative centrifugal force 
(rcf), and 10 minutes at 1200 rcf.  The plasma, lymphocyte and monocyte layers were 
carefully removed and discarded by manual aspiration using a glass Pasteur pipette.  The 
neutrophil layer was located at the top of the red blood cell layer and transferred, again using 
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a glass Pasteur pipette, to a 50ml centrifuge tube containing 30ml lysis buffer (2.1.1.2).  The 
tube was gently inverted to mix, and incubated at room temperature for 5-10 minutes until red 
blood cells had lysed.  This was then centrifuged for 6 minutes at 500 rcf to pellet the 
neutrophils.  The supernatant was discarded and the pellet re-suspended in a further 2ml lysis 
buffer and incubated for 5 minutes at room temperature prior to re-centrifugation (6 minutes 
at 500 rcf).  The supernatant was removed, the pellet washed in 2ml PBS, and centrifuged 
once more for 6 minutes at 500 rcf before re-suspension in 2ml PBS.  Cells were counted 
using a haemocytometer (Naubauer, Reichart) and viability checked by trypan blue exclusion 
(1:1 mix of cells with trypan blue; T8154 Sigma) and visualisation by light microscope (Leitz 
Laborlux s).  
 
Neutrophils were resuspended at 1x10
6
 cells/ml in glucose supplemented PBS for assay of 
ROS generation (2.1.7) or RPMI for assay of NET release (2.1.3-2.1.6) and used immediately.  
 
2.1.2 Culture and differentiation of HL60 cells  
To develop a readily available source of neutrophil-like cells for the study of NET release, 
and potentially eliminate inter-personal and temporal variation observed using primary 
neutrophils, the promyelocytic cell line, HL60, was cultured for comparison to primary 
neutrophils with regards to NET release. 
 
HL60 cells were a kind gift from the laboratory of Professor Helen Griffiths at Aston 
University, originally obtained from the European Collection of Cell Cultures (ECACC 
98070106).  Cells were seeded at a concentration of 2x10
5
 cells/ml in RPMI 1640 (L0500 
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Biosera) supplemented with 300mg/L L-glutamine, 10% foetal calf serum (FCS; S1810 
Biosera) and 1% penicillin-streptomycin (P4333 Sigma).  Cells were incubated at 37C in 5% 
CO2 for 2 days or until confluent and then stimulated to differentiate into neutrophil-like cells 
by the addition of 1.25% DMSO (Sigma D2438 sterile filtered) and incubated for 3 days.  
Subsequently cells were washed twice by centrifuging for 5 minutes at 150 rcf, removing the 
supernatant and re-suspending the pellet in sterile PBS before a cell count was performed 
using a haemocytometer and cell viability assessed by trypan blue exclusion.  Cells were 
resuspended at 1x10
6
/ml for use in subsequent experiments. 
 
2.1.3 NET staining 
For qualitative assessment of NET release from isolated peripheral neutrophils, cells were 
seeded onto glass slides and fluorescently stained for visualisation for extruded NETs as 
detailed below. 
 
2.1.3.1 Paraformaldehyde (PFA) 8% 
1.6g PFA (P-6148 Sigma) was dissolved in 20ml PBS by gentle mixing and heating to 60C.  
The solution was allowed to cool before passing though filter paper and stored at 4C. 
 
2.1.3.2 NET staining 
Multiwell slides (10.5mm diameter; PH068 C.A. Hendley, Essex) were sterilised overnight at 
140C in an oven (OP30, LTE Scientific Ltd.) and coated in 0.01% poly-L-lysine (P4707 
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Sigma) diluted in water.  Slides were then placed in a humid container lined with damp filter 
paper.  1x10
5
 neutrophils in 100l of RPMI (L0500 Biosera) plus 10% heat inactivated FCS 
were placed on each well of the slide and allowed to settle for 30 minutes at 37C.  
Neutrophils were stimulated with 12.5l of designated stimulus (Table 2) diluted to the 
appropriate concentration in sterile PBS and left to incubate for up to 3 hours at 37C.  The 
medium was then removed and cells fixed with 100l (per well) of 4% PFA (2.1.3.1) for 20 
minutes at room temperature.  PFA was removed and the cells were stained with 100µl 
1.25M SYTOX® green in PBS (S7020 Invitrogen) for 10 minutes and from this point slides 
were kept covered in aluminium foil to exclude light.  Cells were rinsed in 100l PBS before 
the slides were mounted using aqueous mounting agent (G0918 VWR) and a coverslip 
 
2.1.3.3 Image capture and processing 
Cells were visualised using an epi-fluorescent microscope (Nikon Eclipse TE300) with 
fluorescent filter excitation 472nm and emission 520nm (BrightLine
®
 GFP-3035B, Semrock).  
Images were captured using a digital camera (Nikon Coolpix 990).  To demonstrate the extent 
of fluorescent staining, a light microscope image of the same field was also captured and the 
fluorescent and light microscope images overlayed using ImageJ (1.38d).  Both images were 
opened and the ‘channel merge’ function used to assign each image to a separate channel (red, 
green or blue) and generate a composite image. 
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2.1.4 Fluorometric analysis of NET release 
The release of extracellular NET-DNA was quantified fluorometrically using a fluorescent 
DNA dye (SYTOX
®
 green).  Assays were performed in black 96-well microplates (3915 
Corning).  Added to each well were 1x10
5
 cells in 100µl media (RPMI L0500 Biosera plus 
10% FCS), 25µl 10µM SYTOX
®
 green in PBS (S7020 Invitrogen) and 50µl PBS, the volume 
of which could be replaced with modulating agents as necessary (2.1.9).  The fluorescence 
from each well was recorded at 37C in arbitrary fluorescent units (AFU) using a fluorometer 
(Twinkle LB970, Berthold Technologies) with an excitation wavelength of 485nm and an 
emission wavelength of 525nm.  After 30 minutes settling time, 25µl of each stimulus was 
added and the plate was read for up to 3 hours. 
 
2.1.5 Micrococcal nuclease (MNase) assay of NET release 
To separate extruded NET-DNA from cellular debris, MNase was used to digest and liberate 
the DNA into the supernatant for subsequent fluorometric quantification.  NETs were 
produced in black 96-well plates as previously described (2.1.4).  3 hours post stimulation, 
MNase (LS004797 Worthington Biochemical Corporation) 1 unit/ml was added to each well, 
and allowed to digest at room temperature for 20 minutes prior to centrifugation at 1800rcf for 
10 minutes to pellet the cells. 150µl of the supernatant containing the liberated extracellular 
DNA was then read in the fluorometer for 10 minutes to quantify the DNA. 
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2.1.6 SEM of NETs 
Neutrophils were seeded onto baked and poly-L-lysine coated 13mm glass coverslips and 
stimulated as previously described (2.1.3.2).  After 3 hours samples were fixed in 4% PFA for 
20 minutes, rinsed in PBS for at least 20 minutes and dehydrated though graded solutions of 
ethanol (459844 Sigma) diluted in distilled water (20%, 30%, 40%, 50%, 60%, 70%, 90%, 
95%, 95%, 100%, 100% for at least 10minutes each).  Samples were then critical point dried 
(Bio-Rad E3000).  Samples were initially placed in to the critical point drier chamber 
immersed in 100% ethanol.  The ethanol was then replaced with carbon dioxide (CO2; from 
gas cylinder) by rinsing though the chamber approximately 5 times.  The chamber was then 
gently heated to 32C, the critical point of carbon dioxide, in order to evaporate all the liquid 
CO2.  The dried sample was then mounted onto 25mm aluminium stubs (G3024 Agar 
Scientific) using silver in isobutyl methyl ketone (G3648 Agar Scientific) and coated in gold 
for 90 seconds (Denton Vacuum Desk II).  Samples were analysed using a JOEL JSM-840 
scanning electron microscope at an accelerating voltage 10 kilovolts (kV). 
 
2.1.7 Enhanced chemiluminescence assay for ROS 
Given that NADPH oxidase activation is necessary for NET formation (Fuchs et al. 2007), 
generation of ROS was analysed alongside NET production to assess the responsiveness of 
the cells to the various stimuli. 
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2.1.7.1 GPBSS (glucose supplemented PBS) 
GPBSS comprised 1.8g glucose, 0.15g CaCl2 (10070 BDH) and 1.5ml MgCl2 (1M; 22093 
BDH) which were added to 1 litre PBS and stored at 4C. 
 
2.1.7.2 Blocking buffer (PBS BSA) 
10g BSA (A4503 Sigma) was dissolved in 1 litre PBS to give 1% BSA in PBS.  The solution 
was aliquoted into working volumes and stored at -20C until use. 
 
2.1.7.3 Luminol and isoluminol 
A 30mM stock solution was made by dissolving 0.5g luminol (A8511 Sigma) or isoluminol 
(A8264 Sigma) in 94.05ml 1mM NaOH and stored at 4C.  The working solution was made 
by diluting 1ml stock luminol or isoluminol with 9ml PBS and the pH adjusted to 7.3. 
 
2.1.7.4 Lucigenin 
A 1mg/ml stock solution of lucigenin (B49203 Sigma) in PBS was prepared and stored at 
4C.  The working solution was made by diluting 1:3 in PBS. 
 
2.1.7.5 Method for enhanced chemiluminescent assay for ROS 
Neutrophils and HL60 cells were prepared as previously described (2.1.1 and 2.1.2) and 
100µl (1x10
5 
cells) in GPBSS were added to white 96-well plates (Microlite; 7567 Thermo 
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Scientific) that had been coated with blocking buffer (2.1.7.2) overnight at 4C.  To detect 
total radical generation 30µl luminol (2.1.7.3) was added.  To detect extracellular radical 
generation, 60µl isoluminol (2.1.7.3) in addition to 1.5 units horseradish peroxidase (in PBS; 
P8415 Sigma) were added.  To specifically detect superoxide generation, 30µl lucigenin 
(2.1.7.4) was added.  The total volume of each well was made up to 175µl using PBS and the 
light output was recorded for 1 second per well in relative light units (RLU) using a Berthold 
microplate luminometer (LB96v Bethold Technologies U.K. Ltd.) at 37C.  The plate was 
read for 30 minutes before 25µl of stimuli were added to give a total volume of 200µl per 
well and read for a further 120 minutes. 
 
2.1.8 Stimuli used to induce NETs 
The stimuli listed in Table 2 were used for in vitro stimulation of peripheral neutrophils and 
HL60 cells for the assay of NET and ROS production.  PMA is an established stimulus for 
NETs which bypasses cell surface receptors and directly activates intracellular PKC.  fMLP is 
a chemotactic peptide which acts via surface fMLP receptors and is reported to primarily 
induce degranulation.  A variety of Gram negative and Gram positive periodontal bacteria 
were also used (Table 6) and can act via a multitude of antigen-receptor interactions.  One of 
the major cell wall componants of Gram negative bacteria, such as F. nucleatum, is LPS 
which activates TLR4/2 in conjunction with CD14, MD-2 and LPS binding protein.  In Gram 
positive bacteria the major constituent of the cell wall is lipoteic acid which acts via TLR2.  S. 
aureus is a Gram positive bacteria and was opsonised with IgG to enable stimulation of 
cellular Fcγ-receptors.  The calcium ionophore, A23187, was used for the stimulation of 
HL60 cells to increase intracellular free calcium levels. 
 68 
Table 2. Stimuli used to induce NETs 
Stimuli Acronym Supplier/Cat N
o.
 
 
Phorbol 12-myristate 13-acetate 
 stock concentration 1.62M in DMSO 
 working concentration 405nM in PBS 
 final concentration 50nM 
 
PMA Sigma P8139 
N Formyl Met-Leu-Phe 
 stock concentration 1mM in 99% ethanol 
 working concentration 8000nM in PBS 
 final concentration 1000nM 
 
fMLP Sigma F3506 
Various bacteria 
 working concentration 6x10
8
/ml in PBS 
 final concentration MOI
1
 1:150 
 
 Grown in house 
(Section 2.1.8.1) 
Calcium ionophore A23187 
 Stock concentration 5mM in DMSO 
 Working concentration 32µM in PBS 
 Final concentration 4µM 
CI 
(Ionomycin) 
Sigma C7522 
1
MOI multiplicity of infection i.e. number of bacteria per neutrophil. 
 
2.1.8.1 Preparation of bacterial stimuli 
For use as stimuli of neutrophils or HL60 cells, bacteria were grown in broth cultures as 
described later (2.4.4), rinsed twice by centrifugation at 1087 rcf for 40 minutes and re-
suspended in sterile PBS, before being stored at -20C.  Bacterial numbers were estimated by 
spectrophotometry (2.6.2) and diluted to 6x10
8
 per ml in sterile PBS for use in experiments 
and stored at 4C. 
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2.1.8.2 Opsonisation of S. aureus  
Staphylococcus aureus (ATCC 9144) was cultured on agar without blood as described later 
(2.4.3) and used to inoculate tryptone soya broth as described later (2.4.4) with the exception 
of aerobic culture at 30C (Gallenkamp Plus II Incubator).  After overnight growth bacteria 
were pelleted by centrifugation at 3800 rcf for 5 minutes, the supernatant removed and the 
pellet re-suspended in sterile PBS.  This was repeated 3 times.  After the third centrifugation 
step the bacterial pellet was re-suspended in 3% formaldehyde (P6148 Sigma) in PBS and 
incubated at room temperature for 1 hour to fix.  The bacteria were again washed 3 times by 
centrifugation and re-suspension in sterile PBS.  Bacterial concentration was estimated by 
spectrophotometry (2.6.2) and diluted in additional sterile PBS to give a suspension of 1x10
9
 
bacteria per ml.  The bacteria were heat treated by incubation at 80C for 20 minutes prior to 
the addition of 33µl Vigam liquid (5mg/ml IgG; Bio Products Laboratory) per ml of bacteria 
and incubated overnight at room temperature with constant agitation to allow opsonisation.  
Finally, bacteria were again rinsed twice in sterile PBS by centrifugation and re-suspension, 
and stored at -80C.  Bacterial numbers were again estimated by spectrophotometry to allow 
resuspension in PBS to give 6x10
8
/ml prior to use. 
 
2.1.9 Modulators of neutrophil function used in NET assays 
The agents listed in Table 3 were used to assess their effect on NET release based on their 
modulation of neutrophil functions, especially ROS generation which reportedly affects NET 
release.  DPI directly inhibits the NADPH oxidase enzyme, sodium azide primarily inhibits 
the azurophilic granule protein myeloperoxidase responsible for the conversion of hydrogen 
peroxide to hypochlorous acid and SOD is an endogenous enzyme responsible for the 
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conversion of superoxide to hydrogen peroxide.  In addition, curcumin was used as it is an 
antioxidant with widespread anti-inflammatory properties, and also cytochalasin B which is 
an actin polymerisation inhibitor and as such prevents bacterial phagocytosis.  In each case 
the background fluorescence due to the addition of the agents and/or stimuli was controlled 
for by simultaneously processing wells containing all reagents but no cells, and this value was 
subtracted from that of the test wells. 
 
Table 3. Modulators of NET release 
Modulating agent 
 
Cat N
o.
 / Supplier  
Diphenyleneiodonium chloride (DPI) 
 stock concentration 0.6mM in PBS 
 working concentration 0.2mM 
 final concentration 50µM 
 
D2926 Sigma  
Superoxide dismutase (SOD) 
 stock concentrations 4750U/ml in PBS 
 mixed working concentration 1267U/ml 
 final concentration 95U/ml 
 
S5395 Sigma (Cu/Zn-SOD) 
S5639 Sigma (Mn-SOD) 
Curcumin 
 stock concentration 10mM in 99% ethanol 
 working concentration 0.1mM in PBS 
 final concentration 5µM 
 
28260 Fluka 
Cytochalasin B (cytoB) 
 stock concentration 14mg/ml in DMSO 
 working concentration 143.3µg/ml 
 final concentration 10µg/ml 
 
C6762 Sigma 
Sodium azide 
 stock concentration 2.1M in dH2O 
 working concentration 42mM in PBS 
 final concentration 2mM 
 
S2002 Sigma 
15µl of the working concentration of each modulating agent was added to a 200µl well at the 
start of the experiment, prior to the addition of the cells. 
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2.2 Comparison of NET production between periodontal patients and healthy 
individuals 
The following section details the use of the previously described NET and ROS assays to 
compare the responses of peripheral neutrophils of periodontitis patients to healthy controls. 
 
2.2.1 Selection of volunteers 
Periodontitis patients were recruited as part of an ongoing clinical trial (ID: NCT00952536), 
and ethical approval was obtained from the South Birmingham Local Research Ethics 
Committee (05/Q2707/252).  Inclusion criteria were patients with chronic periodontitis 
suffering from at least 30% bone loss and aged between 30 and 60 years.  Exclusion criteria 
included diabetes, pregnancy, smokers and use of vitamin supplements.  A 12ml blood sample 
was obtained using two 7ml lithium heparin vacutainers (Greiner, Bio-One) at baseline, i.e. 
prior to treatment.  On the same day, blood samples were also taken from age and sex 
matched periodontally healthy controls who were recruited using the same exclusion criteria.   
 
2.2.2 Assay of peripheral blood neutrophils 
Neutrophils were isolated as previously described using a Percoll density gradient (2.1.1).  
NET production was evaluated as previously described by MNase assay (2.1.5) and ROS 
production was also assayed as previously described (2.1.7).  Cells were stimulated using 
PMA, F. nucleatum subsp. polymorphum (ATCC 10953), opsonised S. aureus (2.1.8) or were 
unstimulated (PBS exposure). 
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2.3 HL60 cell characterisation 
 
2.3.1 Gene expression analysis by RT-PCR in HL60 cells and primary neutrophils 
Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to compare the gene 
expression profile of neutrophil related gene transcripts (primers listed in Table 4) in 
differentiated HL60 cells and primary neutrophils. 
Table 4. Primers and conditions used for gene expression analysis in HL60 cells  
Gene (Gene Abbreviation) 
 Primer sequence (5’→3’) 
 
Cycle  
number 
Product  
size 
Source Accession number 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
 F-TCT AGA CGG CAG GTC AGG TCC          
 R-CCA CCC ATG GCA AAT TCC ATG 
 
24 391bp (McLachlan et al. 2004)  
Haemoxygenase 1 (HMOX1) 
 F-AAC CTC CAA AAG CCC TGA GT 
 R-CAC CCC AAC CCT GCT ATA AA 
 
34 207bp Designed in-house
*
 NM_0002133.1 
Superoxide dismutase 2 (SOD2) 
 F-TGG AGG CAT CTA GTG GAA AAA 
 R-CCC AGT CTC TCC CCA TTA CA 
 
34 305bp Designed in-house
*
 S77127 
Toll like receptor 2 (TLR2) 
 F-GAT GCC TAC TGG GTG GAG AA  
 R-CGC AGC TCT CAG ATT TAC CC 
 
34 392bp Designed in-house
*
 NM_003264.3 
Toll like receptor 4 (TLR4) 
 F-AAC CAT CCT GGT CAT TCT CG  
 R-CGG AAA TTT TCT TCC CGT TT 
 
34 315bp Designed in-house
*
 NM_138444-2 
Toll like receptor 9 (TLR9) 
 F-CTG CGT CTC CGT GAC AAT TA  
 R-GTC CTG TGC AAA GAT GCT GA 
 
34 443bp Designed in-house
*
 AB045180.1 
Phox22 (p22) 
 F-GTT TGT TTT GTG CCT GCT GGA GT 
 R-TGG GCG GCT GCT TGA TGG T  
 
30 325bp (Jones et al. 1996)  
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Gene (Gene Abbreviation) 
 Primer sequence (5’→3’) 
 
Cycle  
number 
Product  
size 
Source Accession number 
Phox47 (p47) 
 F-ACC CAG CCA GCA CTA TGT GT 
 R-AGT AGC CTG TGS CGT CGT CT 
 
37 767bp (Jones et al. 1996)  
Phox67 (p67) 
 F-CGA GGG AAC CAG CTG ATA GA 
 R-AGT AGC CTG TGA CGT CGT CT 
 
37 726bp (Jones et al. 1996)  
Gp91 Phox (gp91) 
 F-GCT GTT CAA TGC TTG TGG CT 
 R-TCT CCT CAT CAT GGT GCA CA 
 
37 403bp (Jones et al. 1996)  
NFκB2 
 F-CGT ACC GAC AGA CAA CCT CA 
 R-CCG TAC GCA CTG TCT TCC TT 
 
34 186bp Designed in-house
*
 NM_002502.2 
Heat shock protein 40 (Hsp40) 
 F-TAC AGG AGC ACT GTG GAA CG 
 R-AGG TCT GAG CAC TGG ACT GG 
 
30 192bp Designed in-house
*
 D49547.1 
CXCL3/GRO3 
 F-TAA ATG ACA GGG TGG GGA AC 
 R-GCA TTA TGC CCT ACA AGC AA 
 
44 224bp Designed in-house
*
 NM_002090 
Colony stimulating factor 1 (CSF1) 
 F-GCA CTA ATT GGG TCC CAG AA 
 R-GAT GCA GGG AGT GGA GAA GA 
35 159bp Designed in-house
*
 M64592.1 
All primers supplied by Invitrogen (UK) except p22, p47, p67 gp91 (AltaBioscience, University of Birmingham, UK).  *Designed in-house from 
the Affymetrix probe target identifier sequences using the Primer3 program (frodo.wi.mit.edu/cgi-bin/ primer3/primer3_www.cgi).
2.3.1.1 mRNA extraction 
Following differentiation of HL60 cultures using 1.25% DMSO for 3 days (2.1.2), cells were 
washed twice and re-suspended in sterile PBS at 2.5x10
6
 cells per ml.  For comparison, 
primary neutrophils were also isolated as described previously (2.1.1) before also being re-
suspended in sterile PBS at 2.5x10
6
 cells per ml.  1ml of cells was added to 500µl PBS 
containing either PMA (50nM), F. nucleatum (MOI 1:150) or PBS alone and incubated 
(uncapped) at 37C for 3 hours.  Cells were then pelleted by centrifugation for 5 minutes at 
1800 rcf, the supernatant removed and the cell pellet re-suspended by vigorous agitation using 
a bench top vortex (VortexGenie2, Scientific Industries) in 1ml TRI REAGENT™ (T9424 
Sigma).  RNA was extracted using a phenol, phenol-chloroform, chloroform extraction 
technique.  200µl chloroform (C2432 Sigma) was added to the 1ml TRI REAGENT, mixed 
for 15 seconds and left at room temperature for 15 minutes.  This was centrifuged at 12000 rcf 
for 5 minutes to separate the protein, DNA and RNA layers.  The clear top layer containing 
the RNA was transferred by pipette to a separate microfuge tube and 500µl isopropanol (I-
9516 Sigma) added, mixed thoroughly and kept on ice for 10 minutes.  At this stage 1µl 
GlycoBlue (9515 Ambion) was added to enable visualisation of the RNA pellet following 
centrifugation at 12000 rcf for 5 minutes.  The supernatant was removed and the pellet 
washed by re-suspension in 1ml ethanol (E7023 Sigma) by vortexing.  The RNA was again 
pelleted by centrifugation at 7500 rcf for 5 minutes, the supernatant was carefully removed 
and the pellet allowed to air dry for 10 minutes.  The RNA was subsequently re-suspended in 
ribonuclease (RNase) free water and stored at -80C until further processing. 
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2.3.1.2 Reverse transcription 
RNA was reverse transcribed to complementary DNA (cDNA) using an Omniscript RT Kit 
(205111 Qiagen).  2µg RNA (estimated by absorbance at 260nm) in 12µl water was 
combined with 2µl Oligo (dT) primer (10µM; AM5730G Ambion) and heated at 80C for 10 
minutes then cooled on ice for 5 minutes.  The reagents supplied in the Omniscript RT Kit 
were added to each reaction and consisted of 2µl buffer RT, 2µl dNTP Mix, 1µl Omniscript 
Reverse Transcriptase plus 1µl RNasin
®
 RNase inhibitor (10units/µl; N211B Promega).  The 
mix was incubated at 37C for 60 minutes then 95C for 5 minutes.  The reverse transcribed 
cDNA was washed with RNase free water and concentrated by centrifugation at 7267 rcf 
through Microcon
®
 centrifugal filters (30,000 MWCO; 42410 Millipore) until only 
approximately 50µl remained in the filter.  This was collected into a sterile microfuge tube by 
inverting the filter and centrifuging at 1162 rcf for 3 minutes. 
 
For analysis of primary neutrophils, the cDNA from 4 different healthy individuals (2 male 
and 2 female) was pooled, and for analysis of HL60 cells the cDNA from 2 different flasks of 
cells cultured in successive passages was pooled. cDNA samples were stored at -20C until 
use. 
 
2.3.1.3 PCR amplification of selected transcripts 
Amplification of genes characteristic of neutrophil functions (Table 4) was performed by 
mixing 1.25µl cDNA with 12.5µl REDTaq ReadyMix PCR mix (R2523 Sigma), 10.25µl 
molecular biology grade water and 0.5µl each of the forward and reverse primers (12.5µM).  
Amplification was performed in a GeneAmp
®
 PCR System 2700 (Applied Biosystems).  The 
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temperature profile consisted of an initial denaturing step at 94°C for 5 minutes, followed by a 
specified number of cycles (Table 4) of a denaturation step of 94°C for 20 seconds, a primer 
annealing step of 61°C for 20 seconds, and an extension step at 72°C for 20 seconds.  Finally 
an extension step of 72°C for 10 minutes was employed. 
 
2.3.1.4 Gel electrophoresis and image capture 
A 1.5% agarose gel was made by dissolving 1.5g agarose (AGR-500 Web Scientific) per 
100ml TAE buffer (129237 Qiagen) by gentle heating (Microwave, Sanyo) prior to addition 
of ethidium bromide (E7637 Sigma) to a final concentration of 0.5µg/ml.  The gel was poured 
and allowed to set at room temperature before a 6µl PCR sample was loaded per well and 
electrophoresed in TAE buffer at 80 volts for up to 1 hour.  The gel was visualised under 
ultraviolet transillumination (EtBr/UV filter) using G:BOX (SynGene) and an image was 
captured using GeneSnap software (SynGene).   
 
For relative expression level analysis the band intensity of the amplified products were 
normalised to the band intensity of the housekeeping gene GAPDH using GeneTools software 
(SynGene).  Briefly images were opened in GeneTools in the ‘manual band quantification’ 
mode and the ‘spot: rectangle’ tool was used to isolate individual bands.  The ‘assign 
quantity’ tool was used to assign the brightest or control band a value of 100% by setting the 
‘calibrated quantity’ at 100.  All other band intensities were subsequently displayed as a 
percentage relative to this reference band (100%). 
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2.3.2 Staining of HL60 cells 
To compare the cell morphology of undifferentiated and differentiated HL60 cells to primary 
neutrophils, cells were washed in PBS, re-suspended at 1x10
6
 cells/ml in PBS and placed onto 
poly lysine treated multiwell slides (2.1.3) for 30 minutes.  The cells were then fixed using 
dry acetone (20065 VWR) for 15 minutes prior to air drying for 10 minutes and storage at 
-80°C until staining.  
 
2.3.2.1 Haematoxylin and Eosin staining 
For Haematoxylin and Eosin staining slides were treated with Gill’s III Haematoxylin 
(Surgipath Europe Ltd.) for 2 minutes 30 seconds, rinsed in water, 0.3% acetic acid (Merck 
Ltd.) for 1 minute, 0.3% HCl (Merck Ltd.) in 70% ethanol (459844 Sigma) for 1 minute, 
rinsed in tap water, followed by Scotts Tap Water Substitute (Surgipath Europe Ltd.) for 1 
minute, rinsed in tap water, Eosin (Surgipath Europe Ltd.) for 30 seconds, rinsed in tap water, 
100% ethanol (459844 Sigma), xylene (Genta Medical) for 1 minute x3 and finally mounted 
using XAM neutral medium (361194Y BDH). 
 
2.3.2.2 Immunocytochemical staining 
For immunocytochemical staining of neutrophil elastase and myeloperoxidase, endogenous 
peroxidise activity was first blocked using 0.3% H2O2 (H-1009 Sigma) in methanol (20847 
VWR) for 10 minutes then rinsed in PBS.  Primary antibody diluted in 1% BSA in PBS 
(Table 5) was applied for 2 hours, the cells were then rinsed twice in PBS before the 
secondary antibody (Table 5) diluted in 10% human serum, was applied for 2 hours.  Cells 
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were again washed twice in PBS and a concentrated label (peroxidise-conjugated streptavidin; 
HK320-UK BioGenex) was diluted 1:50 in 10% human plasma, and applied for 1 hour.  Cells 
were washed twice in PBS and 0.05% diaminobenzidine in PBS supplemented with 1.25µl/ml 
H2O2 (30%; H-1009 Sigma) was applied for 5 minutes.  The slides were washed well in water 
before being dehydrated through 70%, 80%, 90% and 100% ethanol for 5minutes each, and 
kept in xylene until being mounted in XAM. 
 
Table 5. Antibodies and dilutions used for immunocytochemical staining. 
Primary 
antibody 
Polyclonal Sheep Anti-Human 
Neutrophil Elastase 
Polyclonal Rabbit Anti-Human MPO 
 (The Binding Site, PC052) (Dako, A0398) 
 
Dilution 
 
 
11.75µg/ml 
 
11µg/ml 
Secondary 
antibody 
Donkey Anti-Sheep/Goat Ig (biotin 
conjugate) 1:1600  
(AB360 The Binding Site) 
MultiLink
®
 (biotinylated anti-
immunoglobulins)1:50  
(HK268-UK BioGenex) 
 
 
2.4 Culture of bacteria 
A panel of 34 anaerobic periodontal bacteria (Table 6) obtained from the Forsyth Institute, 
Boston and originally purchased from the American Type Culture Collection (ATCC) were 
cultured i) for use as stimuli of neutrophils and HL60 cells in the assay of NET and ROS 
generation (2.1), ii) for bacterial DNase activity characterisation (2.7) and iii) for 
antimicrobial susceptibility testing using histones (2.6). 
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Table 6. Oral microorganisms used in this study 
ATCC 
number 
Bacterial strain 
10556 Streptococcus sanguis 
10558 Streptococcus gordonii 
10790 Veillonella parvula 
10953 Fusobacterium nucleatum subsp. polymorphum 
11827/8 Propionybacterium acnes 
12102 Actinomyces israelii 
12104 Actinomyces naeslundii genospecies 1 
14201 Leptotrichia buccalis 
17929 Actinomyces odontolyticus I 
19696 Neisseria mucosa 
25175 Streptococcus mutans 
25586 Fusobacterium nucleatum subsp. nucleatum 
25611 Prevotella intermedia 
25845 Prevotella melaninogenica 
27335 Streptococcus intermedius 
27823 Streptococcus constellatus 
27824 Gemella morbillorum 
29523 Aggregatibacter actinomycetemcomitans serotype a 
33236 Campylobacter gracilis 
33238 Campylobacter rectus 
33270 Peptostreptococcus micros 
33277 Porphyromonas gingivalis  
33397 Streptococcus anginosus 
33612 Capnocytophaga sputigena 
33563 Prevotella nigescens 
33624 Capnocytophagia gingivalis 
35037 Streptococcus oralis 
35308 Prevotella denticola 
43037 Tannerella forsythensis 
43146 Actinomyces viscosus (naeslundii genospecies 2) 
43718 Aggregatibacter actinomycetemcomitans serotype b 
49456 Streptococcus mitis 
51146 Campylobacter showae 
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2.4.1 Storage of bacteria 
All bacteria were stored at -80
o
C in 2ml cryovials containing 1.5ml tryptone soya broth 
(2.4.4.1) supplemented with 10% v/v DMSO.  Initial innoculae were established by defrosting 
the frozen microorganism aliquots at room temperature prior to pouring on to agar plates 
(2.4.3) for 1 week anaerobic incubation with plates facing upwards.  Subsequently cultures 
were grown and assayed on agar plates or planktonically in liquid culture. 
 
2.4.2 Culture conditions 
All oral microorganisms were grown in an anaerobic chamber (Don Whitley Scientific, 
Modular Atmosphere Controlled System, CAL-3200, Shipley, UK) to provide an 
environment of carbon dioxide 9.97%, hydrogen 9.92% with nitrogen balance at 37
o
C.  Re-
plating of all oral organisms was required every 7 days and were used in subsequent assays on 
day +5 or +6. 
 
2.4.3 Blood agar 
All oral microorganisms were cultured on blood agar plates.  These comprised tryptone soya 
agar (CM0131 Oxoid) prepared according to the manufactures instructions at 40g in 1 litre 
distilled water.  After autoclaving at 121C for 15 minutes the agar was cooled to 50C in a 
water bath, before 5% defibrinated horse blood (SR0050B Oxoid) was aseptically added.  
Agar was poured into triple vented Petri dishes (101VR20 Sterilin) and left inverted for 24 
hours to allow ventilation of excess moisture, prior to storage at 4C.  Before use, dishes were 
allowed to equilibrate at room temperature for 1 hour.  
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2.4.3.1 Enriched blood agar  
The growth of P. gingivalis and T. forsythensis required blood agar enriched with the 
components described below - hemin (2.4.3.2), NAM (2.4.3.3) and vitamin K (2.4.3.4) - and 
termed HNK agar. 
 
2.4.3.2 Hemin (100x concentration) 
50mg hemin (H-5533 Sigma) and potassium phosphate 1.74g (P-5504 Sigma) were added to 
100ml of distilled water.  This solution was boiled until the hemin had dissolved.  After 
cooling to room temperature, the solution was stored at 4
o
C covered in aluminium foil. 
 
2.4.3.3 N-acetylmuramic acid (NAM; 100x concentrated solution) 
100mg of NAM (A3007 Sigma) was dissolved in 10ml of distilled water and filter sterilised 
(0.2m, BC591 Appleton Woods) prior to storage at -20oC. 
 
2.4.3.4 Vitamin K (100x concentrated solution) 
5mg menadione (M-5625 Sigma) was dissolved in 1ml of 95% ethanol (Sigma).  99ml 
distilled water was added and the resultant solution filter sterilised (430944 Corning) prior to 
storage at -20
o
C. 
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2.4.3.5 Preparation of enriched blood agar 
For the preparation of 10 HNK agar plates the following were added to 250ml distilled water: 
5.0g tryptone soya agar (CM0131 Oxoid), 6.5g brain heart infusion (CM225 Oxoid), 2.5g 
yeast extract (Y-1001 Sigma) and 2.5ml hemin (2.4.3.2).  This solution was sterilised by 
autoclaving at 121
o
C for 15 minutes.  The agar was cooled to 50C and 300µl NAM (2.4.3.3), 
2.5ml vitamin K (2.4.3.4) and 12.5ml defibrinated horse blood (SR0050B Oxoid) was 
subsequently added before pouring into 90mm triple vented Petri dishes and allowed to set at 
room temperature. 
 
2.4.4 Planktonic growth of bacteria 
All liquid media were allowed to equilibrate at room temperature for 1 hour before use.  
Sterile broth was inoculated by transfer of bacterial growth from agar plate cultures using a 
flame sterilised loop.  Cultures were then incubated anaerobically with gentle agitation 
(Vibrax VXR basic, IKA) until turbidity was observed. 
 
2.4.4.1 Tryptone soya broth 
Tryptone soya broth (CM0129 Oxoid) was prepared according to the manufacturers 
instructions.  10ml of the tryptone soya broth was aliquotted into borosilicate glass culture 
tubes (FB59537 Fisher Scientific) with vented plastic caps (TB51373 Fisher Scientific) and 
autoclaved at 121C for 15 minutes prior to storage at 4C. 
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2.4.4.2 Enriched tryptone soya broth 
An enriched tryptone soya broth was required for the growth of T. forsythensis and P. 
gingivalis.  1mg/ml glucose powder and 0.01ml per ml hemin were added to the standard 
tryptone soya broth prior to autoclaving, in addition to either 10µg/ml NAM or 0.3µg/ml 
vitamin K for T. forsythensis and P. gingivalis respectively after autoclaving. 
 
2.5 Identification of bacteria 
The identification of bacteria was verified by streak plating out to single colonies to observe 
colony morphology.  Bacteria were also Gram stained to observe microscopic cell 
morphology and tested for catalase activity primarily to distinguish streptococci and 
staphylococci.  The reference system used for identification was Bergey’s Manual of 
Determinative Bacteriology (Holt 1994).  Bacterial identity was also validated using PCR 
amplification of species specific genes which predominantly included analysis of the 16s 
ribosomal RNA.  This analysis was possible for 29 of the 34 test bacteria used in these 
studies. 
 
2.5.1 Gram stain 
Gram staining distinguishes between Gram positive bacteria which have peptidoglycan outer 
layer and are stained purple by crystal violet, and Gram negative bacteria which have an outer 
lipid membrane which is removed by acetone along with the purple staining and are therefore 
counter-stained pink with carbol fuchsin. 
 85 
2.5.1.1 Crystal violet solution 
10g of crystal violet (C0775 Sigma) was dissolved in 100ml 95% ethanol. 20ml of this was 
mixed with 80ml of 1% ammonium oxalate (A8545 Sigma) in distilled water and allowed to 
stand for several weeks prior to use. 
 
2.5.1.2 Carbol fuchsin 
Strong carbol fuchsin (351874U BDH) was diluted 1:9 in distilled water. 
 
2.5.1.3 Method for Gram stain 
A drop of sterile 85% saline was placed on a microscope slide.  A sterile loop was used to 
transfer bacterial colonies and emulsified in the saline.  The suspension of bacteria was dried 
by passing the slide several times through a flame to fix the bacteria.  The bacteria were then 
covered with crystal violet for 30 seconds, rinsed under tap water, Lugols iodine (L6146 
Sigma) was applied for 15 seconds, rinsed, flooded with acetone and washed immediately, 
then treated with carbol fuchsin for 15 seconds and rinsed.  The slide was blotted dry and 
viewed under oil immersion microscope (Leitz Dialux 22).  Images were captured using a 
digital camera (Nikon Coolpix 990).  ‘Blank’ photographs taken at the same magnification 
and focus of an empty field were also obtained to perform background subtraction using 
ImageJ software.  Both images were subsequently opened in the ImageJ software and the 
‘morphology’: ‘calculator plus’ plugin used to ‘divide’ the image by the background image.  
The resultant image was subsequently saved. 
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2.5.2 Catalase test  
A small glass capillary tube was used to contact a bacterial colony on an agar plate and the 
other end dipped into 3% hydrogen peroxide (H-1009 Sigma).  The tube was inverted and the 
hydrogen peroxide was allowed to run down the capillary tube until it came into contact with 
the bacteria.  A positive result was indicated by the production of bubbles observed visually, 
as oxygen was liberated from the hydrogen peroxide as it was converted by catalase. 
 
2.5.3 PCR identification 
Genes specific to each bacterial species were amplified by PCR   
 
2.5.3.1 PCR primers 
Where possible, primer sequences were taken from the existing literature.  Where no primers 
existed, bacterial gene sequences were obtained from NCBI Entrez nucleotide database 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=nuccore&itool=toolbar) and primers were 
designed in-house.  A search for genes with similar sequences was performed using 
nucleotide BLAST (basic local alignment search tool) with microbial genomes 
(http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi) and genes with a >90% homology with 
the desired gene as well as those from related bacterial species were aligned using ClustalW2 
(Larkin et al. 2007) (http://www.ebi.ac.uk/Tools/clustalw2/index.html).  Regions of sequence 
unique to the gene of interest were identified to give primers of approximately 20 base pairs 
(bp) in length which could be used to amplify DNA products of approximately 300-650bp 
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(Table 7).  For gene sequence alignments which were used for species specific primer design, 
see Appendix (Figure 92). 
 
 
 
 
Table 7. Primers and PCR conditions used for bacteria identification 
Bacterial species (gene) 
 Primer sequence (5’-3’) 
 
Cycles Annealing 
conditions 
Source Accession number 
S. sanguis  (glucosyltransferaseP) 
 GGA TAG TGG CTC AGG GCA GCC AGT T 
 GAA CAG TTG CTG GAC TTG CTT GTC  
 
30 70°C 1min (Hoshino et al. 2004)  
V. parvula (16S rRNA) 
 TGA AAG GTG GCC TCT ATT TAT 
 CAA TCC TTC TAA CTG TTC GCA AG 
 
35 60°C 20sec (Rôças et al. 2006)  
F. nucleatum (16S rRNA) 
 CTA AAT ACG TGC CAG CAG CC                  
 CGA CCC CCA ACA CCT AGT AA 
 
33 55°C 20sec (Kulekci et al. 2001)  
L. buccalis (16s rRNA) 
 TGC CAG CAC GCA TGT GCC CGG CA  
 ACG GAC ACT CTT CAT GCC C 
 
30 50°C 20sec Designed in-house X90831 
A. odontolyticus (16s rRNA) 
    GCT CAT GGT CAA GCC GC 
 ATC TCT GCA GTG CCG CC 
 
30 50°C 20sec Designed in-house AJ234054 
N. mucosa (penicillin binding protein A) 
 GGT TTT GTC TTT GGA TCA AC 
 ATG GTG TTA AAA CGA TCA GC 
 
35 50°C 20sec Designed in-house X59635 
S. mutans  (glucosyltransferaseD) 
 GGC ACC ACA ACA TTG GAA GCT CAG TT 
 GGA ATG GCC GCT AAG TCA ACA GGA T 
30 70°C 1min (Hoshino et al. 2004)  
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Bacterial species (gene) 
 Primer sequence (5’-3’) 
 
Cycles Annealing 
Conditions 
Source Accession number 
P. intermedia (16S rRNA) 
 TTT GTT GGG GAG TAA AGC GGG 
 TCA ACA TCT CTG TAT CCT GCG T 
 
36 55°C 1min (Ashimoto et al. 1996)  
S. intermedius (intermedilysin) 
 CTC ACC CTC AAT CAT GAT GGT GC 
 CGA CTC ACT ATA GGG AGA TCA GCA TGG 
 
36 55°C 1min (Goto et al. 2002)  
S. constellatus  (hyaluronate lyase) 
 TGG TGG GAC TAC GAG ATT GG 
 CTC TCT CTT GAG ATT GTT GC 
 
30 58°C 15sec (Takao et al. 2004)  
A. actinomycetemcomitans a  (mannosyltransferase) 
 GCA ATG ATG TAT TGT CTT CTT TTG GA 
 CTT CAG TTG AAT GGG GAT TGA CTA AAA C 
 
40 55°C 5sec (Suzuki et al. 2001)  
C. gracilis (16S rRNA) 
 AAC GGA ATT TAA GAG AGC TT  
 CTT TCC CGA TTT ATC TTA TG 
 
26 53°C 45sec (Siqueira Júnior et al. 
2003) 
 
C. rectus and C. showae (16S rRNA) 
 TTT CGG AGC GTA AAC TCC TTT TC 
 TTT CTG CAA GCA GAC ACT CTT 
 
36 60°C 1min
 
(Slots et al. 1995) 
 
 
P. micros (16S rRNA) 
 TCG AAC GTG ATT TTT GTG GA 
 TCC AGA GTT CCC ACC TCT 
28 55°C 1min (Riggio et al. 2001)  
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Bacterial species (gene) 
 Primer sequence (5’-3’) 
 
Cycles Annealing 
conditions 
Source Accession number 
P. gingivalis (fimbrial protein) 
 ATA ATG GAC AAC AGC AGG AA 
 TCT TGC CAA CCA GTT CCA TTG C 
 
40 55°C 30sec (Watanabe et al. 
1993) 
 
S. anginosus (16S rRNA) 
 GCG TAG GTA ACC TGC CTA TTA GA 
 CGC AGG TCC ATC TAC TAG C 
 
30 58°C 15sec (Takao et al. 2004)  
C. sputigenia (16s rRNA) 
 AGA GTT TGA TCC TGG CTC AG 
 GAT GCC GCT CCT ATA TAC CAT TAG G 
 
35 55°C 20sec (Hayashi et al. 2001)  
P. nigrescens (16S rRNA) 
 ATG AAA CAA AGG TTT TCC GGT AAG 
 CCC ACG TCT CTG TGG GCT GCG A 
 
36 55°C 1min (Ashimoto et al. 1996)  
C. gingivalis (16s rRNA) 
 AGA GTT TGA TCC TGG CTC AG 
 GGA CGC ATG CCC ATC TTT CAC CAC CGC 
 
30 65°C 20sec (Hayashi et al. 2001)  
S. oralis  (glucosyltransferaseR) 
 TCC CGG TCA GCA AAC TCC AGC C 
 GCA ACC TTT GGA TTT GCA AC 
 
30 66°C 1min (Hoshino et al. 2004)  
T. forsythensis (16S rRNA) 
  GCG TAT GTA ACC TGC CCG CA 
 TGC TTC AGT GTC AGT TAT ACC T 
36 60°C 1min (Slots et al. 1995)  
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Bacterial species (gene) 
 Primer sequence (5’-3’) 
 
Cycles Annealing 
conditions 
Source Accession number 
A. viscosus (unknown protein) 
 ATG TGG GTC TGA CCT GCT GC 
 CAA AGT CGA TCA CGC TCC G 
 
40 55°C 20sec (Suzuki et al. 2004)  
A. actinomycetemcomitans b (deoxyglucose reductase) 
 CGG AAA TGG AAT GCT TGC 
 CTG AGG AAG CCT AGC AAT 
 
40 55°C 5sec (Suzuki et al. 2001)  
P. acnes (16s rRNA) 
 GGG TTG TAA ACC GCT TTC GCC T 
 GGC ACA CCC ATC TCT GAG CAC 
 
30 54°C 20sec (Sfanos et al. 2008) 
 
 
A. israelii (16s rRNA) 
 AGA GTT TGA TCC TGG CTC AG 
 CCA AAA CAC CAC AAA AGT GA 
 
30 58°C 20sec (Conrads et al. 1997)  
A. naeslundii (fimbrial protein) 
 GTC CAC GTC TAC CCC AAG AAC 
 CAG GAA GAT GAC GCC GTT GGC 
 
36 60°C 20sec (Tran et al. 1996)  
P. melaninogenica (haemolysin) 
 CGT CAT GAA GGA GAT TGG 
 ATA GAA CCG TCA ACG CTC 
 
35 54°C 20sec (Yoshida et al. 2005)  
P. denticola (16s rRNA) 
 TTC TTC GAT GAC GGC ATC AGA TT 
 GTC AGA CGT TGG GCG CCT ACA 
35 55C 20sec Designed in-house L16467 
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2.5.3.2 Bacterial PCR 
1x10
6
 bacteria suspended in 1µl molecular biology grade water were mixed with 12.5µl 
REDTaq ReadyMix PCR reaction mix (R2523 Sigma), 10.5µl molecular biology grade water 
and 0.5µl each of the forward and reverse primers (25µM).  Amplification was performed in a 
GeneAmp
®
 PCR System 2700 (Applied Biosystems).  The temperature profile consisted of an 
initial denaturing step at 94°C for 5 minutes which also served to lyse the bacteria.  This was 
followed by a specified number of cycles (Table 7) of a denaturation step of 94°C for 20 
seconds, a primer annealing step (Table 7), and an extension step at 72°C for 20 seconds.  
Finally an extension step of 72°C for 10 minutes was performed. 
 
PCR products were analysed by 1.5% agarose gel electrophoresis and images captured as 
previously described (2.3.2.4). 
 
2.6 Antimicrobial susceptibility testing using histone proteins 
A major structural component of NETs is chromatin (i.e. DNA in complex with histones), and 
purified histone H2A has been reported to exert an antimicrobial effect (Brinkmann et al. 
2004).  Therefore the antimicrobial capacity of mixed histone to inhibit the growth of 
periodontal pathogens was assayed by the methods detailed below. 
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2.6.1 Microtitre plate analysis for antimicrobial susceptibility testing 
10ml tryptone soya broth (2.4.4.1) was inoculated with bacteria and incubated anaerobically 
overnight with agitation.  The culture was homogenised by mixing and 1ml of the culture read 
in a spectrophotometer (2.6.2).  All cultures were then adjusted to 2x10
5
 bacteria/ml by 
addition of sterile tryptone soya broth using values listed in Table 8.  In a clear sterile 96-well 
plate (3360 Corning) 100µl bacteria were added to 80µl sterile tryptone soya broth and 20µl 
mixed histone (H9250 Sigma) in PBS 1mg/ml, 20µl penicillin-streptomycin as a positive 
control (100units penicillin/100µg streptomycin per ml diluted in PBS) or 20µl PBS as a 
negative control.  The plate was incubated anaerobically overnight at 37C with gentle 
agitation (Vibrax VXR basic, IKA).   
 
2.6.2 Determination of bacterial growth by spectrophotometry 
Cell growth was estimated using a spectrophotometer (Jenway 6300) by measuring optical 
density at 600nm (OD600nm).  Non-inoculated samples of media were used to correct for media 
changes in absorbance at OD600nm not due to bacterial growth.  The OD600nm values used to 
estimate bacterial growth were calculated by the Forsyth Institute, Boston and are listed in 
Table 8.  For spectrophotometric readings of bacterial growth in microtitre plates after 
overnight anaerobic incubation (2.6.1), an automated plate reader (ELx800, Bio-Tek 
Instruments Inc.) was used to record absorbance at 590 or 630 nm. 
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Table 8. OD values of bacteria 
ATCC 
number 
Bacterial strain Bacteria per ml 
if OD600=1 
 
10556 S. sanguis 1.69 x 10
9
 
10558 S. gordonii 1.69 x 10
9
 
10790 V. parvula 6.80 x 10
9
 
10953 F. nucleatum subsp. polymorphum 1.62 x 10
9
 
11827/8 P. acnes 1.69 x 10
9
 
12102 A. israelii 8.30 x 10
8
 
12104 A. naeslundii 1 8.30 x 10
8
 
14201 L. buccalis 8.30 x 10
8
 
17929 A. odontolyticus I 8.30 x 10
8
 
19696 N. mucosa 1.69 x 10
9
 
25175 S. mutans 1.69 x 10
9
 
25586 F. nucleatum subsp. nucleatum 1.62 x 10
9
 
25611 P. intermedia 1.69 x 10
9
 
25845 P. melaninogenica 1.69 x 10
9
 
27335 S. intermedius 1.69 x 10
9
 
27823 S. constellatus 1.69 x 10
9
 
27824 G. morbillorum 1.69 x 10
9
 
29523 A. actinomycetemcomitans a 6.80 x 10
9
 
33236 C. gracilis  6.80 x 10
9
 
33238 C. rectus 6.80 x 10
9
 
33270 P. micros 1.69 x 10
9
 
33277 P. gingivalis 1.69 x 10
9
 
33397 S. anginosus 1.69 x 10
9
 
33612 C. sputigena 1.62 x 10
9
 
33624 C. gingivalis 1.62 x 10
9
 
33563 P. nigescens 1.69 x 10
9
 
35037 S. oralis 1.69 x 10
9
 
43037 T. forsythensis 8.30 x 10
8
 
43146 A. viscosus 8.30 x 10
8
 
43718 A. actinomycetemcomitans b 6.80 x 10
9
 
49456 S. mitits 1.69 x 10
9
 
51146 C. showae 6.80 x 10
9
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2.6.3 Determination of bacterial growth by colony count 
After overnight incubation in a microtitre plate (2.6.1) a sample from each well was diluted 1 
in 30,000 and 1 in 3,000,000 in sterile PBS and 50µl of each spread on a tryptone soya agar 
plate (without horse blood; 2.4.3).  These plates were incubated anaerobically for 2 days and 
colony counts performed. 
 
2.6.4 Determination of bacterial growth by fluorescence 
The microtitre plate was frozen at -20
o
C until fluorometric assay of bacterial growth was 
performed.  The plate was then defrosted and a 25µl sample from each well was mixed with 
150µl water and 25µl SYTOX
®
 green (10µM) in a black 96 well microplate (3915 Corning).  
DNA fluorescence was then measured in the fluorometer at excitation 485nm and emission 
525nm for 10 minutes at 37C. 
 
 
2.7 Deoxyribonuclease (DNase) activity assays 
Two methods were used to assess the DNase activity of the panel of oral microorganisms.  
This data may indicate their ability to degrade and evade NETs.   
 
2.7.1 Plate flooding method 
DNase test agar plates are used routinely by the NHS for identification of pathogenic 
staphylococci.  The method involves growing bacteria on solid agar enriched with DNA, the 
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hydrolysis of which is detected by staining with a metachromatic dye (toluidine blue O), 
indicating DNase expression and activity. 
 
2.7.1.1 Preparation of DNase test plates 
DNase test agar (70136 Sigma) was prepared according to the manufacturers instructions and 
preparation of solid culture media described previously (2.4.3).  An enriched DNase test agar 
was also prepared for the testing of P. gingivalis and T. forsythensis by the addition of 
previously prepared hemin, N-acetylmuramic acid and vitamin K (2.4.3.1). 
 
2.7.1.2 Toludine blue O (TBO) 0.05% 
0.3g solid TBO (Hopkin and Willams, Essex, UK) was dissolved in 500ml distilled water and 
stored at room temperature. 
 
2.7.1.3 Innoculation of DNase test plates 
A sterile loop was used to take an inoculum from 4-7 day culture plates and touched once 
onto the test plate. One test plate was used for 3 spot innoculae.  Plates were subsequently 
incubated under anaerobic conditions for 5 days. 
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2.7.1.4 Plate flooding method 
Plates were flooded with 0.05% TBO (2.7.1.2) for 3 minutes prior to rinsing under tap water 
and observed after a further 10 minute incubation at room temperature. 
 
2.7.1.5 Image analysis 
A positive result was indicated by a zone of purple staining around DNase producing colonies 
(Figure 22).  The absence of any zone was used to indicate a negative result. 
                                  
For relative quantification analysis, digital photographs of plates were captured (Fujifilm 
FinePix 2800z) under white light illumination (Light box, Hancocks).  ImageJ (1.38d) 
software analysis was then used to quantify the area of DNase positive zones.  Images were 
binarised using the ‘binary’ process function (Figure 23).  The area around a single bacterial 
colony and its zone of hydrolysis was determined using the ‘selection’ tool, and the remainder 
of the image was cleared using the ‘clear outside’ function.  The number of black pixels, 
representing the zone of DNA hydrolysis, was quantified using the ‘analyze particles’ 
function.  The ‘selection’ tool was again used to select only the area of bacterial growth 
27823 
1cm2 33270 
25611 
Figure 22. DNase test 
plate flooded with 
TBO.  Bacteria 
identified by ATCC 
number.  25611 and 
27823 are examples of 
DNase positive 
bacteria and 33270 was 
regarded as being 
DNase negative. 
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(shown in white; Figure 23).  The white pixels were then converted to black using the ‘invert’ 
function to allow quantification of the pixels (analyze particles function).  The 1cm black 
square was also selected and pixels quantified in the same way to enable conversion of 
number of pixels to area in millimetres.  DNase activity was expressed as the area of 
hydrolysis per area of bacteria growth (mm
2
 per mm
2
). 
                                   
 
2.7.2 Agarose gel method 
To allow more robust quantification than DNase test plate assay, and to utilise bacteria grown 
in the planktonic rather than solid state an agarose gel method for DNase detection was 
developed. 
 
2.7.2.1 Preparation of test samples 
Day +5 or +6 broth cultures of bacteria were briefly vortexed for homogenisation.  Cultures 
were then transferred to DNase free centrifuge tubes (91015 TTP) and bacteria were pelleted 
by centrifugation at 1087 rcf for 40 minutes at 4C.  500µl of the supernatant was filter 
Figure 23. Binarised 
image of Figure 22  
using ImageJ software. 
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sterilised (BC591 Appleton Woods) and retained for further analysis.  The remaining 
supernatant was removed and the bacterial pellet re-suspended in 1ml of sterile PBS.  This 
was again centrifuged at 1087 rcf for 40 minutes, and the pellet was re-suspended in 1ml PBS 
for storage, along with the sterile filtered supernatant at -20
o
C. 
 
2.7.2.2 Reaction mixture for agarose gel method of DNase assay 
Pellet samples were adjusted by the addition of molecular biology grade water (443847D 
VWR) to give a suspension of 1x10
9
 bacteria per ml.  10µl of test sample, 10µl DNase I 
reaction buffer (BO303S New England Biolabs), 10µl molecular biology grade water 
(443847D VWR) and 20µl calf thymus DNA 1µg/µl (89370 Sigma) were incubated at 37C 
for 2 hours.   
 
The positive control samples included consisted of 0.5-250 Kunitz/L bovine pancreatic DNase 
(D4263 Sigma) diluted with molecular biology grade water.  A negative control reaction was 
performed using 10µl of a non-inoculated bacterial culture media.  Kunitz are a measure of 
enzymatic activity specifically of DNase developed since M. Kunitz first described a 
spectrophotometric method for measuring the degradation of DNA by the newly identified 
bovine pancreatic DNase in 1950 (Kunitz 1950). 
‘Unit definition: One Kunitz unit will produce a change in A260 of 0.001 per minute 
per ml at pH 5.0 at 25 °C using DNA, Type I or III, as the substrate. This enzyme 
assay reaction is performed in 83 mM acetate buffer, pH 5.0,at 25°C, containing 
4.2mM Mg
2+, in a 3 ml reaction.’ Sigma. 
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The reaction was stopped by the addition of 8.25µl of 0.5M ethylamineditetraacetic acid 
(EDTA; E-7889 Sigma) which functioned to chelate the divalent cations (Mg
2+
 and Ca
2+
 
contained within the DNase I reaction buffer) reported to be essential for the activity of 
DNase (Pan et al. 1999).  A sample was mixed with 10x loading buffer (Bioline) before 
electrophoresis on a 0.8% agarose gel and image capture as previously described (2.3.1.4). 
 
2.8 Detection of DNase in plaque and GCF samples 
The in vivo presence of DNase in an experimental 21-day model of gingivitis was examined 
by assay of plaque and GCF samples.  
 
2.8.1 Clinical study period 
A 21 day model of experimental gingivitis involving ten undergraduate dental students was 
undertaken by the Periodontal Department of the School of Dentistry as described by Chapple 
et al (1996).  Ethical approval for this study was obtained from the South Birmingham Local 
Research Ethics Committee (LREC 2004/074).  10 volunteers with no periodontal disease 
(past or present), unremarkable medical histories, who were not undergoing orthodontic or 
prosthetic appliance therapy, or taking medication that may have affected results were 
enrolled and informed consent obtained.  A split mouth model was employed whereby a soft 
vinyl mouth guard was constructed to cover maxillary left 4-6 teeth which was to be worn 
during tooth brushing for the 3 week study period to shield from mechanical or chemical 
cleaning.  The maxillary right 4-6 teeth were used as control teeth undergoing normal oral 
hygiene.  Volunteers were asked to refrain from chewing gum during the study period which 
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consisted of an initial assessment at baseline followed by 3 weeks using the tooth shield to 
facilitate plaque accumulation at test teeth with assessment at days 7, 14 and 21. 
 
2.8.2 Clinical measures of gingival inflammation 
To document the progression of gingival inflammation 3 clinical parameters were measured – 
gingival index scores 0-3, plaque index measured by the modified Quigley-Hein index, and 
GCF volume measured by Periotron 8000
™
 (Oraflow, USA).  Ginigval and plaque scores 
were recorded by Mr Mike Milward and GCF volume by Professor Iain Chapple. 
 
2.8.3 Plaque sampling  
Plaque samples were taken from test and control teeth in each subject by methods modified 
from Kalfas et al (1990) and Lingström et al (1993) and performed by Professor Iain Chapple.  
A sterile size 30 finger spreader (25mm, Claudius Ash) was used to remove plaque from the 
palatal aspect of the tooth and the sample suspended in 100µl PBS.  Samples were vigorously 
vortexed (VortexGenie2, Scientific Industries) to homogenise the plaque sample and they 
were stored at -20C until assay.  Different sites were sampled on each of the 4 test days so 
that the sample represented undisturbed plaque accumulation from day 0.  
 
2.8.4 GCF sampling 
GCF was collected by Professor Iain Chapple using a modified version of the methods 
reported by Chapple et al (2007a). 
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2.8.4.1 PBS-BSA 
50mg BSA (A4530 Sigma) was added to 1litre sterile PBS and stored at 4C. 
 
2.8.4.2 GCF sampling 
A periopaper
™
 strip was inserted into the mesio-buccal gingival crevice of each of the 3 test 
teeth and 3 control teeth for 30 seconds.  These were read on a pre-calibrated Periotron 8000
™
 
(Chapple et al. 1999) for calculation of GCF volume before the 3 strips were pooled into 
300µl PBS-BSA and stored in liquid nitrogen. 
 
2.8.5 Assay of samples for DNase activity 
DNase assay was performed as previously described gel based assay (2.7.2). 10µl plaque or 
30µl GCF sample was used in the assay.  
 
2.9 Statistical analysis 
Microsoft Office Excel or GraphPad InStat (Graphpad Inc.) were used for all statistical 
analysis.  For parametric and normally distributed data paired student T test was used.  For 
non-parametric data (e.g. clinical indices) and non-normally distributed data Wilcoxon 
matched pairs test was used.  For correlation analysis of normally distributed data Pearson test 
was used.  P≤0.05 was considered significant in all cases. 
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CHAPTER 3 RESULTS                                                                                                    
Assay of NET release 
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Vitkov et al. (2009) have previously described the presence of NETs on the gingival pocket 
surface and in purulent crevicular exudate (Figures 18 and 19).  Immunofluorescence analysis 
of tissue sections obtained in our laboratory has also shown for the first time the presence of 
NET structures within the gingival tissues with these appearing more abundant in inflamed 
than healthy tissues (Figure 20; confocal microscopy by Dr S Yousefi, University of Berne, 
Switzerland).  However, as it is known that the neutrophils recruited from the peripheral 
vasculature to the diseased or infected tissues are the primary source of NETs, it is these cells 
that are routinely isolated and used to study ex vivo NET release in response to stimuli (Gupta 
et al. 2005, Clark at al. 2007).  Therefore, in the current study peripheral blood neutrophils 
were isolated from systemically and periodontally healthy individuals and stimulated to 
mimic exposure to NET inducers that may arise within the periodontal tissues.  Stimuli used 
included the periodontal pathogen F. nucleatum, in addition to opsonised S. aureus (an Fcγ-
receptor ligand), fMLP and PMA.  The latter has routinely been reported within the literature 
as a positive control to stimulate NETs (Gupta et al. 2005, Ermert et al. 2009).  Methods 
previously described for the assay of NET production vary widely, and different methods for 
cell isolation, culture, stimulation, fixing and staining, and quantification have all been 
reported.  Therefore, initially for this study, an optimised and standardised NET production 
technique was developed to enable quantification and comparison between experimental 
approaches employed in subsequent studies.  The NET detection methods described in this 
chapter are, 
 i) Visualisation of SYTOX stained NETs on glass slides or in culture dishes. 
 ii) Real-time fluorometric quantification of SYTOX stained DNA throughout the 3 
 hour neutrophil incubation period. 
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 iii) End-point fluorescence of SYTOX stained DNA at end of neutrophil incubation 
 period only i.e. after 3 hours. 
 iv) MNase assay – fluorometric quantification of extracellular NET-DNA liberated by 
 MNase treatment of neutrophils after 3 hours incubation period. 
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3.1 Fluorometric quantification of NET release 
NETs can be produced by seeding and stimulating neutrophils on glass slides and visualised 
by staining the NET-DNA with SYTOX
®
 green fluorescent dye.  However, to enable 
comparison between experimental conditions it is important to be able to objectively quantify 
NET release.  One reported approach for quantification utilises fluorometric analysis of the 
light output generated by DNA-bound SYTOX
®
 dye and is measured in arbitrary fluorescent 
units (AFU) (Brinkmann et al. 2004; Martinelli et al. 2004).  To develop this technique for a 
high throughput approach, the fluorescently labelled (SYTOX
®
) extracellular NET-DNA was 
assayed in a 96-well format (2.1.4) and fluorescence quantified throughout the 3 hour 
incubation period.   
 
3.1.1 Sensitivity of fluorometric detection of DNA 
Initially the sensitivity range for fluorometric detection of DNA following SYTOX
®
 
(1.25µM) staining was determined using known concentrations of calf thymus DNA (Figure 
24).  As stimulation of cells is routinely performed over a 3 hour incubation period at 37C, 
the fluorescence of the DNA standards was read at 10 minutes (following mixing) to allow the 
dye to bind and then again at 3 hours.  Data demonstrated that there was on average a 38% 
decrease in fluorescence at 3 hours compared to the readings obtained at 10 minutes. 
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Figure 24. Fluorometric detection of SYTOX
®
 stained calf thymus DNA.  Readings were 
obtained after 10 minutes and 3 hours incubation at 37C. Data represents mean values of 
experiment performed in triplicate ± standard deviation (SD).  Fluorescence is measured in 
arbitrary fluorescent units (AFU). 
 
 
3.1.2 Determination of optimal concentrations of cells 
Unlike calf thymus DNA, NET derived nuclear DNA is complexed with histone and non-
histone proteins in the form of chromatin which may affect dye binding and subsequent 
fluorescence.  Reportedly neutrophils contain ~620ng DNA per 1x10
5
 cells (Fuchs et al. 
2007) therefore the predicted fluorescence for this number of cells in the assay would locate 
on the first half of the standard curve (Figure 24).  However, as the SYTOX
® 
dye can enter 
and stain the nuclei of dead cells only, and as components of the cell media may influence 
background fluorescence, the optimal concentration of cells for use in the subsequent 
monitoring of fluorescence over 3 hours incubation at 37°C was assayed.  The aim of this 
analysis was to determine cellular conditions which would enable consistent readings to be 
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obtained using the fluorometer in future experiments to determine NET production following 
stimulation (Figure 25).   
 
A range of cell concentrations (1x10
3
 to 7.8x10
5
 cells/ml) encompassing those previously 
reported (Martinelli et al. 2004; Fuchs et al. 2007) were used in the microplate assay and real-
time fluorescence measured (Figure 25).  The fluorescence intensity of unstimulated cells 
throughout the incubation period was minimal for all cell concentrations used except the 
highest (7.8x10
5
 cells/ml) which produced elevated and highly variable readings (Figure 25a).  
All lower concentrations of cells gave consistent fluorescence readings which did not increase 
notably over the 3 hour incubation period indicating a low level of cell death in unstimulated 
cells.  When stimulated with 50nM PMA (Figure 25b) the lower concentrations of cells used 
(50000 cells/ml and below) produced a minimal increase in fluorescence over 3 hours and this 
increase occurred at a later time-point in comparison to the higher concentrations used (1x10
5
-
5x10
5
 cells/ml).  With PMA stimulation, the highest concentration of cells (7.8x10
5
 cells/ml) 
again gave highly variable readings throughout the test period.  The highest concentration 
which gave highest total fluorescence and provided consistent readings, was 5x10
5
 cells/ml.  
This concentration was used in all subsequent assays for detection of both NET and ROS 
production. 
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b)   PMA stimulated cells 
real time fluorescence from 50nM PMA stimulated neutrophils
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c)   PMA stimulated minus unstimulated cells 
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Figure 25. Fluorescent time course analysis using a range of cell concentrations (cells per 
ml) a) unstimulated cells,  b) PMA stimulated cells (50nM),  c) PMA stimulated minus 
unstimulated fluorescence (i.e. values in b-a).  Results show mean values of experiment 
performed in triplicate. 
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3.1.3 Correlation analysis of real-time fluorometric assay and visualisation of NET 
formation 
Whilst real-time fluorescence analysis of cells identifies extracellular DNA release, and 
therefore NET release, this technique also detects the nuclei of dead cells.  Therefore to 
determine the likely accuracy of real-time fluorescence analysis for detecting NET 
production, SYTOX
®
 stained and PMA stimulated cells were concomitantly visualised for 
NET production at various time points to examine correlations with the real-time fluorometry 
readings (Figure 26). 
 
Prior to stimulation, and for 60 minutes post stimulation, relatively low levels of fluorescence 
were detected (Figure 26A) which correlated with the visualisation data obtained by SYTOX
®
 
staining indicating that relatively few dead cells were present and that NET release was 
minimal (Figure 26B a and d).  At 60 to 190 minutes post stimulation, fluorescence levels 
increased steadily.  Microscopic visualisation of stimulated neutrophils over this time period, 
initially indicated relatively small and distinct stained nuclei, which gradually increased to 
indistinct nebulous staining prevalent by 190 minutes post-stimulation (Figure 26c).  These 
nebulous stained areas proved to be extracellular DNA which could be disrupted by brief 
mechanical stimulation (i.e. addition of 50µl PBS to the well) to resemble a more typical 
strand-like NET morphology (Figure 26B g, h and i) (as described by (Brinkmann et al. 2007; 
Behrendt et al. 2010). 
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Figure 26. A) Time course analysis of fluorescence and B) visualisation of PMA 50nM 
stimulated NET production.  A) Time course of fluorescence representative of experiment 
performed in triplicate.  B) Visualisation of NETs and neutrophil viability  a-c) SYTOX
®
 
stained neutrophils showing nuclei of dead cells and extracellular DNA (green)  d-f) Merged 
images derived from light microscope (red) and fluorescence microscope (yellow) to show 
proportion of dead cells (SYTOX-positive nuclei) and extracellular DNA (images overlayed 
using ImageJ section 2.1.2.3)  g-i) NET visualisation after mechanical disruption.  Results 
representative of 3 independent experiments.  
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3.1.4 Quantification of NET production following MNase digestion 
As real-time fluorescence analysis following SYTOX
®
 staining detects extracellular DNA, 
the nuclei of dead/dying cells and the presence of bacterial DNA (Roth et al. 1997), a further 
analytical approach was evaluated which may enable a more specific assay of NET 
production.  Subsequently, micrococcal nuclease (MNase) was used to digest the extracellular 
NET-DNA, as previously described (Fuchs et al. 2007, Ramos-Kichik et al. 2009, Wang et al 
2009), and following centrifugal pelleting of cells and cellular debris the liberated DNA 
present in the supernatant was quantified fluorometrically.  MNase was added after the 
incubation time (at 3 hours) and DNA-digestion was allowed to progress for 10 minutes 
(Fuchs et al. 2007) and for comparison, MNase was included for the duration of the 
incubation (at time 0).  It was hypothesised that MNase inclusion throughout the incubation 
period may enable more complete NET-DNA digestion and would not therefore require the 
additional digestion step after the incubation period.  However, it was recognised that MNase 
co-incubation may interfere with normal cellular processes. 
 
As PMA is a well characterised inducer of NETs (Gupta et al. 2005, Ermert et al. 2009) this 
was initially used to stimulate their release (Figure 27).  The addition of MNase at 3 hours and 
subsequent fluorometric analysis resulted in a significant increase in fluorescence detected 
from stimulated cells (P=0.02), however no significant difference in unstimulated cells was 
observed (P=0.18).  Immediately prior to MNase treatment at 3 hours and subsequent 
fluorometric quantification, the cells were visualised to indicate whether the readings were 
likely to be representative of NET formation (Figure 28).  Observational data indicated an 
increase in background fluorescence in stimulated wells suggesting the presence of solubilised 
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NET-DNA fragments.  Image merge (Figure 28a and b) showed the number of dead cells 
(SYTOX-positive nuclei) was not notably affected by the addition of MNase to otherwise 
unstimulated cells.  However, the nuclei of those cells that had taken up the SYTOX
®
 dye 
were observed to have a more segmented appearance than was present in the absence of 
MNase.   
 
 
Figure 27. Quantitative analysis of NET release from PMA (50nM) stimulated cells by 
MNase digestion of NET-DNA. No MNase or MNase (1 unit/ml) was added either initially 
at time 0 or after 3 hours incubation.  Results show mean values of 6 independent experiments 
± SD. *P<0.05 by two-tailed paired T-test. 
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Figure 28. Microscopic images from wells of 24-well plates used for assay in Figure 27.  
Unstimulated or 50nM PMA stimulated cells with no MNase (-MNase) or MNase added at 
time 0 (+MNase). a) and b) light microscope (blue) and fluorescent images (green) merged 
using ImageJ to show proportion of unstimulated cells that have died and taken up SYTOX
®
 
stain. c) and d) SYTOX
®
 stained images showing intact NETs in the absence of MNase and 
solubilised NET-DNA in supernatant in the presence of MNase. 
 
 
Subsequently the MNase assay procedure for quantitative NET detection was repeated using 
the periodontal pathogen, F. nucleatum.  This analysis was performed to determine whether 
reported bacterial fluorescence interfered with the detection of NET-DNA (Figure 29).  The 
addition of MNase at 3 hours did not result in a significant increase in the amount of DNA 
detected (with or without stimuli) compared to absence of MNase.  However, whilst the 
difference between unstimulated and bacteria-stimulated cells was not statistically significant 
(P=0.1) in the absence of MNase, upon addition of MNase at time 0 or 3 hours the difference 
between unstimulated and bacterial-stimulated cells was significant (P=0.01 and P=0.04 
respectively). 
 
Unstimulated 
 
 
 
 
 
 
 
PMA stimulated 
  - MNase                              + MNase 
a b 
c d 
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Figure 29. Quantification of NET release from F. nucleatum stimulated cells following 
MNase digestion of NET-DNA.  Mean of 3 experiments performed in triplicate ± SD.  
(Multiplicity of infection; MOI 150).  *P<0.05 by two-tailed paired T-test. 
 
3.1.5 Comparison of quantitative NET production data obtained by end-point 
fluorescence and MNase assay 
Finally the relationship between the real-time fluorescence after 3 hours incubation (termed 
end-point fluorescence) was compared to the DNA detected in the supernatant after MNase 
digestion and assay of PMA-stimulated cells (Figure 30).  When the DNA from various 
concentrations of PMA stimulated cells was measured, a similar trend was observed by both 
assay procedures (Figure 30a).  Subsequent statistical analysis confirmed a significant and 
positive correlation between the readings obtained by the two assay procedures by Pearson 
correlation (R
2
=0.80) (Figure 30b). 
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a) Comparison of end-point and MNase fluorescence at various cell concentrations 
 
 
b) Correlation of end-point and MNase fluorescence 
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Figure 30. End-point fluorescence (i.e. at 3 hours incubation) and fluorescence values 
after MNase assay of various cell concentrations (0 to 7.8x10
5
 cells/ml) stimulated with 
50nM PMA.  a) Comparison between data sets, b) correlation between data sets analysed by 
Pearson correlation. 
 
 
 
To validate whether the equation generated by the trendline (Figure 30b) could be used to 
accurately estimate the value of the other assay and therefore whether the two assay methods 
were interchangable, the actual values and the values predicted by the equation were used to 
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1986) (Figure 31).  100% of the data points were between 2 standard deviations either side of 
the mean, indicating that although the data set consisted of only 8 points it is likely that either 
of two methods for the quantification of PMA induced NET release could be used to replace 
the other method. 
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Figure 31. Validity of inferring one assay value from the other based on equation of 
trend line (Figure 30b) y=3.0785x-2056.  a) End-point fluorescence values and b) MNase 
assay values.  When the average of the real and predicted values are plotted against the 
difference between the real and predicted values 100% of the data points lie within +/- 2 S.D. 
from the mean. 
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3.2 Determination of optimal concentration of serum for NET release 
 
3.2.1 Effect of foetal calf serum (FCS) on NET release 
FCS is commonly used as a supplement in cell culture to provide nutrients for growth, whilst 
bovine serum albumin (BSA), a purified fraction of FCS, is used to coat assay plates to 
prevent activation of cells in response to contact with the plastic culture surface (Matthews et 
al. 2007a).  With regard to the assay of NETs, it has previously been reported that FCS 
supplementation of media inhibited NET production (Fuchs et al. 2007).  Therefore the 
optimum concentration of FCS necessary to prevent neutrophil activation in the absence of 
stimulation, yet still enable NET release in the presence of stimulation, was investigated both 
by visualisation (Figure 32) and using the MNase assay described above (Figure 33).  A range 
of stimuli were used to activate several neutrophil receptor pathways.  These included the 
gram negative periodontal pathogen F. nucleatum which reportedly activates TLR4/2 (Remer 
et al. 2003) and opsonised bacteria (S. aureus) to stimulate Fcγ-receptors (Huizinga et al. 
1989).  The chemotactic peptide N Formyl Met-Leu-Phe (fMLP) was also used as it has been 
reported to evoke neutrophil responses such as degranulation and superoxide generation via 
fMLP receptor binding (Kuan 2005). 
 
Visualisation of SYTOX
®
 stained neutrophils on glass slides (Figure 32) demonstrated that as 
the concentration of FCS increased, the amount of NETs produced decreased in response to 
all 3 stimuli used.  In addition, spontaneous NET production (from unstimulated cells) also 
appeared to be inhibited dose-dependently by FCS.  Notably whilst 10% and 20% FCS 
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supplementation of media resulted in minimal NET release from unstimulated cells, some 
NET production in response to stimuli (F. nucleatum, opsonised S. aureus and fMLP) was 
observed. 
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Figure 32.  SYTOX
® 
stained NETs produced on glass slides in media supplemented with 0-20% heat inactivated (FCS).  Cells were 
stimulated with F. nucleatum polymorphum (MOI 1:150), opsonised S. aureus (MOI 1:150), fMLP 8000nM or were unstimulated.  Cells 
were incubated for 3 hours prior to fixing and staining. Images shown are representative of two independent experiments. 
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 121 
The inhibition of NET release by increasing concentrations of FCS was also confirmed by the 
quantitative MNase assay in unstimulated cells, i.e. baseline NET release (Figure 33).  The 
addition of 10% FCS caused a significant decrease in NET-DNA detected compared to the 
control (absence of FCS; P=0.008).  A further significant reduction was also observed when 
the FCS was increased from 10% to 20% (P=0.001).  Based on this data and that of previous 
publications which have used FCS supplementation for the assay of NET release (Martinelli 
et al. 2004; Ramos-Kichik et al. 2008), 10% FCS was deemed the most appropriate 
concentration to prevent spontaneous neutrophil activation whilst enabling the detection of 
responses to stimulation.  
 
Figure 33.  Effect of FCS supplementation of media on MNase detection of NET-DNA 
from unstimulated cells.  Results show mean ± SD of 5 independent experiments.  
**P≤0.01, ***P≤0.001 by two tailed paired T-test. 
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chemiluminescent assay of ROS production (Chapple et al. 1997) which is utilised later in 
this thesis in conjunction with the assay of NETs.  Therefore as BSA is commonly used to 
‘block’ assay plates for ROS analysis (Steinckwich et al. 2007) its potential use in the assay 
of NETs was analysed.  Initially, cells were seeded onto glass slides for staining and 
visualisation of NET release, however as the glass slides had already been coated in poly-L-
lysine to aid the adherence of extruded NETs, the BSA was used to supplement the media at 
concentrations up to 2% rather than to coat the slide (Figure 34).  The range of concentrations 
used were based upon previous publications describing NET release in the presence of human 
serum albumin (HSA) at 2% (Fuchs et al. 2007, Beiter et al. 2006) and BSA at 1% (Alghamdi 
et al. 2005).  The effect of BSA on NET release was less clear as extracellular staining was 
evident, but this was not found as distinct strands characteristic of previously observed NETs.  
Even in unstimulated cells the nuclei did not stain with a distinct edge and exhibited a hazy 
and distorted appearance.  Evidence of dose-dependant inhibition of NET formation was 
however apparent (Figure 34).   
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Figure 34.  Visualisation of SYTOX
®
 stained neutrophils in RPMI supplemented with a range of concentrations of BSA.  Cells were 
stimulated on glass slides for 3 hours using F. nucleatum polymorphum MOI 1:150 or were unstimulated. 
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3.2.3 Effect of BSA and FCS on NET release using fluorometric quantification 
Data indicated that the established MNase assay provided a robust quantification of NET 
release, and also facilitated a high throughput analysis.  Therefore BSA was also used in this 
assay to pre-treat the wells of the microplate (rather than to supplement the media).  This 
treatment was assessed, alongside and in addition to, 10% FCS supplementation of the media 
to determine the most effective conditions to prevent spontaneous NET activity, whilst still 
maintaining cellular responses to stimulation (Figure 35). 
 
Baseline levels of detected fluorescence (i.e. prior to stimulation) and up to 5400 seconds (1.5 
hours) after stimulation was higher for cells which had no serum supplementation or BSA 
‘blocking’.  Fluorescence under these conditions also increased less rapidly when stimulated, 
as demonstrated with PMA (Figure 35b) or opsonised S. aureus (Figure 35c) exposure.  The 
absence of BSA or FCS resulted in highly variable readings in the unstimulated cells.  With 
PMA stimulation it is apparent that the addition of BSA, FCS or both allowed the initiation of 
increased fluorescence from 5400 seconds (1.5 hours) onwards.  The largest fluorescence 
increase was observed in the presence of BSA, the smallest increase was observed with the 
addition of FCS, whilst a moderate increase was observed in the presence of both BSA and 
FCS.  After 3 hours incubation (Figure 35e) BSA plate-coating resulted in the lowest readings 
in unstimulated cells although FCS supplementation gave the lowest fluorescent readings 
following stimulation. 
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a) Unstimulated cells 
 
b) PMA stimulated cells 
 
c) opsonised S. aureus stimulated cells 
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d) F. nucleatum poly. stimulated cells 
 
 
 
 
e)  End-point fluorescence (12000 seconds) 
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Figure 35.  Real-time traces of the effect of BSA and FCS on SYTOX
®
 detected 
fluorescence in response to a) no stimulation   b) PMA (50nM)   c) opsonised S. aureus 
(MOI 1:150) and d) F. nucleatum  poly. (MOI 1:150)   e) Combined results under all stimuli 
conditions displaying end-point fluorescence at 3 hours post-stimulation (~12000 seconds). 
Results show mean of experiment performed in triplicate.  Results are representative of 3 
independent experiments. 
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The cells incubated for 3 hours with FCS supplementation and/or BSA plate-blocking (Figure 
35) were subsequently treated with MNase and the NET-DNA in the supernatant was 
fluorometrically quantified (Figure 36).  The absence of FCS supplementation and BSA 
blocking generated the highest fluorescent under all stimulatory conditions except that of 
PMA stimulation.  FCS supplementation, followed by BSA plate blocking, followed by a 
combination of both caused a sequential decrease in detected fluorescence under all 
conditions of stimulation except F. nucleatum.  The MNase assay was the method utilised in 
the majority of subsequent NET release experiments, therefore as 10% FCS media 
supplementation in this assay demonstrated a reduction in unstimulated DNA detection and 
the largest increase in NET-DNA fluorescence in response to PMA (the positive control NET 
stimulus), this was the preferred treatment for subsequent experiments. 
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Figure 36. Effect of BSA plate blocking and/or 10% FCS supplementation of media on 
MNase assay of NET release.  A single well of cells used in Figure 35 i.e. unstimulated, 
PMA 50nM, opsonised S. aureus (MOI 1:150) or F. nucleatum poly. (MOI 1:150) stimulated 
were subsequently processed by the MNase assay procedure. 
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3.3 Determination of optimal concentration of stimuli 
Previously published data has demonstrated that NET release is a part of a cell suicide 
mechanism (Fuchs et al. 2007, Brinkmann and Zychlinsky 2007).  Therefore the 
concentration of stimuli needed to evoke this response in the neutrophils above any other 
responses, including phagocytosis or degranulation, was determined using PMA exposure 
(Figure 37) and the Fcγ receptor agonist, opsonised S. aureus (Figure 38). 
 
3.3.1 Dose-response analysis following PMA stimulation 
Based on previous publications reporting the stimulation of NET release using 25nM PMA 
(Gupta et al. 2005; Beiter et al. 2006; Fuchs et al. 2007) up to 50nM PMA (Brinkmann et al. 
2004), a range of 0-50nM were used to stimulate neutrophils in a 96 well microplate.  Figure 
37a displays the real-time fluorescence trace recorded over a 3 hour stimulatory period.  The 
lowest concentration of PMA, 1.6nM (and lower concentrations; see appendix Figure 93) 
reduced the fluorescent signal compared to unstimulated cells.  Concentrations of 6.3nM 
PMA and above resulted in a dose-dependant increase in measured fluorescence.  Of the two 
highest concentrations of PMA tested, 50nM PMA initiated an increase in fluorescence 
marginally earlier than the 25nM PMA concentration, however both reached the same level of 
fluorescence output by 3 hours post stimulation (Figure 37b).  This pattern of response was 
also confirmed by subsequent MNase assay of the released DNA (Figure 37b).  This too 
demonstrated reduced DNA release at low PMA concentrations followed by an increase and 
plateau at high PMA concentrations.  50nM PMA resulted in the most rapid increase in 
fluorescence (Figure 37a) and one of the highest final fluorescent readouts measured by both 
 129 
the end-point and MNase assays (Figure 37b) and was therefore used for all subsequent 
experiments. 
 
a)  Real-time fluorescence 
 
 
 
b) 3 hour fluorescence and MNase assay 
 
 
Figure 37. Effect of PMA concentrations (0-50nM) on NET release. Measured by a) real-
time fluorescence and b) 3 hour fluorescence and MNase assay.  Results show mean of 
experiment preformed in triplicate. 
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3.3.2 Dose-response analysis following stimulation with opsonised S. aureus  
Real-time fluorescence analysis of NET-DNA release from opsonised S. aureus stimulated  
cells is complicated by the use of dead bacteria whose nuclei bind the SYTOX
®
 DNA 
fluorescent stain in a dose dependant manner.  Evidence for this is presented in Figure 38a at 
approximately 1800 seconds (30 minutes) when the bacterial stimulus was added resulting in 
an immediate and significant increase in detected fluorescence.  Although it has been reported 
that the most potent NET stimulus, PMA, can evoke NET release in as little as 10 minutes 
(Brinkmann et al. 2004) this was not observed here (Figure 37a), therefore it is unlikely to be 
as dramatic with the bacterial stimulus applied in this study.  The increase in fluorescence 
upon addition of the bacterial stimulus occurred notably more rapidly and was complete 
within approximately 2 minutes indicating it is likely to result from dead bacteria, with 
minimal neutrophil contribution.  Therefore the fluorescence at 1800 seconds was subtracted 
from the 3 hours fluorescence readings and data is shown in Figure 38b.  The results 
demonstrate a peak in released DNA at an intermediate multiplicity of infection (MOI), of 
between 75-150 bacteria per neutrophil.  For all experiments bacterial stimuli were therefore 
used at an MOI of 1:150. 
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a) Real-time fluorescence 
 
b)  MNase assay and 3 hour fluorescence 
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Figure 38.  Dose response of opsonised S. aureus (MOI 0-300) on NET release determined 
by a) real-time fluorescence and b) MNase assay and 3 hour real-time fluorescence (minus 
fluorescence at 30 mins i.e. post stimuli addition).  Results show mean fluorescence of 
experiment performed in triplicate ± SD. 
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Discussion 
 
Developing a robust in-house methodology for the assay of NET release proved challenging 
due to the relatively few reports of this recently described antimicrobial mechanism within the 
literature and the variability in the reported assay conditions employed. 
 
Quantification techniques 
The most basic method for observing NET release is visualisation on glass slides by staining 
various components of NETs.  Previous reports have utilised antibodies to detect the DNA-
histone complex and granule protein components (Fuchs et al. 2007), however, the major 
constituent of NETs is the DNA backbone and as such are stained by dyes which fluoresce 
upon binding to DNA e.g. SYTOX
®
 as utilised here and previously (Grinberg et al. 2008).  
Although it has been claimed that DNA intercalating dyes inhibit the formation of NETs 
(Brinkmann et al. 2004), this was not found to be the case in this analysis or in subsequent 
publications (Ermert et al. 2009).  Notably, in concordance with previously published 
descriptions (Behrendt et al. 2010) the staining of PMA induced NET-DNA, produced a 
cloudy and diffuse appearance (Figure 26) prior to mechanical stimulation, which resulted in 
the appearance of discrete DNA strands resembling those more frequently described 
(Brinkmann et al. 2004; Urban et al. 2009).  A further observation from these studies, was 
that the DNA strands aggregated and associated with cells, especially when NETs were 
abundant (Figure 26Bi) resulting in clustering as previously described (Alghamdi et al. 2009).  
This meant that capturing clear images of NET production was highly dependant upon the 
field visualised.  Previous studies have reported attempts to quantify NET release based on 
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captured images such as the number of discrete areas of DNA larger in size than a neutrophil 
(Buchanan et al. 2006), or the number of neutrophils forming NETs as a percentage of total 
cell count (Grinberg et al. 2008).  These approaches are however highly subjective and 
unreliable when individual cells cannot be distinguished amongst clusters.  Therefore, a 
quantitative approach using a fluorescence plate reader was employed.  This technique meant 
that time course studies could be performed, allowed a relatively high throughput, and was a 
technique previously described by Alghamdi et al. (2005) and subsequently by Ermert et al. 
(2009).  Fluorescence readings were representative of NET release and were comparable to 
visually obtained results (Figure 26).  Initially however, the concentration of cells used 
required optimisation and notably high cell densities resulted in significant fluctuations in 
fluorescent output (Figure 25).  These fluctuations commenced from approximately 1 hour 
post-stimulation, a time coinciding with NET release.  Therefore it is possible that the 
abundance of cells were physically shielding the fluorescence emitted from NET-DNA bound 
SYTOX
®
 dye.  Similar fluctuations in fluorescent output were often observed with the 
addition of F. nucleatum as a stimulus which also may have been shielding the fluorescent 
emission. 
 
A complicating factor in the fluorometric measurement of extracellular NET-DNA was the 
staining of intracellular DNA of dead cells.  Therefore, to separate the extracellular DNA and 
cells that have died by processes other than NETosis, cultures were treated with the MNase 
enzyme as previously described (Fuchs et al. 2007; Ramos-Kichik et al. 2009), prior to 
centrifugation of cell debris.  MNase is a DNase secreted by S. aureus and acts as an endo- 
and exo-nuclease to yield 3’mono- or di-nucleotides.  It is relatively non-specific in terms of 
base sequence preference, making it suitable for the digestion of extracellular genomic DNA 
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and it preferentially cleaves chromatin at the linker region between nucleosomes (Noll 1974).  
In addition to including the MNase at the end of the incubation period as previously 
described, it was also included for the duration of the 3 hour incubation period in an attempt 
to minimise the number of processing steps.  Although continuous incubation with MNase 
produced a more effective liberation of the DNA, when examining the appearance of the 
unstimulated cells treated continuously with MNase (Figure 28) the nuclei of dead cells 
(SYTOX
®
 positive cells) appeared multilobulated and discrete areas of intracellular DNA 
staining could be observed.  Additionally mammalian DNase has previously been 
demonstrated to bind actin, preventing polymerisation and promoting depolymerisation 
(Hitchcock 1980).  As MNase may exert other cellular effects, it was therefore deemed more 
appropriate to add the MNase at the 3 hour time point.  It was also interesting to note that the 
MNase assay gave a similar pattern of results to the real time fluorometer assay of PMA-
stimulated NET production (Figure 31) indicating the potential validity of both methods.  
However, in the majority of subsequent experiments described in this thesis MNase assay was 
deemed the most appropriate method for the quantification of NET release. 
 
Serum supplementation of media 
Of particular importance to NET analysis is the concentration and type of serum proteins 
present.  As previously reported (Fuchs et al. 2007) and also demonstrated here (Figures 32 
and 33) serum exerts a dose-dependant inhibition of NET release.  Whilst the majority of 
publications reported the use of isolated neutrophils suspended in RPMI, the serum protein 
supplementation in this media ranged significantly, including 10% FCS (Martinelli et al. 
2004), 2% human serum albumin (Beiter et al. 2006; Fuchs et al. 2007) and 2% heat activated 
autologous plasma (Buchanan et al. 2006) and the absence of serum (Alghamdi et al. 2005; 
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Gupta et al. 2005).  In addition, Fuchs et al. (2007) claimed that NET induction was optimal 
at low serum concentrations (≤2%), which was also representative of conditions at sites of 
inflammation.  When assay conditions were optimised for the study reported here, FCS 
supplementation of media (0-20%), BSA supplementation of media (0-2%) and BSA coating 
of the assay plate were all analysed.  Initially NETs were produced and visualised on glass 
slides and therefore FCS supplementation of media was the most practical and appropriate, 
however, in subsequent investigations the assay of NETs was compared to the 
chemiluminescent assay of ROS and therefore BSA coating of the plate was more 
appropriate.  As it has previously been reported (Fuchs et al. 2007) and supported by the 
variability in the data obtained here (Figure 27 and 29) that NET release exhibits significant 
inter-individual variation, the optimum concentration of serum may also be subject to inter-
individual and temporal variation.  In general however, 10% FCS media supplementation 
proved optimum for the assay of NET release both qualitatively (Figure 32) and quantitatively 
(Figure 33).  Recently it has been reported that the dose-dependant reduction in NET 
detection by the addition of serum is due to the presence of serum nucleases degrading 
extruded NETs (von Kockritz-Blickwede et al. 2009).  Notably it was reported that the serum 
nuclease activity could be destroyed by heat inactivation at 70C but not by the standard heat 
inactivation at 56C as used in this study.  However, when NETs were produced in the 
presence of MNase (Figure 28), this resulted in an obvious green colouration of the 
supernatant due to SYTOX
®
 green staining of liberated nucleic acid fragments.  This effect 
was absent when NETs were produced in the presence of FCS alone, indicating that this does 
not represent a significant source of nuclease activity.  Whilst the endogenous nuclease 
activity of the FCS used in these experiments does not appear to have an effect comparable to 
exogenously added MNase, it is possible that the sensitivity of the NET assay is reduced.  
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Conversely it has also been reported that serum contains high levels of DNA (Behrendt et al. 
2010).  Experiments to assess the nuclease activity of FCS are therefore warranted and could 
include incubation of the culture media with purified DNA and subsequent analysis by 
agarose gel electrophoresis to visualise the extent of degradation.  Alternatively it has been 
indicated by Chapple et al. (1997) that FCS possesses antioxidant properties.  For this reason 
FCS cannot be used in the enhanced chemiluminescent assay of neutrophil radical production 
and BSA coating of the assay plate is used instead.  If NET release is dependent on the 
presence of reactive oxygen species as suggested (Fuchs 2007), it is possible that antioxidant 
activity within the FCS is responsible for the dose-dependent reduction in NET release.  
  
Stimuli 
The reported stimuli capable of evoking the release of NETs include those deriving from host 
cells (e.g. cytokines, complement and opsonising molecules), those deriving directly from 
bacteria (e.g. endotoxins), as well as other pathogens such as parasites and yeast.  During the 
5 years of research into NETs, PMA has emerged as a positive control or ‘gold standard’ for 
NET release.  This molecule is derived from croton oil purified from the leaves of an Asiatic 
shrub (Busch 1971) and is known for its tumour promoting and also inflammatory properties.  
In neutrophils it is able to activate protein kinase C (PKC) and as such, takes the place of the 
physiological activator diacylglycerol (DAG).  PMA is lipophilic so is able to directly cross 
the cell membrane and act rapidly because it has a relatively short signalling pathway, 
bypassing any cell surface receptor interactions.  It is also less readily metabolised than DAG 
so results in a relatively prolonged activation of PKC (Newton 1995).  The ability of PMA to 
induce a cell death process distinct from apoptosis and necrosis was observed years before 
NETosis was described (Takei et al. 1996).  In this early report, PMA induced cytotoxicity 
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was described as involving loss of lobulation of the nucleus, decondensation of the chromatin, 
subsequent disintegration of the nuclear membrane with organelles remaining intact, and an 
increase in cell permeability only occurring at the end of the process.  Significantly this form 
of cell death appeared not to involve DNA degradation (a hallmark of apoptosis) and was also 
dependant on oxygen radical production and therefore in hindsight was likely to represent one 
of the first descriptions of NETosis.  The relationship between PMA concentration and NET 
release showed an unusual pattern in that a decrease in NET release was observed at mid-
range concentrations of PMA (Figure 37).  Published data on the effect of increasing PMA 
concentrations on the amount of NET release, previously found no correlation (Palic et al. 
2007) and results here appear to corroborate this finding.  Research by Palic et al. (2007), 
utilising fish neutrophils, also tested several stimuli for dose effects on NET production with 
mixed findings.  With LPS stimulation NET release reached a peak in response at 0.5µg/ml 
and then decreased as LPS concentration was increased further.  In addition a yeast β glucan 
commonly used to stimulate fish neutrophil degranulation was found to significantly increase 
DNA release at only two unrelated concentrations and displayed no pattern.  This indicates 
that the trigger for NET release is complex or that the sensitivity of the assay is not sufficient 
to detect subtle variations in release.  Similarly the NET response to opsonised S. aureus did 
not display a linear relationship and instead peaked at an intermediate concentration of 75 
bacteria per neutrophil (Figure 38). 
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CHAPTER 4 RESULTS                                                                                          
Modulation of NET release 
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Having characterised assays for the release of NETs in the previous chapter, these were 
subsequently utilised to examine the relationship between NET production and other 
neutrophil bactericidal functions, namely ROS generation which has been reported to be 
necessary for NET release (Fuchs et al. 2007), and also phagocytosis.  Various relevant 
inhibitors, enzymes and antioxidants were employed to modify various stages of the ROS 
generation pathway as well as the actin polymerisation process required for phagocytosis. 
 
4.1 ROS inhibitor, diphenyleneiodonium (DPI) 
DPI is a widely reported inhibitor of NADPH oxidase (O’Donnell et al. 1993).  To examine 
the relationship between NADPH oxidase dependant ROS production and NET release, 
initially an effective concentration for inhibiting ROS production was determined.  
 
Addition of DPI to the enhanced chemiluminescent assay for detection of ROS caused a dose-
dependent reduction in luminol (total ROS), isoluminol (extracellular ROS) and lucigenin 
(primarily superoxide) dependant ROS production in PMA stimulated neutrophils (Figure 
39).  The magnified view (Figure 39) shows that this trend in reduction continued at the 
higher concentrations of DPI used.  Based on this data, 25µM DPI was applied in all 
subsequent experiments as it resulted in optimal reduction in ROS generated. 
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Figure 39. Effect of DPI on ROS production.  Peak ROS from PMA (50nM) stimulated 
cells with DPI (0-25µM).  Results representative of two independent experiments.  Dashed 
box indicates range displayed in magnification (inset). 
 
 
To determine whether DPI inhibition of NADPH oxidase-ROS production also inhibited NET 
release, 25µM DPI was used in the MNase assay.  Data indicated that DPI inclusion resulted 
in a significant decrease in NET release stimulated by PMA (P=0.001), opsonised S. aureus 
(P=0.01) and F. nucleatum (P=0.04) (Figure 40).  Exposure of unstimulated neutrophils to 
DPI had no significant effect on spontaneous NET formation (Figure 40).  The fluorescence 
observed in unstimulated cells may indicate a baseline level of spontaneous NET release that 
is independent of NADPH oxidase ROS generation as DPI exerted no apparent effect, or may 
be due to spontaneous cell death and lysis occurring naturally in the neutrophil population 
over the 3 hour incubation period.  There was also a background level of SYTOX
®
 
fluorescence resulting from the media which was 2000-3000 AFU and therefore a ‘blank’ 
consisting of all reagents minus cells was assayed and subtracted during all subsequent 
inhibition studies utilising the MNase assay.   
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Figure 40. Effect of 25µM DPI on MNase assay of NET production.  Sixteen individuals 
were assayed in triplicate.  *P≤0.05,  **P≤0.01,  ***P≤0.001 by two-tailed paired T-test. 
 
4.1.1 Effect of DPI on cell viability 
Whilst data presented in Figure 40 indicates that DPI inhibition of ROS generation may 
subsequently regulate NET production, it is possible that modulation of ROS may affect cell 
viability which may subsequently affect readouts obtained from the fluorescence assay, i.e. 
SYTOX
®
 staining of dead cells.  Therefore a fluorescence cell viability assay (MultiTox-
Fluor Multiplex Cytotoxicity assay, Promega) was employed which utilised a protease and 
therefore provided a DNA independent readout of cell death (Figure 41).  This approach 
clearly demonstrated that there were fewer dead cells present in wells exposed to DPI.  Dead 
cell fluorescence in the presence of DPI increased gradually over the time period studied and 
readouts appeared unaffected by the addition of the stimuli as there was no increase in 
fluorescence at 1500 seconds when the stimuli were included.  In the absence of DPI, detected 
cell death increased from the point of stimulus addition (with both PMA and blank), however 
dead cell fluorescence of stimulated cells also increased in comparison to unstimulated cells 
from 5400 seconds (1.5 hours) onwards.  The data obtained using the live cell stain was in 
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contrast to the dead cell stain data in that fewer live cells were observed in the presence of 
DPI.  However, the differences in live cell-fluorescence with and without DPI were less 
obvious.  A similar pattern was seen with all stimuli used (opsonised S. aureus and F. 
nucleatum; see appendix Figure 94). 
 
a) Dead cell stain (protease dependant) 
 
b) Live cell stain (protease dependant) 
Figure 41. Time course analysis of the effect of DPI (25µM) on cell viability using the 
protease dependant MultiTox-Fluor Multiplex Cytotoxicity assay (Promega).  a) Dead 
cell stain read using filter 485/535nm, b) Live cell stain read at 355/460nm.  Cells stimulated 
with PMA (50nM) or left unstimulated over 3 hour incubation period.  Results show mean of 
experiment performed in triplicate. 
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As SYTOX
®
 green also enters dead cells it was used simultaneously with the cell viability kit 
(Figure 41) to examine its detection of cell viability (Figure 42a) in addition to its use for 
detection of extruded NET-DNA.  After 3 hours incubation, the cells were processed as 
previously described for MNase detection of extracellular NET-DNA (Figure 42b). 
 
SYTOX
®
 detection of cell death increased from 6000 seconds (~1 hour post stimulation) 
onwards in PMA stimulated cells which, based on previous data (Figure 26A) coincides with 
NET release (Figure 42a).  This effect was absent in PMA stimulated cells with the addition 
of DPI which remained at a low level of fluorescence throughout, displaying a similar trace to 
that of unstimulated cells.  Notably, the addition of DPI to unstimulated cells resulted in a 
moderate increase in fluorescence which occurred concomitantly with the increase in PMA 
stimulated fluorescence (~1 hour post stimulation).  Time course SYTOX
®
 fluorescence of 
bacterially stimulated cells (opsonised S. aureus and F. nucleatum) resembled that of 
unstimulated cells exhibiting a low level of fluorescence throughout the incubation period 
(see appendix Figure 95).  MNase assay of the same cells (Figure 42b) confirmed this 
increased DNA release in unstimulated cells by the addition of DPI (P=0.02).  It also 
confirmed the decreased DNA release by PMA stimulated cells caused following addition of 
DPI (P=0.02; both by unpaired two-tailed T-test). 
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a)  SYTOX
®
 green time course fluorescence. 
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Figure 42. Effect of DPI on  a) cell viability detected by SYTOX
®
 fluorescence over 3 
hours incubation, and b) MNase assay detection of extracellular DNA in supernatant.  
Results show mean of experiment performed in triplicate ± SD. *P≤0.05 by two-tailed paired 
T-test. 
 
4.2 Phagocytosis inhibitor, cytochalasin B (cytoB) 
The primary function of neutrophils is phagocytosis thus bacterial stimulation evokes this 
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determine whether the process of phagocytosis contributes to detected NET release, therefore 
neutrophils were treated with the actin polymerisation inhibitor, cytochalasin B.  The effect of 
10µg/ml cytochalasin B (Grinberg et al. 2008) on ROS generation (Figure 43) was also 
assayed alongside MNase assay of NET production (Figure 44). 
 
As cytochalasin B is a known inhibitor of neutrophil phagocytosis of bacteria, three different 
bacterial stimuli were used in this experiment including the periodontal pathogen T. 
forsythensis.  The addition of cytochalasin B to the assay caused a reduction in the level of 
luminol-, isoluminol- and lucigenin-dependent ROS produced in response to all stimuli 
(Figure 43).  This difference was significant for all stimuli used except T. forsythensis 
however notably a large variation in the level of ROS detected in the absence of cytochalasin 
B with T. forsythensis stimulation was observed.  Compared to the reduction in PMA-
stimulated ROS, the reduction in bacteria-stimulated ROS appeared more dramatic and was 
reduced to similar levels to those detected in unstimulated cells. 
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b) Isoluminol detection of peak ROS 
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c) Lucigenin detection of peak ROS 
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Figure 43. Analysis of cytochalasin B (10µg/ml) on peak ROS production in response to 
bacterial stimuli (MOI 1:150) or PMA 50nM. Detected by a) luminol, b) isoluminol and c) 
lucigenin.  Results show mean of 3 experiments ± SD. * P≤0.05 **P≤ 0.01  ***P ≤ 0.001 by 
two-tailed paired T-test. 
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Notably MNase assay of NET production (Figure 44) demonstrated a reduction in NETs 
detected in the presence of cytochalasin B in all stimulated and unstimulated cells.  This 
reduction was statistically significant for all stimuli used except F. nucleatum and T. 
forsythensis. 
 
 
Figure 44. Analysis of cytochalasin B (10µg/ml) on NET production as determined by 
MNase assay in response to bacterial stimuli (MOI 1:150) or PMA 50nM.  Results show 
mean of 4 experiments ± SD. * P<0.05 **P<0.01 by two-tailed paired T-test. 
 
4.3 Effect of combination of ROS and phagocytosis inhibitors on NET release  
The NADPH oxidase inhibitor, DPI, and the phagocytosis inhibitor, cytochalasin B, were 
used alone and in combination as real-time fluorescence was recorded to monitor cell death 
and NET-DNA release (Figure 45).  This treatment should act to inhibit the main killing 
mechanisms of neutrophils (phagocytosis and ROS/NET release) and help to elucidate the 
contributions of each mechanism in the NET response, as measured by fluorescence, when 
challenged with different stimuli. 
cytochalasin B
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
unstimulated F.nuc.poly op S.aureus T.forsythensis PMA
stimuli
A
F
U
- cytoB
+ cytoB
** 
** ** 
 148 
With all stimuli used the absence of inhibitors resulted in the highest detected fluorescence.  
The largest reduction in fluorescence was observed using a combination of both inhibitors in 
response to all stimuli but not in unstimulated cells.  Notably, singly cytochalasin B was the 
most effective inhibitor of NET production in bacteria-stimulated cells, whilst, DPI was more 
effective in reducing NET levels in PMA-stimulated cells. 
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d) F. nucleatum stimulation 
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e) T. forsythensis stimulation 
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Figure 45. Effect of NADPH oxidase inhibitor (DPI 10µM) and/or phagocytosis inhibitor 
(cytochalasin B 10µg/ml) on NET release detected by real-time fluorescence.  Fluorescent 
traces for a) unstimulated cells  b) PMA 50nM  c) opsonised S. aureus MOI 1:150  d) F. 
nucleatum MOI 1:150  e) T. forsythensis MOI 1:150. Results show mean of experiment 
performed in triplicate. 
 
 
Data derived from subsequent MNase assay of cells incubated with DPI and/or cytochalasin B 
(Figure 46) demonstrated a similar trend to real-time fluorescence analysis (Figure 45).  The 
absence of inhibitors generally exhibited the highest level of fluorescence and a combination 
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of both inhibitors resulted in the lowest DNA fluorescence detected.  In PMA stimulated cells 
incubation with DPI alone or cytochalasin B alone caused a similar reduction in fluorescence.  
However, in bacterially stimulated cells cytochalasin B exposure resulted again in a greater 
reduction in detected fluorescence than following incubation with DPI. 
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Figure 46.  Effect of NADPH oxidase inhibitor (DPI 10µM) and/or phagocytosis 
inhibitor (cytochalasin B 10µg/ml) on NET release measured by MNase assay.  A single 
well of cells used in Figure 45 were also assayed by MNase assay after 3 hours stimulation 
using bacterial stimuli (MOI 1:150) or PMA (50nM).   
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4.4 Superoxide dismutase (SOD) 
NET release has been demonstrated to be dependant on ROS generation (Fuchs et al. 2007, 
Figure 40), however, it was notable that cytochalasin B produced additional NET inhibition 
following DPI inhibition of NADPH-oxidase generated ROS (Figure 45 and 46).  Therefore 
the relationship between ROS and NET production was further characterised using agents 
which modify the NADPH oxidase ROS generation pathway (Figure 8) in order to identify 
key steps necessary for induction of NETosis.  Initially superoxide dismutase (SOD) which 
catalyses the conversion of the superoxide anion to hydrogen peroxide, was employed to 
ascertain whether either of these molecules were involved in NET induction.  
 
Figure 47 demonstrates that the exposure of neutrophils to SOD was in general effective at 
reducing ROS production.  Notably reduced levels of ROS production were primarily 
identified in isoluminol detected ROS (P≤0.05 under all stimuli conditions).  Lucigenin 
detected ROS exhibited a minor reduction with SOD however this was not significant in F. 
nucleatum stimulated cells.  The reduction in luminol detected ROS was only significant in 
PMA stimulated cells. 
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Figure 47. Effect of SOD 95U/ml on peak ROS production in response to PMA 50nM or 
bacterial stimulation (MOI 1:150).  Detected by a) luminol b) isoluminol and c) lucigenin. 
Mean of 5 experiments performed in duplicate ± SD.  * P≤0.05  **P≤0.01 by two tailed 
paired T-test. 
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Data presented in Figure 48 demonstrates that the addition of SOD resulted in increased NET 
release as measured by MNase assay.  This increase was significant (P≤0.01) in both 
stimulated and unstimulated cells.  This indicates that generation of the reaction product, i.e. 
hydrogen peroxide, facilitates NET release in concordance with previous data utilising 
catalase (Fuchs et al. 2007). 
Figure 48. Effect of SOD (95U/ml) on MNase assay of NET production.  Results show 
mean of 5 experiments performed in triplicate ± SD. *P<0.05 **P<0.01 by two-tailed paired 
T-test. 
 
 
4.5 Antioxidant/radical scavenger, curcumin 
Antioxidants remove or neutralise oxygen radicals therefore the ability of the antioxidant, 
curcumin, to reduce ROS production (Figure 49) and NET release (Figure 50) was examined.  
The addition of 5µM curcumin proved an effective concentration capable of reducing detected 
ROS under all conditions tested (Figure 49).  A significant reduction in ROS was seen in 
luminol detected ROS in response to PMA, F. nucleatum and unstimulated cells (P≤0.05).  
Isoluminol and lucigenin detected ROS only reduced significantly in response to F. 
nucleatum stimulation (P=0.01 and P=0.04 respectively). 
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a) Luminol detection of peak ROS 
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Figure 49. Effect of 5µM curcumin on peak ROS production in response to PMA 50nM 
and bacterial stimulation (MOI 1:150) detected by a) luminol b) isoluminol and c) lucigenin.  
Results show mean of 3 independent experiments performed in triplicate ± SD.  
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MNase detection of NET release was reduced in the presence of curcumin in response to all 
stimuli (Figure 50) however this reduction was significant only in response to PMA exposure 
(P=0.01). 
 
Figure 50. Effect of 5µM curcumin on NET release detected by MNase assay.  Results 
show mean of 5 experiments performed in triplicate minus blanks (no cells) ± SD. ** P≤0.01 
two-tailed paired T-test. 
 
4.6 Myeloperoxidase inhibitor, sodium azide 
The conversion of hydrogen peroxide to hypochlorous acid by endogenous myeloperoxidase 
(MPO) can be inhibited by sodium azide.   The effect of 2mM sodium azide was therefore 
tested on the generation of ROS (Figure 51) as well as NET release (Figure 52).  The 
concentration of sodium azide applied was based on previous publications (Mundi et al. 1991; 
Dahlgren et al. 1999) in which 1mM sodium azide was used to inhibit MPO in the 
chemiluminsescent assay of ROS production by neutrophils. 
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Sodium azide exposure caused a significant reduction in luminol detected ROS in response to 
all stimuli and in unstimulated cells (Figure 51a).  Isoluminol and lucigenin detected ROS did 
not significantly change with the addition of sodium azide although minimal increases and 
decreases were observed (Figures 51b and c).   This result was as expected as isoluminol only 
detects extracellular ROS and MPO is an intracellular enzyme, and lucigenin detects 
superoxide anion production which is upstream of MPO and also primarily detects 
extracellularly.   
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Figure 51. The effect of sodium azide (2mM) on peak ROS production in response to 
PMA (50nM) and bacterial stimulation (MOI 1:150).  Detected by a) luminol b) isoluminol 
and c) lucigenin.  Results show mean of 4 experiments performed in triplicate minus blanks 
(no cells) ± SD.  * P≤0.05  **P≤0.01 by two-tailed paired T-test. 
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Data presented in Figure 52 demonstrates that MNase detected NET release was significantly 
decreased by the addition of sodium azide under all stimulatory conditions analysed (P≤0.05). 
 
 
  
Figure 52. Effect of sodium azide (2mM) on NET production by MNase assay.  Results 
show mean of 4 experiments performed in triplicate minus blanks (no cells) ± SD.  * P≤0.05  
**P≤0.01 by two-tailed paired T-test. 
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Discussion 
 
NADPH oxidase inhibitor, DPI 
Whilst DPI is a known inhibitor of NADPH oxidase, descriptions of its precise activity and 
mechanism of action are limited.  It has been reported to have no effect on phagocytosis 
although degranulation of both azurophilic and specific granules in response to opsonised 
latex beads was inhibited (Ellis et al. 1988) indicating either more widespread non-specific 
effects of the inhibitor, or knock-on effects resulting from the inhibition of NADPH oxidase 
ROS production.  It is suggested that DPI removes an electron as it is transferred between the 
redox centres of the oxidase enzyme to form a phenyl radical which covalently binds a 45kDa 
protein thought to be the reduced flavin, thereby inhibiting the enzyme (O'Donnell et al. 
1993).  The action DPI has on the activated enzyme may depend on the stimuli used to 
activate the enzyme because PMA induced superoxide production has been shown to be more 
sensitive to DPI inhibition than fMLP stimulated superoxide production (Ellis et al. 1988).  
DPI was first used in the study of NET release by Fuchs et al. (2007) and contributed to the 
conclusion that NET release was dependant on NADPH oxidase ROS generation.  However, 
the relationship between NET release and ROS generation is subject to mixed reports.  For 
example, the neutrophils of human neonates are reported to have the capacity for ROS 
generation but not for NET release (Yost et al. 2009) although more recently debate has 
arisen as to whether neonatal neutrophils are capable of severely delayed NET release 
(Marcos et al. 2009).  In addition, milk proteins are reported to inhibit ROS generation but not 
NET release (Lippolis et al. 2004).  In the chemiluminescent assay of ROS employed here, 
DPI was applied at a range of concentrations and significantly reduced the level of ROS 
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detected even at DPI concentrations as low as 0.6µM (Figure 39).  However, ROS levels were 
reduced further up to the highest concentration of 25µM.  As it is unknown as to whether the 
relationship between ROS generation and NET release is quantitative, or whether a small 
level of ROS generation is sufficient to trigger NET release under the correct stimulation 
conditions, it was decided to use the highest concentration of DPI (25µM) for subsequent 
experiments.  In the presence of DPI, real time analysis of stimulated neutrophils over a 3 
hour incubation period demonstrated a clear reduction in DNA fluorescence compared with 
values obtained in the absence of DPI (Figure 42a).  This result may be attributable to DPI 
inhibition of NET release or simply due to the fact that DPI inhibited the generation of 
cytotoxic ROS resulting in increased cell survival.  Subsequently a live-dead cytotoxicity 
assay was utilised (Promega), based on the fluorescent detection of proteases rather than 
DNA, allowing the detection of apoptosis independently of NETosis.  The substrates are 
peptides which upon cleavage by cellular proteases emit fluorescence which is indicative of 
either live or dead cells.  Data from the live cell stain indicated slightly fewer live cells in the 
presence of DPI, which was in contrast to the data generated simultaneously by the dead cell 
stain.  The dead cell indicator is cell-impermeable and is only cleaved by proteases released 
from cells which have lost membrane integrity.  As over 24 neutrophil proteins have been 
identified as components of NETs to date (Urban et al. 2009) and originate from the 
neutrophils nucleus, granules, cytoplasm and cytoskeleton, it is conceivable that proteases 
utilised in the cytotoxicity assay are released as part of NETs.  However, the distinction 
between live cell fluorescence in the presence compared to the absence of DPI was only small 
and the experiment was only performed as a single preliminary experiment.  The dead cell 
fluorescence showed a more marked difference over the 3 hour incubation period and when 
this data was examined, no cytotoxic effect of DPI was observed, in concordance with 
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previous publications (Ellis et al. 1988).  Indeed, dead cell fluorescence data indicated 
increased survival of both unstimulated and PMA stimulated cells in the presence of DPI 
(Figure 41) which may be due to the reduced level of NADPH oxidase production of 
cytotoxic ROS, in addition to reduced NETosis.  The MNase assay also allowed improved 
distinction between cells that had undergone NETosis from those that had undergone 
apoptosis.  This data appeared to indicate that DPI did indeed reduce the level of NET release 
in stimulated cells.  However, in unstimulated cells DPI consistently appeared to induce a 
small increase in NET release (Figures 40 and 42).  The difference in unstimulated NET 
release was insignificant when the average of 16 independent assays of 16 different 
individuals were examined, this result was likely due to interpersonal and experimental day-
to-day variation (Figure 40).  However, when a single experiment was performed in triplicate, 
a statistically significant increase in unstimulated NET release was observed in the presence 
of DPI (P=0.02; Figure 42) and this finding was representative of observations throughout 
these studies.  This implies that DPI stimulates a low level of NET release in unstimulated 
cells.  In addition DPI may also cause a low level of NET release in stimulated cells which is 
insignificant in comparison to levels generated by the intended stimulus, and therefore the 
level of NADPH oxidase dependant NET release may be underestimated in studies employing 
DPI. 
 
Phagocytosis inhibitor, cytochalasin b 
Cytochalasin b is a cell permeable fungal metabolite that inhibits the polymerisation of actin 
and therefore inhibits phagocytosis.  It has been utilised in a published method describing the 
inhibition of phagocytic killing so that NET-mediated killing could be measured 
independently (Beiter et al. 2006; Buchanan et al. 2006; Grinberg et al. 2008; Carlin et al. 
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2009; Katzenback et al. 2009).  The actin cytoskeleton has been shown not to form part of the 
extruded NET (Palic et al. 2007).  However this same study also utilised cytochalasin B and 
described a significant increase in PMA induced NET release in the presence of cytochalasin 
B.  In contrast, NET release here was found to be dramatically reduced in the presence of 
cytochalasin B (Figure 44), and since completing this work, cytochalasin inhibition of the 
final stage of NET extrusion into the extracellular space has been described (Neeli et al. 2009) 
indicating that the actin cytoskeleton is necessary for NET release.  This is unsurprising as all 
cell types so far listed as possessing extracellular trap capacity are also capable of 
phagocytosis and therefore possess an extensive cytoskeleton.  The data presented here also 
indicates that cytochalasin B dramatically reduces neutrophil ROS generation (Figure 43) 
which is likely to indicate that phagolysosome formation was prevented and as such ROS 
generation not initiated on the phagolysosome membrane.  Evidence in support of this theory 
is that the bacterially stimulated ROS response was reduced to a greater extent than the non-
bacterial PMA stimulation.  Taken together the data suggests there may be a two-fold 
inhibition of NET release by cytochalasin B, resulting from reduced initiation of post-
phagocytic ROS generation within the phagosome and also the reported lack of actin 
cytoskeleton-mediated NET extrusion. 
 
Superoxide dismutase 
Superoxide dismutase is an enzyme endogenous to neutrophils responsible for converting 
superoxide to hydrogen peroxide.  As the release of NETs is reported to be dependant on 
hydrogen peroxide (Fuchs et al. 2007) it was hypothesised that the addition of exogenous 
SOD and therefore, the increased generation of hydrogen peroxide would increase NET 
release.  Whilst SOD is reported to be a hydrophobic glycoprotein (Marklund 1984), the 
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majority of publications describing the addition of exogenous SOD are concerned with only 
extracellular effects.  SOD has been shown to have an affinity for the cell membrane although 
its migration through into the intracellular space is relatively slow (Emerit et al. 1996).  This 
observation was supported here by the isoluminol detection of ROS (Figure 46).  This 
represents extracellular ROS and was the only measure of ROS generation which was 
statistically significantly reduced under all 4 stimulatory conditions upon the addition of 
SOD.   
 
Antioxidant and anti-inflammatory micronutrient, curcumin  
Curcumin is a highly lipid soluble phenolic compound responsible for the yellow 
pigmentation of turmeric.  Whilst it has wide ranging effects it is well known for its anti-
inflammatory properties and the actions of interest here are those as a radical scavenger.  
Curcumin is a potent hydrogen peroxide and superoxide radical scavenger, to a similar if not 
superior level to established antioxidants such as α-tocophercol and Trolox (Ak et al. 2008).  
However, it was also found to act as a chelator of ferrous ions (Fe
2+
) which may result in 
indirect antioxidant effects on radical production.  In the studies described here, curcumin was 
found to reduce detected ROS in response to all stimuli, however this was most significant for 
luminol-dependant ROS which represented total radical production (Figure 49).  Isoluminol 
and lucigenin-dependant ROS were only significantly reduced after F. nucleatum stimulation, 
with these data representing extracellular and superoxide radical production respectively.  
These results indicate that the antioxidant activity of curcumin likely occurs intracellularly, 
and later in the radical generation pathway than superoxide formation.  NET release also 
appeared decreased upon the addition of curcumin following activation with all stimuli and 
basal levels in unstimulated cells were also decreased (Figure 50).  Levels of reduction 
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however, were only significant upon PMA stimulation.  This was unexpected as PMA-
induced radical production only incurred a significant reduction with luminol detection.  F. 
nucleatum stimulated radical production was significantly reduced when measured by all 
three chemiluminescent substrates, however, the detected NET release was not significantly 
reduced.  It is understood that curcumin, as a highly lipophilic antioxidant, works best in 
conjunction with a water soluble antioxidant such as ascorbic acid (Jovanovic et al. 2001).  
Curcumin is able to insert into the cell membrane to intercept lipid radicals and form a 
phenoxyl radical which is then more able to move to the surface for repair by the water 
soluble antioxidant.  Therefore further studies should be undertaken which utilise a 
combination of antioxidants for their efficacy in reducing the NET response. 
 
Sodium azide 
Azide molecules easily cross the cell membrane and therefore exert intracellular effects on 
endogenous enzymes such MPO.  The enzyme specificity of this inhibitor is subject to mixed 
reports with reportedly sensitive enzymes being catalase (Lieber et al. 1970), SOD (Rigo et 
al. 1975) and MPO (Lundqvist et al. 1996a) and  azide in-sensitive enzymes including 
glutathione peroxidase (Lundqvist et al. 1996b) and HRP (Dahlgren et al. 1987).  Data from 
the chemiluminsecent assay of ROS (Figure 51) demonstrated a significant decrease in only 
luminol (total) detected ROS.  In contrast, lucigenin detected ROS did not significantly 
change in the presence of sodium azide.  As this reagent is thought to primarily detect the 
superoxide radical (Williams et al. 1981), this suggests that the point of inhibition by sodium 
azide occurs following superoxide anion production in the radical generation pathway (Figure 
8).  In addition, no difference in isoluminol detected ROS was observed in the presence of 
sodium azide.  As isoluminol is cell impermeable and therefore solely detects extracellular 
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ROS, this suggests that the point of inhibition at which sodium azide works is on an 
intracellular enzyme.  Moreover, this data also indicates that the inhibition does not directly 
involve hydrogen peroxide as this radical is able to cross the cell membrane and as such 
alterations in its level are likely to be detected both intra- and extracellularly.  Although either 
endogenous catalase or MPO could be inhibited, it is hypothesised here that MPO is the target 
of sodium azide.  MPO is also the most relevant enzyme in terms of the antimicrobial 
response as it generates bactericidal hypochlorous acid, unlike catalase which generates water, 
and as such MPO is likely to take a primary role under stimulatory conditions.  Sodium azide 
resulted in a significant reduction in detected NET release under all stimulatory conditions 
(Figure 52), and combined this data now implicates hypochlorous acid as a key molecule in 
the initiation of NET release.  Previous research into the signalling pathway of NET release 
was unable to distinguish key molecules beyond hydrogen peroxide generation (Fuchs et al. 
2007).  Addition of exogenous catalase was found to decrease NET release which may be due 
to the removal of hydrogen peroxide as a substrate for MPO generation of hypochlorous acid.  
Inhibition of endogenous catalases induced increased NET release which again may have 
been due to the increased availability of hydrogen peroxide for MPO conversion, and further 
supports the hypothesis that sodium azide is inhibiting MPO rather than catalase as opposite 
effects were seen on NET release.  Future work should therefore utilise taurine or 5-
aminosalicylic acid (Dallegri et al. 1990) as hypochlorous acid scavengers to assess whether 
this product of MPO is important for NET release.  Interestingly, although CGD patients 
lacking in ROS generation suffer recurrent and life threatening infections, patients with 
complete MPO deficiency do not suffer from any increase in infection rate (Lanza 1998) 
indicating that if MPO is a key enzyme in NET release, this process is a last resort in 
antimicrobial defence after oxygen radical attack which appears to be essential. 
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CHAPTER 5 RESULTS                                                                                                    
HL60 cells as a model system for NET release 
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Obtaining primary neutrophils for analysis of NET release from whole blood is time 
consuming and requires invasive procedures.  In addition it has been shown here (Figure 66), 
and previously reported (Fuchs et al. 2007) that there is significant inter-individual and 
temporal variation in NET production levels.  Therefore, use of a standardised human cell line 
as a model for primary neutrophils and NET release would be advantageous for future study.  
The well documented human promyelocytic HL60 cell line which can be differentiated into 
cells with a neutrophil-like phenotype using dimethyl sulphoxide (DMSO) may provide a 
suitable model system.  Currently HL60 cells have been used by several groups to examine 
ROS release (Dahlgren 1989; Teufelhofer et al. 2003) however, one of only two papers 
reporting their use in the study of NET release described that >8% of differentiated cells 
extruded NETs upon stimulation with the calcium ionophore A23187 (Wang et al. 2009).  
Notably, within the literature there is also a large amount of variation in the reported 
differentiation conditions which can be used and the resultant characteristics of differentiated 
cells.  Therefore, initially differentiation conditions were analysed and subsequently the 
differentiated cells were characterised prior to assay of NET production.   
 
5.1 Differentiation of HL60 cells by DMSO 
HL60 cells can be differentiated into a monocytic cell using vitamin D (Miyaura et al. 1981), 
a macrophage-like cell using PMA (Rovera et al. 1979) or a granulocytic cell using DMSO or 
retinoic acid (Gallagher et al. 1979; Breitman et al. 1980).  Based on previous work from our 
group (Dias et al. 2008), DMSO was used for differentiation in this study.  Initially the 
concentration required to achieve optimal differentiation after 3 days incubation was 
determined.  Chemiluminescent detection of ROS production in response to PMA was used as 
 169 
a surrogate marker of neutrophil phenotype and an indicator of functional differentiation 
(Figure 53). 
 
As the applied concentration of DMSO increased, ROS production following PMA (50nM) 
stimulation increased in a dose-dependant manner, with the highest production of ROS 
observed in cells differentiated with 1.5% DMSO (Figure 53).  Notably, the average peak 
luminol-detected ROS produced by 1.5% DMSO-differentiated cells was 1082 RLU which 
was significantly lower than ROS levels produced by the equivalent number of viable primary 
neutrophils (average peak PMA-induced luminol-detected ROS in excess of 30,000 RLU; see 
Figures 49 and 51).  Notably there was also a high level of variation between cells of 
sequential passages differentiated in independent experiments (represented by the standard 
deviation; Figure 53).  In addition, the number of viable cells obtained from cultures 
decreased as the concentration of DMSO increased resulting in insufficient cells for assay 
from 1.5% DMSO cultures.  Therefore a concentration of 1.25% DMSO exposure for 3 days 
was used in all subsequent experiments to generate differentiated HL60 (dHL60) cells, in 
order to ensure effective differentiation without compromising cell survival. 
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Figure 53.  Peak ROS production detected by luminol, isoluminol and lucigenin from 
PMA (50nM) stimulated 3-day HL60 cells differentiated using 0.75%-1.5% DMSO 
concentrations.  Results show mean of 3 independent experiments on cells from sequential 
passages ± SD. 
 
5.2 PCR characterisation of dHL60 cells 
The functionality of cells is dependant upon the proteins expressed, which in turn depends on 
the transcriptional profile of the cell.  Therefore selected transcripts were analysed by RT-
PCR in dHL60 cells and compared to that of undifferentiated cells and primary neutrophils 
(Figure 54) with and without stimulation.  The genes selected for analysis included those 
associated with the NADPH oxidase enzyme pathway, which is necessary for ROS 
production, genes responsive to oxidative stress, and enzymes involved in ROS metabolism.  
Transcript levels for several receptors and intracellular molecules involved in cytokine and 
bacterial component signalling were also assessed.  The mRNA expression for these genes 
may indicate the ability of these cells to respond to appropriate stimulants of ROS and/or 
NET production. 
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Figure 54 provides data showing the PCR products of 13 transcripts and their responsiveness 
to changes in gene expression upon 3 hours bacterial (killed F. nucleatum) or PMA 
stimulation.  Quantification of band intensity relative to normalised GAPDH levels is also 
shown (Figure 55).  The expression levels of the 4 genes encoding subunits of the NADPH 
oxidase enzyme (p22 
PHOX
, p47 
PHOX
, p67 
PHOX
 and gp91 
PHOX
) whose translated products are 
responsible for ROS generation, appeared up-regulated in dHL60 cells compared to 
undifferentiated cells, although levels remained relatively lower than those detected in 
primary neutrophils.  After 3 hours incubation, dHL60 cells appeared to be less 
transcriptionally responsive to stimuli compared with primary neutrophils, as expression of 
the NADPH oxidase subunits were less dramatically affected by 3 hours incubation compared 
with the unstimulated cells.  The exception was the p47 
PHOX
 transcript which whilst its 
expression appeared altered, levels increased rather than decreased as seen in primary 
neutrophils.  In general, PMA appeared to be the most effective stimuli with regard to down-
regulating gene expression of NADPH oxidase subunits in primary neutrophils.  However, in 
dHL60 cells there was either no observable change (e.g. p22 
PHOX
 and p67 
PHOX
) or a 
relatively small increase in expression (e.g. p47 
PHOX
 and gp91 
PHOX
) for these transcripts.  Of 
the genes involved in oxidative stress responses, superoxide dismutase 2 (SOD2) was 
detected at relatively low levels in HL60 cells compared to primary neutrophils.  After 3 
hours incubation, SOD2 levels decreased in primary neutrophils, however, in dHL60 cells 
expression increased but did not reach levels detected in primary neutrophils.  Heat shock 
protein 40 demonstrated relatively low expression levels in dHL60 cells compared to primary 
neutrophils and responded with a modest increase upon stimulation similar to primary 
neutrophils.  The transcription factor NFκB2 showed reduced expression in dHL60 cells 
compared to primary neutrophils under all conditions tested except following PMA 
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stimulation in which a moderate increase in expression in dHL60 cells was detected.  
Conversely a notable decrease in NFκB2 expression was observed in primary neutrophils.  Of 
the cytokines analysed, CXCL3 was expressed at a relatively lower level in differentiated as 
compared to undifferentiated HL60 cells, however, the increases in expression upon 
stimulation were similar to that observed for primary neutrophils, although this was notably 
less dramatic.  Colony stimulating factor 2 was also expressed at a higher level without 
DMSO induced differentiation in HL60 cells.  Analysis of toll-like receptor (TLR) transcript 
levels revealed their expression levels to be relatively low in undifferentiated HL60 cells 
compared to primary neutrophils and expression appeared unaffected following DMSO 
differentiation.  No consistent profile of stimulated TLR expression was observed in 
undifferentiated or differentiated HL60 cells as well as primary neutrophils.  
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Figure 54.  RT-PCR analysis of relative transcript levels in unstimulated and stimulated 
undifferentiated and DMSO differentiated HL60 cells compared to primary neutrophils. 
Key : L - ladder, Un – untreated time 0, N – no stimulation, P – PMA stimulation, Fn – F. 
nucleatum stimulation.  Cells were incubated with or without stimulants for 3 hours prior to 
RNA isolation.  The housekeeping gene GAPDH was used as a PCR normalisation control. 
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Figure 55. Densitometric profiles of RT-PCR transcript levels in unstimulated and 
stimulated undifferentiated and DMSO differentiated HL60 cells compared with 
primary neutrophils. Band intensity of gene products expressed as a percentage of GAPDH 
band intensity.  White bars - untreated time 0, striped bars – no stimulation, grey bars - PMA 
stimulation, black bars - F. nucleatum polymorphum stimulation.  Cells were incubated with 
or without stimulants for 3 hours prior to RNA isolation. 
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5.3 Cytological analysis of dHL60 cells 
The functional assay (Figure 53) or gene expression analysis (Figures 54 and 55) does not 
distinguish the proportion of HL60 cells that may have differentiated.  Therefore cell 
morphology was assessed by haematoxylin and eosin staining (Figure 56) as well as granule 
protein staining (Figure 57).   
 
Both undifferentiated and differentiated HL60 cells stained more intensely than primary 
neutrophils following H+E staining (Figure 56).  No differences were observed between 
undifferentiated and differentiated HL60 cells in terms of staining although differentiated 
cells did appear to display some spreading and cell adhesion whilst undifferentiated cells 
appeared rounded.  Whilst primary neutrophils have a distinctive multi-lobulated nucleus this 
was not evident in dHL60 cell cultures.  The overall morphology of neutrophils also appeared 
more irregular, in contrast to HL60 cells which exhibited a more regular and rounded 
morphology. 
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Figure 56. Haematoxylin (nucleic acid) and eosin (cytoplasmic) staining of 
undifferentiated and differentiated HL60 cells compared to primary neutrophils. 
 
 
 
Whilst immunocytochemical staining indicated the presence of the neutrophil granule 
components neutrophil elastase and myeloperoxidase in HL60 cells (Figure 57), there 
appeared to be no difference in staining intensity or distribution between differentiated and 
undifferentiated HL60 cells.  Immunostaining of primary neutrophils demonstrated the 
presence of neutrophil elastase and myeloperoxidase in spontaneously extruded NETs (Figure 
57). 
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Figure 57. Immunocytochemical staining of undifferentiated and differentiated HL60 
cells using primary antibodies against the neutrophil granule components - neutrophil 
elastase and myeloperoxidase. Negative controls (no primary antibody) show endogenous 
peroxidase activity.  Primary neutrophils stained for comparison. 
 
5.4 NET production in dHL60 cells 
Following characterisation of differentiation for HL60 cells (1.25% DMSO for 3 days) their 
ability to produce NETs was assessed.  The three techniques previously reported were applied 
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including direct visualisation by SYTOX
®
 staining on slides (2.1.3), fluorometric real-time 
SYTOX
®
 analysis (2.1.4), and MNase purification and fluorometric quantification of 
extracellular DNA (2.1.5).  For NET induction several stimuli were used including PMA 
which is an effective stimulus of the respiratory burst in dHL60 cells (Newburger et al. 1979; 
Dahlgren 1989; Levy et al. 1990), fMLP which mimics bacterially-derived peptides and acts 
via the fMLP receptor (Snyderman et al. 1981), and the heat-killed gram negative periodontal 
bacteria F. nucleatum polymorphum, which likely acts via TLR2/4 binding of bacterial LPS 
(Remer et al. 2003).  The calcium ionophore A23187 was also applied as this increases 
cytoplasmic free calcium and has been used to prime the respiratory burst in HL60 cells 
(Dahlgren 1989), as well as being reported to stimulate NET release from HL60 cells (Wang 
et al. 2009). 
 
5.4.1 Visualisation of NETs in dHL60 cells 
Initially dHL60 cells were seeded onto poly-L-lysine coated slides and incubated for 3 hours 
with NET stimuli and visualised using SYTOX
®
 staining of the DNA (Figure 58).  
 
Visualisation of dHL60 cells stimulated for NET production indicated relatively low level 
release (Figure 58).  No extracellular NET-DNA release was evident following F. nucleatum 
polymorphum or fMLP stimulation.  PMA exposure resulted in a minimal increase in the 
presence of extracellular DNA however, dHL60 cell stimulation using the calcium ionophore 
resulted in more apparent NET formation, though levels appeared minimal compared to NET 
levels released from primary neutrophils. 
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F. nucleatum MOI 150                                           fMLP 1000nM 
                            
 
Unstimulated                                                          Positive control (primary neutrophils) 
                            
 
Figure 58.  SYTOX
®
 stained DNA in dHL60 cells.  Representative images for dHL60 cells 
stimulated with PMA (50nM), calcium ionophore – A23187 (4µM), F.nucleatum 
polymorphum (MOI 1:150), fMLP (1000nM) or unstimulated control.  Positive control shows 
primary neutrophils stimulated with PMA (50nM).  Results are representative of 3 
independent experiments. 
 
5.4.2 Fluorometric quantification of NET release from dHL60 cells 
To quantify NET release, the fluorescence of dHL60 cells during the 3 hours stimulatory 
period was recorded (Figure 59).  As has previously been described (Fuchs et al. 2007 and 
Section 4.1), the NADPH oxidase inhibitor, DPI, was included as a control within the analysis 
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to determine if increases in fluorescence after stimulation were ROS-dependant and therefore 
likely to be due to NET release. 
 
With the addition of stimuli at 20 minutes (Figure 59a) PMA and F. nucleatum resulted in no 
detectable increase in fluorescence over the incubation time, however inclusion of the calcium 
ionophore A23187 stimulated DNA release and a marked increase in fluorescence with onset 
at 625 seconds (10 minutes) post-exposure.  With the addition of the NADPH oxidase 
inhibitor, DPI (Figure 59b) the calcium ionophore induced fluorescence increased following 
the same pattern as that previously observed in the absence of DPI for the first 4065 seconds 
(67 minutes) after stimulation prior to reaching a plateau.  DPI exposure resulted in only a 
marginal increase in the fluorescence of PMA and unstimulated cells beginning 1.5 hours 
post-stimulation. 
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Figure 59. Real time fluorescence of differentiated HL60 cells a) without and b) with 
DPI (25µM).  Cells stimulated after 20 minutes using PMA 50µM, calcium ionophore 4µM, 
F. nucleatum polymorphum MOI 1:150 or unstimulated.  Results show mean of experiment 
performed in triplicate. 
 
 
5.4.3 MNase assay of dHL60 cell NET production 
Subsequently, NET release from dHL60 cells was quantified by MNase assay (Figure 60).  
Data demonstrated minimal NET release from dHL60 cells following PMA or F. nucleatum 
stimuli 
added 
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polymorphum exposure as the mean DNA-fluorescence detected did not significantly differ 
from that of unstimulated cells (indicated by dashed line).  Calcium ionophore stimulation 
showed an increase in the extracellular DNA detected by MNase assay although this was not 
significant by two tailed T test when compared to unstimulated cells (P=0.11).  Addition of 
the NADPH oxidase inhibitor DPI resulted in a minimal and statistically insignificant increase 
in the DNA-fluorescence of PMA stimulated (P=0.1) and bacterially-stimulated (F. 
nucleatum) cells (P=0.5) and had no effect on unstimulated cells.  DPI addition to calcium 
ionophore stimulated dHL60 cells resulted in the only statistically significant reduction in 
detected DNA (P=0.04). 
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Figure 60.  MNase assay of NET-DNA release from differentiated HL60 cells with and 
without DPI (25µM).  Cells were stimulated at 20 minutes using PMA (50µM), calcium 
ionophore (4µM), F. nucleatum polymorphum (MOI 1:150) or were unstimulated (control).  
Results show mean experiments performed in triplicate ± SD.  * P≤0.05 by two tailed 
unpaired T-test.  Dashed line indicates fluorescence detected in unstimulated cell supernatant 
i.e. baseline NET release. 
 
* 
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5.5 ROS production by dHL60 cells 
To compare ROS and NET production, ROS levels (Figure 61) were assayed simultaneously 
in the same dHL60 cell populations previously assayed for NET release (Figures 59 and 60).  
Calcium ionophore exposure resulted in low levels of ROS generation whilst F. nucleatum 
polymorphum stimulation resulted in no detectable effect (Figure 60).  Notably only PMA 
stimulation resulted in significant ROS production. 
 
Data presented in Figure 62 shows the kinetics from which the peak ROS generation was 
calculated for Figure 61.  Notably the kinetics of PMA-induced ROS production were 
comparable to that observed for primary neutrophils (see appendix Figure 96).  Calcium 
ionophore exposure caused an immediate and rapid increase in luminol and isoluminol 
dependent ROS production which may have continued to increase had the assay plate been 
read more frequently than the standard 3 minute intervals.  Whereas PMA-induced luminol 
and isoluminol dependant ROS increased relatively rapidly and decreased more gradually, 
calcium ionophore induced ROS increased rapidly and decreased at the same rate to return to 
baseline levels only 40 minutes after exposure. 
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Figure 61. Peak ROS production by differentiated HL60 cells detected by luminol, 
isoluminol and lucigenin.  Cells stimulated after 20 minutes using PMA 50µM, calcium 
ionophore 4µM, F. nucleatum polymorphum MOI 1:150 or unstimulated.  Results show mean 
of experiment performed in triplicate ± SD. 
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Figure 62.  Time course of ROS production by dHL60 cells (1.25% DMSO 3 days) over 
time in response to stimulation using a) PMA 50nM b) calcium ionophore 4µM C) F. 
nucleatum polymorphum MOI 1:150 d) unstimulated. 
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Discussion 
 
Differentiation of HL60 cells 
The cytological (Figures 56 and 57) and molecular (Figure 55) data presented here indicated 
that the differentiation of HL60 cells using DMSO was relatively inefficient although the 
functional measure of differentiation, i.e. ROS generation (Figures 53 and 62) was more 
indicative of success.  This is in agreement with previous publications in which day 1-3 HL60 
cell cultures were described as morphologically immature but were capable of superoxide 
production, degranulation and bactericidal activity (Newburger et al. 1979).  Whilst a key 
reason for using a cell line rather than primary cells was to eliminate day-to-day and person-
to-person variation, data from the ROS assay indicated that this still varied greatly for each 
passage of the HL60 cells analysed (Figure 53).  Notably whilst normal cell culture practice 
attempts to use only cells from relatively low passages, publications utilising HL60 cells have 
claimed that these cells were only used after 3 years continuous culture as responses to 
stimulation were increased (Preiss et al. 1987).  Whilst transcriptional analysis indicated that 
HL60 cell DMSO exposure induced noticeable changes in the expression of genes encoding 
components of the NADPH oxidase enzyme, the expression of most other genes tested was 
not altered by treatment with DMSO (Figure 55).  The expression of genes encoding the 
NADPH oxidase subunits in dHL60 cells was lower than in primary neutrophils, which is in 
agreement with the finding that ROS generation was also lower than in primary neutrophils 
(Figure 53).  For the majority of genes studied, 3 hour stimulation with either F. nucleatum or 
PMA resulted in a change in gene expression indicating that the cells possessed the receptors 
and pathways to respond to these stimuli.  The changes in gene expression however, were not 
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always consistent with those detected in primary neutrophils.  For example, the relative level 
of SOD gene expression decreased over 3 hours incubation in primary neutrophils but 
increased in HL60 cells.   
 
dHL60 cell responses 
The most effective stimulus of dHL60 cells for evoking the generation of ROS was PMA 
(Figure 61), however, the most effective stimulus for evoking the release of NETs was the 
calcium ionophore A23187 (Figure 60).  Interestingly however whilst the calcium ionophore 
was not the most effective stimulus for the generation of ROS, the NET release it evoked did 
appear to be dependent on ROS as the addition of the NADPH oxidase inhibitor, DPI, 
resulted in a significant reduction in detectable levels of NETs (Figure 60).  The success of 
the calcium ionophore as a stimulus for NET production suggests that a short burst of ROS 
production is sufficient for the initiation of NET release.  Whilst ROS release increased 
immediately upon stimulation, reached a peak within 10 minutes and returned to baseline 
within 40 minutes (Figure 62), in contrast, NET release was detectable from 30 minutes post-
stimulation and increased for the duration of the 3 hour incubation period (Figure 59).  An 
alternative form of calcium ionophore (ionomycin) has previously been reported to prime 
dHL60 cells resulting in increased ROS generation upon stimulation however, application of 
this alone was insufficient for ROS production (Dahlgren 1989).  The ROS responses 
recorded here (Figure 62b) were relatively low in comparison to the PMA-induced response 
indicating that the assay previously described (Dahlgren 1989) may not have been sufficiently 
sensitive for the detection of calcium ionophore induced ROS.  However, a ROS response 
was detected in primary neutrophils stimulated with calcium ionophore and displayed similar 
kinetics to those observed here, in that a peak was reached very rapidly within approximately 
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3 minutes (Dahlgren 1989).  The efficacy of the calcium ionophore is consistent with 
evidence that NET release is dependent on calcium.  Not only is the most widely reported 
stimulus of NET release an activator of a calcium dependant kinase, i.e. PMA, but increasing 
intracellular calcium concentrations (using calcium ionophore exposure) is demonstrated both 
here (Figures 59 and 60) and previously (Wang et al. 2009) to evoke NET release.  Calcium is 
known to have widespread signalling roles within the cell so the mechanism by which this is 
able to elicit NET release requires further analysis.  One possible mechanism however, is that 
the calcium ionophore is able to stimulate the generation of diacylglycerol as demonstrated in 
dHL60 cells by Preiss et al. (1987), which subsequently activates PKC, as previously reported 
in T-cells (Chatila et al. 1989) and the same mechanism stimulated by PMA.  
 
Moreover the inconsistency between PMAs ability to stimulate ROS production and its 
ineffectiveness in triggering NET release may reflect the possibility that NET release is not 
entirely NADPH oxidase dependent, or alternatively may reflect phenotypic differences in 
biological pathways between dHL60 cells and primary neutrophils.  Given the variation in 
functional responses between passages, the differences in gene expression and cellular 
appearance when compared to primary neutrophils, and the relative inability to extrude NETs, 
this cell line was considered unsuitable as a model for neutrophils in the further study of NET 
release. 
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CHAPTER 6 RESULTS                                                                                                                
Comparison between NET release in periodontitis patients and healthy controls                                           
and the NET responses to periodontal pathogens 
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It has previously been reported that the production of reactive oxygen species by peripheral 
blood neutrophils from periodontitis patients with untreated disease, differs from that of age 
and gender-matched periodontally healthy controls (Gustafsson et al. 1996; Fredriksson et al. 
2003; Matthews et al. 2007a; Matthews et al. 2007b), particularly in response to Fcγ-receptor 
stimulation by opsonised S. aureus.  As NET release has been reported to depend upon 
hydrogen peroxide generated during the respiratory burst (Fuchs et al. 2007), it was 
hypothesised that NET release by patient’s peripheral blood neutrophils would also be higher 
than from controls.  Subsequently 15 chronic periodontitis patients were recruited with at least 
30% bone loss and a blood sample was collected before treatment was commenced.  
Neutrophils were isolated and assayed for ROS generation by chemiluminescent assay and for 
NET production by MNase assay.  To further investigate the nature of NET release specific to 
the periodontally diseased state, peripheral blood neutrophils from control individuals self-
reported as periodontally healthy were challenged with a panel of 11 periodontal pathogens 
and the same assays were again used to measure ROS and NET release.  The NET release was 
also visualised by SYTOX
®
 staining of the DNA and by scanning electron microscopy 
(SEM).  
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6.1 Comparison between NET release in periodontitis patients and self-reported healthy 
controls 
 
6.1.1 Selection of test subjects 
Periodontitis patients were selected according to the criteria previously detailed (2.2.1).  Ages 
of volunteers at the time of sampling are documented in Table 9. 
 
Table 9. Age of volunteers 
Subject 
number Sex Patient age Control age 
01 F 60y 9m 58y 10m 
02 F 53y 10m 50y 2m 
03 F 48y 0m 48y 4m 
04 F 58y 8m 61y 1m 
05 F 53y 2m 55y 2m 
06 F 46y 10m 48y 7m 
07 M 40y 4m 40y 0m 
08 F 39y 2m 46y 0m 
09 F 30y 10m 30y 11m 
10 M 42y 8m 47y 3m 
11 M 63y 5m 59y 6m 
12 F 35y 0m 33y 2m 
13 M 48y 2m 46y 5m 
14 F 49y 5m 55y 2m 
15 F 58y 11m 57y 10m 
 
      Mean age:        48y 7m             49y 3m      
      Range:             30-63 years       30-61 years 
  
      Gender:           4 male : 11 female 
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6.1.2 ROS production 
The rationale for this study was based on previous reports of peripheral blood neutophil 
hyperactivity, i.e. unstimulated ROS production and hyper-reactivity i.e. stimulated ROS 
production, in periodontitis patients compared with those of healthy controls (Matthews et al. 
2007a).  A significant limitation of this study was that control patients were not examined to 
confirm their periodontal status, due to logistical reasons.  The previous publications reported 
studies on Fcγ-receptor stimulation, therefore opsonised S. aureus was also used as a stimulus 
here, as well as a Gram negative periodontal pathogen (F. nucleatum subsp. polymorphum) 
and a well documented stimulator of NET release (PMA).  These stimulatory conditions were 
assayed for their induction of ROS simultaneously with NET release. 
 
Data from luminol dependant peak ROS generation by patient neutrophils paired with 
matched control neutrophils demonstrated that F. nucleatum was the most effective stimulant 
for evoking ROS generation, with the second most effective stimulus being PMA (Figure 63).  
F. nucleatum and PMA stimulation both demonstrated ROS generation to be generally higher 
in the patient group compared with the control group and this was statistically significant 
(P=0.02 and P=0.01 respectively) by paired T-test.  Isoluminol (Figure 64) and lucigenin 
(Figure 65) dependant ROS generation did not appear to show any consistent or statistical 
differences between patient and control groups.  PMA stimulation appeared to generate 
slightly higher levels of isoluminol-dependant ROS compared with F. nucleatum stimulation 
and both stimuli appeared equally effective at generating lucigenin-dependant ROS. 
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Figure 63.  Luminol detected ROS production by the peripheral neutrophils of 15 patient-control pairs stimulated using PMA 
(50nM), opsonised S. aureus (MOI 1:150), F. nucleatum polymorphum or unstimulated (control).  *P≤0.05. **P≤0.01 using paired T-test. 
** 
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Figure 64. Isoluminol detected ROS production by the peripheral neutrophils of 15 patient-control pairs stimulated using PMA 
(50nM), opsonised S. aureus (MOI 1:150), F. nucleatum polymorphum or unstimulated (control).  No significant differences were detected 
between patient and control groups using paired T-test. 
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Figure 65. Lucigenin detected ROS production by the peripheral neutrophils of 15 patient-control pairs stimulated using PMA 
(50nM), opsonised S. aureus (MOI 1:150), F. nucleatum polymorphum or unstimulated (control).  No significant differences were detected 
between patient and control groups using paired T-test. 
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6.1.3 NET release 
The release of NETs was quantified by MNase assay and is displayed as 15 patient-control 
pairs (Figure 66).  When examining the difference between the DNA-fluorescence from each 
patient and their matched control, paired T-test found no significant differences.  
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Figure 66. NET release from peripheral neutrophils of 15 patient-control pairs.  
Released DNA quantified by MNase assay.  Results show 15 patient-control pairs assayed in 
triplicate. No significant differences were observed between patient and control groups by 
paired T-test. 
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6.1.4 NADPH oxidase-dependant NET release 
Previous publications have reported NET release to be dependant upon the NADPH oxidase 
generation of hydrogen peroxide and use of the NADPH oxidase inhibitor, DPI, here (Chapter 
4) confirmed this finding.  Notably however, a low level of NET formation was still present 
with DPI treatment which may represent NADPH oxidase independent NET release or cell 
death involving lysis.  Therefore DPI (50µM) was used in the NET assay of neutrophils from 
patient-control pairs to elucidate the levels of ROS-dependant NET release in response to 
stimulation.  The DPI-independent DNA fluorescence (i.e. in the presence of DPI) was 
subtracted from the total DNA fluorescence (i.e. in the absence of DPI) to give DPI-
dependant (i.e. NADPH oxidase-dependant) DNA release (Figure 67).  In some cases this 
yielded negative values suggesting that the addition of DPI resulted in an increase in NET 
release.  Alternatively this may simply represent the inherent experimental variation of this 
assay method.  Mean NET release was higher in patient groups compared to control groups in 
response to all 3 stimuli used although the mean NET release from unstimulated neutrophils 
was slightly higher in the control group than the patient group.  The difference in NET release 
between patient-control pairs was statistically significant with PMA stimulation (P=0.04) and 
F. nucleatum stimulation (P=0.01) but was not statistically significant following opsonised S. 
aureus stimulation of neutrophils (P=0.3) by paired T-test. 
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Figure 67. NADPH oxidase-dependant NET release from 15 patient-control pairs.  
Neutrophils stimulated with a) PMA (50nM) b) opsonised S. aureus (MOI 1:150) c) F. 
nucleatum (MOI 1:150) or d) unstimulated.  Released DNA quantified by MNase assay with 
or without DPI (50µM).  Results show results for 15 patient-control pairs assayed in triplicate. 
*P≤0.05  **P≤0.01 by paired T-test. 
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6.1.5 Comparison between ROS production and NADPH oxidase-dependant NET 
release  
Generated ROS levels were compared to released NETs for each individual of the patient and 
control groups to analyse whether there was a link between the level of ROS and the level of 
NET release (Figure 68).  Only PMA simulation in the patient group resulted in a significant 
correlation between luminol-dependant ROS and NADPH oxidase-dependant NET release by 
Pearson test (P=0.0428; Figure 68a).  When patient and control data points were combined to 
compare generated ROS levels to NET release independent of periodontal disease status, a 
correlation remained when examined by Pearson test (R
2
=0.2440) with improved statistical 
significance (P=0.0065). 
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Figure 68. Comparison 
between luminol-
dependant ROS and 
NADPH oxidase-
dependant NET release 
in response to a) PMA 
(50nM) b) opsonised S. 
aureus (MOI 1:150) c) F. 
nucleatum poly. (MOI 
1:150) and d) 
unstimulated neutrophils 
from patients and controls. 
*P≤0.05. 
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6.2 NET production by stimulation with periodontal pathogens and comparison with 
ROS production 
The periodontal diseased state is mediated by a balance between the host response (such as 
that of the neutrophil) and the bacteria present in the plaque biofilm (Section 1.1).  Having 
investigated the responses of peripheral neutrophils from individuals suffering from 
periodontal disease, it was next investigated whether stimulation with periodontal pathogens 
associated with varying degrees of disease severity (Socransky et al. 1998; Figure 4) made a 
difference to the NET response.  The NET response was assessed in the peripheral neutrophils 
from periodontally healthy individuals only, and was visualised by SYTOX
®
 staining and 
scanning electron microscopy (SEM) as well as by quantitative MNase assay along with 
chemiluminescent assay of ROS generation. 
 
6.2.1 SEM of periodontal pathogens interacting with NETs 
Neutrophils were seeded onto polylysine coated coverslips and stimulated with 6 periodontal 
pathogens to allow detailed analysis by SEM of the interaction between the bacteria and the 
NETs produced (Figure 69).  Generally the NETs consisted of thin strand-like structures 
strung between neutrophils (white arrows) with the bacteria or clumps of bacteria (black 
arrows) associated with these strands (e.g. T. forsythensis, S. constellatus, A. 
actinomycetemcomitans and P. gingivalis).  A. actinomycetemcomitans stimulated NETs also 
displayed a more diffuse structure which appeared to more effectively trap small groups of 
bacteria (black arrow).  Opsonised S. aureus also appeared to be associated with smooth 
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diffuse strands (white arrow) which covered the neutrophil and surrounding bacteria.  F. 
nucleatum stimulated NETs appeared more web-like, a phenomenon which had also been 
observed following SYTOX
®
 staining of F. nucleatum stimulated NETs.  These strands may 
represent thin NET filaments with the fusiform/rod shaped bacteria aligned along and adhered 
to these strands.  There was an indication of the strands combining and twisting in a rope-like 
manner (white arrow), which had previously been described for the ultrastructure of NETs 
(Brinkmann et al. 2004; Brinkmann et al. 2007).  SEM analysis of bacterially stimulated 
neutrophils also allowed high magnification visualisation of the bacteria which confirmed T. 
forsythensis to be fusiform, S. constellatus and S. aureus to be cocci, A. 
actinomycetemcomitans to be ovoid, F. nucleatum to be fusiform rods and P. gingivalis to be 
short rods.  
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T. forsythensis 
 
 
S. constellatus 
 
 
 
A. actinomycetemcomitans b 
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Opsonised S. aureus 
 
 
F. nucleatum 
 
 
P. gingivalis 
 
 
Figure 69. Scanning electron micrographs of peripheral blood neutrophils stimulated 
with periodontal pathogens (MOI 1:150). White arrows indicate NETs, black arrows 
indicate bacteria. 
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6.2.2 MNase assay of periodontal pathogen stimulated-NET release   
The release of NETs in response to a panel of 9 periodontal pathogens in addition to 
opsonised and unopsonised S. aureus (all at an MOI of 150 bacteria per neutrophil) was 
quantified by MNase assay (Figure 70).  Data show the mean NET release from 3 
independent experiments performed on separate occasions using neutrophils from 3 different 
individuals.  As a result there is a relatively large degree of variation in NET production, 
represented by the standard deviation, especially with those bacteria which evoked a higher 
level of NET release such as T. forsythensis, A. actinomycetemcomitans and P. intermedia.  
The extracellular DNA fluorescence detected after S. constellatus or unopsonised S. aureus 
stimulation was not increased in comparison to unstimulated cells. 
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Figure 70. MNase assay of NET-DNA release from peripheral neutrophils of healthy 
individuals in response to periodontal pathogens (MOI 1:150).  Results show mean of 3 
independent experiments performed in triplicate ± SD. 
 209 
6.2.3 ROS production in response to periodontal pathogens  
ROS production was quantified by chemiluminescent assay (Figure 71) simultaneously with 
the MNase assay of NET release previously described (Figure 70).  All bacteria were again 
applied at equal concentrations (MOI 1:150) and were used to stimulate neutrophils on 3 
independent occasions, resulting again in a large standard deviation particularly when 
readings were relatively high.  F. nucleatum subsp. polymorphum, P. micros and T. 
forsythensis were the most effective stimuli at evoking luminol- and isoluminol-dependent 
ROS production.  F. nucleatum subsp. polymorphum, F. nucleatum subsp. nucleatum and P. 
micros were the more effective stimuli at evoking lucigenin-dependent ROS generation. 
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a) Luminol detection of peak ROS 
0
50000
100000
150000
200000
250000
A
. v
is
co
su
s
T.
 fo
rs
yt
he
ns
is
S
.c
on
st
el
la
tu
s
A
. a
ct
in
o.
 B
P
. m
ic
ro
s
P
. i
nt
er
m
ed
ia
F.
 n
uc
le
at
um
 n
uc
.
un
op
s 
S
. a
ur
eu
s
op
s 
S
. a
ur
eu
s
F.
 n
uc
le
at
um
 p
ol
y.
P
. g
in
gi
va
lis
un
st
im
ul
at
ed
P
e
a
k
 R
L
U
 
b) Isoluminol detection of peak ROS 
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c) Lucigenin detection of peak ROS 
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Figure 71. ROS production from peripheral neutrophils detected by a) luminol, b) 
isoluminol and c) lucigenin in response to periodontal pathogens MOI 1:150.  Results 
represent mean of 3 independent experiments performed in triplicate ± SD. 
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6.2.4 Correlation analysis between NET release and ROS generation in response to 
periodontal pathogens 
To examine the relationship between the ROS generated and the level of NET release 
detected in response to the 11 bacteria, the data from Figures 70 and 71 were plotted against 
each other (Figure 72).  No statistically significant correlation was observed by Pearson test 
between any measure of ROS generation (luminol, isoluminol or lucigenin) and the 
concurrent release of NETs.  However, 3 bacteria consistently produced some of the highest 
levels of released DNA but produced extremely low levels of detected ROS.  When these 
bacteria (P. gingivalis, P. intermedia and A. actinomycetemcomitans b) were excluded, 
Pearson test revealed a significant positive correlation between NET release and luminol-
dependent ROS production (R
2
=0.5; Figure 72a). 
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a) Correlation of NET release (AFU) with luminol detected ROS generation (RLU) Luminol-MNase 
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b) Correlation of NET release (AFU) with isoluminol detected ROS generation (RLU) 
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c) Correlation of NET release (AFU) with lucigenin detected ROS generation (RLU) 
Lucigenin-MNase
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Figure 72.  Correlation between NET-DNA detected by MNase assay and ROS detected 
by a) luminol  b) isoluminol  c) lucigenin.  Bacterial stimuli used at MOI 1:150  A. viscosus 
(Av), T. forsythensis (Tf), S. constellatus (Sc), A. actinomycetemcomitans a (Aaa), P. micros 
(Pm), P. intermedia (Pi), F. nucleatum nucleatum (Fnn), unopsonised S. aureus (unopSA), 
opsonised S. aureus (opSA), F. nucleatum polymorphum (Fnp), P. gingivalis (Pg), 
unstimulated (unstim).  Results show mean of 3 independent experiments performed in 
triplicate. R
2
 values generated by Pearson test excluding circled data points. 
 
R
2
=0.5 
*P=0.03 
R
2
=0.3 
P=0.1 
R
2
=0.3 
P=0.2 
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Discussion 
 
Differences in patient and control neutrophil responses 
It is well established that peripheral blood neutrophil responses differ between individuals and 
even within the same individual assayed at different times and on different days (Chapple et 
al. 2007b; Fuchs et al. 2007).  Two significant factors affecting interpersonal variation, age 
and gender were controlled for here.  However, a major difference between the patient and 
control groups in the current study was that patients had blood samples taken following over 
night fasting whilst controls had not previously fasted.  This difference may have contributed 
to the fact that statistically significant differences between patient and control groups were 
only observed in the luminol detection of ROS (Figure 63) and the assay of NADPH oxidase-
dependant NET release (Figure 67), since dietary glucose may result in an exaggerated 
NADPH oxidase respiratory burst (Chapple 2009).  For the quantification of NET release, 
DPI was used to eliminate baseline (NADPH oxidase independent) DNA release which may 
have been due to cell necrosis and lysis induced by cell processing rather than active NET 
extrusion.  When this approach was applied, patient responses were significantly higher than 
control responses in PMA and F. nucleatum stimulated cells (Figure 67).  Whilst evidence 
exists that periodontitis is associated with elevated peripheral neutrophil activity in terms of 
chemotaxis (Van Dyke et al. 1980) and ROS generation (Gustafsson et al. 1996; Matthews et 
al. 2007a; Matthews et al. 2007b), the data presented here suggests that NETosis may also be 
elevated in peripheral neutrophils and may contribute to the pathology of this disease rather 
than protect against infection.  When the stimulated NET values in the presence of DPI were 
subtracted from those in the absence of DPI some of the resultant data points were negative 
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(Figure 67).  This suggests that DPI caused increased NET release, a phenomenom previously 
described in unstimulated and ineffectively stimulated cells (Chapter 4).  Indeed, the negative 
values generated for NADPH oxidase-dependant NET release were most dramatic in the 
unstimulated cells.  When ROS and NET production were compared no correlation was 
observed, only a weak correlation in PMA stimulated neutrophils (Figure 68).  This suggests 
that the relationship between ROS generation and NET release may not be quantitative, that 
the quantitative relationship varies between individuals, or that NADPH oxidase independent 
mechanisms of NETosis also exist.  Further investigation including the systematic and 
thorough study of periodontitis patients should therefore be performed.  Moreover, newly 
emerging markers of NET activation could be utilised such as antibodies for the citrullination 
of histone H3 (Wang et al. 2009; Vitkov et al. 2010) which could provide greater specificity 
in the detection of NET release than those employed in this thesis. 
 
NET release in response to periodontal pathogens 
Numerous bacteria have been reported to associate with and be trapped by NETs such as 
Staphylococcus aureus, Salmonella typhimurium, Shigella flexneri (Brinkmann et al. 2004) 
and Streptococcus pneumoniae (Reid et al. 2009).  As predicted, periodontal pathogens were 
also demonstrated to associate with NETs when analysed under SEM (Figure 69).  
Furthermore these NETs were produced in response to the bacteria, unlike in certain previous 
publications in which PMA or IL-8 were used to trigger NET release and the pathogen added 
subsequently.  The morphology of the NETs observed also varied depending on the bacterial 
species associated with them.  This observation may have arisen due to the different charges 
present on the bacterial surfaces which represents the current hypothesised mode of trapping 
(Brinkmann et al. 2007).  For example, PMA is most commonly used to stimulate NET 
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release however the NETs produced often appear diffuse prior to mechanical stimulation (by 
SYTOX staining; Figure 26B).  The presence of bacteria may provide a surface for NETs to 
adhere to and likewise, NETs are often observed to span between two neutrophils (Figure 69 
T. forsythensis).  Whilst in this study only dead bacteria were employed to stimulate NET 
production, previous work has demonstrated that live parasite sporozoites are more effective 
than dead ones at stimulating NET release (Behrendt et al. 2010).  It might be expected that as 
dead bacteria have no motility then the release of NETs to trap the bacteria and prevent their 
dissemination is unnecessary, and therefore live bacteria may be more effective.  Further work 
in this area could investigate whether live or dead periodontal bacteria of the same species 
result in different levels of NET release. 
 
When ROS generation and NET release were quantified (Figures 71 and 72 respectively) a 
wide range of levels detected in response to different periodontal pathogens was evident with 
F. nucleatum polymorphum being amongst the highest producers and unopsonised S. aureus 
amongst the lowest.  Therefore, although there is an ever increasing list of agents, microbes 
and molecules capable of stimulating NET release, these do not stimulate identical responses.  
Each bacterial species will exhibit a different combination of surface antigens which will 
result in variations in stimulation of host cells.  Data presented here identified three bacteria 
as outliers when assayed simultaneously for ROS and NET generation (Figure 72).  These 
bacteria exhibited low levels of ROS generation but surprisingly high levels of detected NET 
release.  Highly variable levels of NET release were detected in response to P. intermedia 
over the three occasions tested (indicated by the standard deviation presented in Figure 70) 
making it difficult to draw any conclusions about the relationship between ROS and NET 
generation for this bacterium.  Reasons for the relatively elevated NET readings in response to 
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the two remaining bacteria (P. gingivalis and A. actinomycetemcomitans b) may relate to 
bacterial DNase activity.  If the majority of bacteria except these outliers expressed some 
level of DNase this may reduce the sensitivity of the NET detection assay relative to the 
outliers.  Alternatively, P. gingivalis has been reported to express the PAD enzyme 
(Rodríguez et al. 2009), which is responsible for the citrullination of proteins, including 
histone H3, which has been demonstrated to be an essential step in NET release (Wang et al. 
2009).  It is possible that enhanced citrullination of histones within the neutrophil facilitates 
NET release even when levels of ROS are low.  Whether any expressed PAD would remain 
bound to the bacteria and its activity preserved during the storage of the bacterial stimuli used 
here needs further investigation, although it has been reported that bacterial PADs do not 
require any cofactors for activity and are relatively robust, as whilst the enzyme aggregates 
upon storage at -20°C (also used here) activity was still subsequently detected following 
thawing (Rodriguez et al. 2009).  If the experiments performed here were repeated utilising 
live bacteria which are more physiologically relevant, other outliers may also be identified.  
For example, catalase expression is a common characteristic amongst bacteria and this 
enzyme has previously been demonstrated to reduce NET release (Fuchs et al. 2007).  It is 
therefore conceivable that bacterial catalase expression may exert the same effect in vivo.  
Although catalase is a large protein and therefore only able to act extracellularly (Dahlgren et 
al. 1999) it is possible that extracellular removal of hydrogen peroxide would maintain a 
gradient promoting its diffusion into the extracellular space and maintaining a reduced 
intracellular hydrogen peroxide concentration.   
 
In conclusion, there are likely to be certain bacterial species with particular virulence or 
susceptibility in terms of their interaction with host neutrophils.  However, if in general the 
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potency of any given species to stimulate ROS generation correlates with the level of NET 
release, this evidence suggests that where there exists a pathology involving the release of 
ROS, NETs are also likely to play a role.  Indeed a statistically significant correlation was 
observed between luminol-dependant ROS production and NET release (Figure 72a) when the 
panel of periodontal pathogens were used as stimuli.  This is in agreement with the 
periodontitis patient data, in which the same two stimuli (PMA and F. nucleatum) resulted in 
a significant difference between the two groups for both luminol-dependant ROS and 
NADPH oxidase-dependant NET release (Figure 63 and 67). 
 218 
 
 
 
 
 
 
 
 
 
 
CHAPTER 7 RESULTS                                                                                    
Characterisation of periodontal pathogens and their susceptibility to killing by histone 
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A panel of 34 anaerobic periodontal pathogens (Table 6) which were all American Type 
Culture Collection (ATCC) strains obtained from cultures maintained at the Forsyth Institute, 
Boston, USA (kind gift by Professor S. Socransky), were utilised in this project.  Members of 
this panel were used to i) stimulate NET release from peripheral blood neutrophils, ii) assay 
for their in vitro DNase activity and iii) test their susceptibility to killing by histones.  Given 
the duration of maintenance and likely phenotypic changes induced by repeated culture, it was 
deemed important to confirm their validity for use.  The bacteria were therefore identified and 
characterised using several complementary approaches including morphological and 
biochemical analysis, and species specific PCR where appropriate. 
 
7.1 Characterisation of periodontal pathogens 
Prior to experimental analysis of the bacteria, their identity was established using PCR of 
species specific genes, morphological and biochemical testing. 
 
7.1.1 PCR identification of bacteria 
Twenty-four primers were obtained from the existing literature and four were additionally 
designed in-house to amplify gene sequences specific to each bacterial species (Table 7).  
Commonly, the target DNA sequences was the small ribosomal subunit (16s rRNA) which 
differs in nucleotide sequence between species but is highly conserved, i.e. not subject to 
significant change between strains of the same species (Woese 1987).  For certain bacteria 
however, 16s rRNA assays were not reported and therefore alternative genomic sequences 
were utilised.  For the purpose of a screening for identification, and to minimise the number 
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of PCR assays performed, a rows and columns approach was utilised (Table 10).  Equal 
volumes of the 6 bacteria in each row and column were combined and 12 PCR assays 
performed on samples of these pooled bacteria (C1-6 and R1-6).  Thereby for any single 
species specific gene, one column (C) and one row (R) should enable detection of a positive 
result, the intersection of which indicates the bacterial species (Table 10). 
 
 
Table 10. Bacterial mixes used for PCR analysis  
Bacterial species identified by ATCC number. 
 
          Columns:     C1            C2            C3            C4           C5            C6 
 
Rows: 
R1 
 
R2 
 
R3 
 
R4 
 
R5 
 
R6 
 
*No PCR assay currently reported for these bacterial species 
 
PCR products generated using the 28 species specific primer pairs available were visualised 
using agarose gel electrophoresis (Figure 73).  No primers were identified from the literature 
or successfully designed for three of the bacterial species (10558 S. gordonii, 27824 G. 
morbillorum and 49456 S. mitis).  These bacteria were still included in the PCR analysis to 
ensure there was no primer cross-hybridisation with these species or that these bacterial 
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cultures were not contaminated with any species for which primers were available.  The 28 
PCR assays utilised gave positive identification of the bacterial species which they were 
designed to identify.  Exceptions were observed for the primer for the fimbrial protein of A. 
naeslundii which only successfully amplified from A. viscosus DNA.  These two bacterial 
species are very closely related and when the primers taken from literature (Tran et al. 1996) 
were aligned with the gene sequences for fimbrial proteins from A. naeslundii and A. viscosus 
the primer sequences appeared more specific for A. viscosus than for A. naeslundii, and would 
predictively yield a PCR product only 6 base pairs shorter (for sequence alignments see 
appendix Figure 97).  The PCR assay for the 16s rRNA DNA sequence of P. denticola not 
only amplified DNA from this bacterial culture but also that from P. melaninogenica, 
indicating the potential for the P. melaninogenica culture being contaminated with P. 
denticola.  However, these two bacterial species are both species of Prevotella and share 91% 
homology in their 16s rRNA gene sequence resulting in the primers designed for the 16s 
rRNA gene assay in P. denticola also reacting with the P. melaninogenica 16s rRNA 
sequence.  Subsequently, under the PCR conditions applied a PCR product of identical size 
was generated.  Similarly, for the identification of the two Campylobacter species (C. showae 
and C. rectus) and also the two subspecies of Fusobacterium nucleatum (subsp. polymorphum 
and nucleatum), a single primer pair for 16s rRNA was identified from the literature and used.  
Therefore, these assays were only able to confirm genera/species and were unable to 
distinguish between the species/subspecies, respectively.  Finally, the primer specific to the 
16s rRNA of P. acnes successfully amplified product from the culture of ATCC 11828 but 
not 11827, and also appeared to amplify DNA from the culture of C. sputigena, suggesting 
that the culture of C. sputigena may be contaminated with P. acnes (see below for further 
characterisation of this potentially mixed culture – section 7.1.2). 
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10556 S. sanguis (glucosyltransferaseP) 
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C6/R2 
 
 
 
 
10790 V. parvula (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C2/R4 
 
 
 
 
10953 F. nucleatum subsp. polymorphum and 
25586 F. nucleatum subsp. nucleatum (16srRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6 
positive identification  
C3/R1 and C4/R1 
 
 
11827 P. acnes and  
11828 P. acnes (16s rRNA) 
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C1/R5 and 
C2/R5. Also detects C5/R3 (33612  
C. sputigena)  
 
 
12102 A. israelii (16s rRNA) 
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C4/R6 
also detects C6/R4 (12104  
A. naeslundii) 
 
 
12104 A. naeslundii (fimbrial protein) 
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C6/R4 
Detects C5/R4 (12102 A. viscosus) 
instead 
 
 
14201 L. buccalis (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C3/R5 
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17929 A. odontolyticus (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
 
positive identification C3/R4 
 
 
 
19696 N. mucosa (penicillin binding protein A)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C4/R5 
 
 
 
 
25175 S. mutans (glucosyltransferase)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C5/R5 
 
 
 
 
25611 P. intermedia (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C5/R1 
 
 
 
 
 
25845 P. melaninogenica (haemolysin)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C6/R5 
 
 
 
27335 S. intermedius (intermedilysin)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C2/R3 
 
 
 
 
27823 S. constellatus (hyaluronate lyase)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C6/R1 
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29523 A. actinomycetemcomitans serotype a (mannosyltransferase)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C6/R3 
 
 
 
33236 C. gracilis (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C5/R2 
 
 
 
 
33238 C. rectus and  
51146 C. showae (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C2/R2 and 
C4/R2 
 
 
 
33270  P. micros (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
 positive identification C1/R2 
 
 
 
33277 P. gingivalis (fimbrial protein)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C1/R1 
 
 
 
 
 
33397 S. anginosus (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C2/R6 
 
 
 
 
33563 P. nigrescens (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C3/R2 
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33612 C. sputigenia (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C5/R3 
 
 
 
 
33624 C. gingivalis  (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C1/R4 
 
 
 
 
35037 S. oralis  (glucosyltransferase)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C3/R3 
 
 
 
 
35308 P. denticola (16s rRNA) 
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C3/R6 
also detects C6/R5 (25845  
P. melaninogenica) 
 
 
43037 T. forsythensis (16s rRNA)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C2/R1 
 
 
 
43146 A. viscosus (unknown protein)  
   L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C5/R4 
 
 
 
 
43718 A. actinomycetemcomitans serotype b (mannosyltransferase)  
    L   C1  C2  C3  C4  C5  C6  R1  R2  R3  R4  R5  R6  
positive identification C4/R4 
 
 
 
Figure 73. PCR amplification of species specific genomic sequences in bacterial mixes.  
Target bacteria identified by ATCC number followed by name and target gene shown in 
parenthesis.  6µl of PCR product was electrophoresed on a 1.5% ethidium bromide stained 
agarose gel.  L = ladder (PCR ranger 100bp DNA ladder, Bioline).   
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7.1.2 Gram stain and cell morphology analysis 
Having previously provided positive evidence for the identity of 23 of the 34 bacterial species 
by PCR assay, along with a further 6 positively identified but not specific to a single bacterial 
species, Gram staining was also applied.  This analysis would provide further evidence 
regarding the identity of the bacteria based on the composition of their cell wall and their 
morphology (descriptions from Bergey’s Manual of Determinative Bacteriology 9th Edition; 
(Holt 1994).  Grams iodine stains the thick peptidoglycan layer of Gram positive bacteria 
purple, whereas Gram negative bacteria exhibit only a thin peptidoglycan layer which is 
covered by an additional outer membrane that is removed by the acetone rinsing step and 
results in pink counterstaining using carbol fuchsin.  Gram stains generally provided further 
data supporting the identity of the bacteria (Figure 74), although due to the variable nature of 
these characteristics this analysis cannot be applied alone.  Indeed, literature indicated that for 
some bacteria, e.g. V. parvula, the Gram stain was uninformative due to these bacteria 
appearing Gram negative or positive under certain culture conditions.  In addition, for 
morphological characterisation certain bacteria e.g. Fusobacterium are pleomorphic and 
therefore morphological characterisation alone can also be misleading.  Data generated using 
these cytological approaches was however useful in the analysis of the C. sputigena cultures 
in which PCR results indicated that cultures may be contaminated with P. acnes.  
Visualisation confirmed the culture to consist of a mixed population of the desired Gram 
negative rods and also Gram positive cocci bacteria likely to be P. acnes.  Therefore a fresh 
vial of stock bacteria was re-cultured and characterised by molecular and cytological 
approaches to ensure the correct homogenous culture was utilised in future experiments.   
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10556 S. sanguis   10558 S. gordonii                        10790 V. parvula 
                      
Gram positive    Gram positive        Gram negative 
Cocci/ovoid               Cocci/ovoid                    Cocci 
 
10953 F. nucleatum subsp. 
polymorphum     11827 P. acnes        11828  P. acnes            
                   
Gram negative     Gram positive                   Gram positive 
Fusiform/rods     Irregular rods/cocci        Irregular rods/cocci 
 
 
12102 A. israelii                      12104 A. naeslundii                    14201 L. buccalis 
                     
Gram positive    Gram positive       Gram positive 
Rods     Rods         Fusiform rods 
 
17929 A. odontolyticus 19696 N. mucosa       25175 S. mutans          
                      
Gram positive   Gram negative       Gram positive 
Rods    Cocci        Cocci/ovoid 
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25586 F. nucleatum subsp.     
nucleatum       25611 P. intermedia         25845 P. melaninogenica   
                       
Gram negative       Gram negative          Gram negative 
Rods/spindles       Pleomorphic rods          Pleomorphic rods 
 
27335 S. intermedius     27823 S. constellatus          27824 G. morbillorum 
                         
Gram positive       Gram positive           Gram positive/variable 
Cocci/ovoid                  Cocci/ovoid                       Cocci/elongate 
 
29523 A.  
actinomycetemcomitans     33236 C. gracilis          33238 C. rectus 
                            
Gram negative       Gram negative           Gram negative 
Rods/ovoid       Rods            Rods 
 
33270 P. micros       33277 P. gingivalis          33397 S. anginosus 
                      
Gram positive        Gram negative           Gram positive 
Cocci                      Short rods            Cocci/ovoid 
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33612 C. sputigena       33563 P. nigrescens           33624 C. gingivalis 
                        
Gram negative         Gram negative            Gram negative 
Rods          Pleomorphic rods            Rods 
 
35037 S. oralis       35038 P. denticola            43037 T. forsythensis 
                         
Gram positive         Gram negative            Gram negative 
Cocci/ovoid                    Pleomorphic rods            Fusiform 
      
     43718 A. 
43146 A. viscosus       actinomycetemcomitans           49456 S. mitis 
                          
Gram positive        Gram negative            Gram positive 
Short rods        Rods/ovoid             Cocci/ovoid 
 
51146 C. showae 
 
Gram negative 
Rods 
Figure 74. Gram stains of bacterial cultures 
obtained from agar plates and emulsified in saline 
on glass slides.  Visualisation by oil immersion 
microscopy.  Gram negative bacteria stained pink and 
Gram positive bacteria stained a deeper purple. Cell 
morphology was either cocci (spherical), ovoid, rods 
(bacilli) or fusiform (spindle shaped). ATCC number 
and bacterial species are provided. 
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7.1.3 Haemolysis and colony morphology 
When bacteria are cultured on blood agar they can exhibit three types of haemolysis (α, β or 
γ) depending on the species analysed.  This is a variable characteristic and is not described for 
many species, therefore only the bacteria for which this effect was reported as a significant 
characteristic in Bergeys Manual (Holt 1994) were analysed (Figure 75).  In addition, the type 
of haemolysis can depend on the type of media and blood used, which for these experiments 
consisted of tryptone soya agar supplemented with whole horse blood.  All bacteria tested 
showed the expected form of haemolysis. 
 
Certain bacteria obtain iron from the heme group in blood agar and produce porphyrin 
resulting in a distinctive black/brown colony pigmentation.  This characteristic allowed 
positive identification of P. intermedia (Figure 75), P. nigrescens (Figure 75), P. 
melaninogenica and P. gingivalis.  In addition P. denticola appeared marginally pigmented 
and the colonies of C. sputigena appeared yellow/orange.   
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α-haemolysis β-haemolysis γ-haemolysis 
Partial lysis of red blood cells 
resulting in greenish 
discolouration of agar. 
Complete lysis of red blood 
cells resulting in clearing of 
the blood in the agar. 
No haemolysis 
 
                   
. 
                          . 
 
 
 
 
 
 
Figure 75. Haemolysis by periodontal pathogens.  i) Description of 3 types of haemolysis   
ii) Photographs of 5 days bacterial growth on agar plates supplemented with whole horse 
blood (α-haemolysis S. gordonii, β-haemolysis P. intermedia, γ-haemolysis P. nigrescens) 
and iii) Bacteria listed for which haemolysis is a reported characteristic (Bergey’s Manual). 
*indicates bacteria shown in example photograph. 
 
 
7.1.4 Catalase testing 
The production of catalase by bacteria is tested by exposing them to hydrogen peroxide and 
observing the liberation of oxygen bubbles.  This is only a significant characteristic for certain 
bacteria present in the test panel and these are shown in Table 11.  Notably, catalase 
production is one of the only phenotypic characteristics that distinguishes C. showae from C. 
rectus (Etoh et al. 1993).  The catalase test also distinguishes catalase negative streptococci 
from catalase positive staphylococci which can appear very similar by cellular morphology.  
All bacteria tested displayed the expected catalase activity listed in Table 11. 
 P. nigrescens* 
 S. mutans  
 N. mucosa 
 T. forsythensis 
 P. intermedia*     
 P. acnes      
 P. melaninogenica 
 A. actinomycetemcomitans                               
 S. gordonii* 
 S. oralis                                  
 G. morbillorum                         
i) 
ii) 
iii) 
 232 
Table 11. Catalase production by periodontal bacteria used in this study 
Negative Positive 
T. forsythensis P. acnes 
S. sanguis N. mucosa 
S. gordonii A. actinomycetemcomitans 
S. mutans C. showae 
S. intermedius  
S. constellatus  
S. anginosus  
S. oralis  
S. mitis  
V. parvula  
G. morbillorum  
C. gracilis  
C. rectus  
C. sputigena  
C. gingivalis  
 
 
7.1.5 Summary of identification 
To summarise the results of all 6 identification tests a positive () or negative () outcome is 
indicated in Table 12.  Where no result is indicated the test was not performed or not relevant.  
All 34 strains were positively identified by 2-4 of the 6 identifying characteristics with the 
exception of bacteria C. sputigena (ATCC 33612).  Where identification was initially 
negative an archived culture was obtained from storage (-80C) and re-tested to confirm 
identity before use in further experiments. 
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Table 12. Summary of identification tests 
ATCC 
number 
 
Bacterial strain 
 
PCR 
 
Gram 
stain 
Cell 
morphology 
Haemolysis Colony 
morphology 
Catalase 
10556 S. sanguis       
10558 S. gordonii       
10790 V. parvula       
10953 F. nucleatum polymorphum       
11827 P. acnes       
11828 P. acnes       
12102 A. israelii       
12104 A. naeslundii       
14201 L. buccalis       
17929 A. odontolyticus        
19696 N. mucosa       
25175 S. mutans       
25586 F. nucleatum  nucleatum       
25611 P. intermedia       
25845 P. melaninogenica       
27335 S. intermedius       
27823 S. constellatus       
27824 G. morbillorum       
29523 A. actinomycetemcomitans a       
33236 C. gracilis       
33238 C. rectus       
33270 P. micros       
33277 P. gingivalis        
33397 S. anginosus       
33612 C. sputigena       
33563 P. nigescens       
33624 C. gingivalis       
35037 S. oralis       
35308 P. denticola       
43037 T. forsythensis       
43146 A. viscosus       
43718 A. actinomycetemcomitans b       
49456 S. mitis       
51146 C. showae       
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7.2 Susceptibility of periodontal pathogens to killing by histones  
Following the provision of data supporting the identity of all 34 ATCC periodontal pathogens 
they were tested for their susceptibility to killing by histones as this has not previously been 
reported for this group of bacteria.  Histones are core chromatin proteins present within NETs, 
which have previously been reported to exert an antimicrobial effect (Brinkmann et al. 2004).  
The effectiveness of purified mixed histone to inhibit growth of the periodontal pathogens 
was assessed using several methods which included spectrophotometric analysis, colony 
counting and fluorometric analysis in order to identify a robust method with high accuracy 
and throughput suitable for the assay of this panel of anaerobic bacteria.  Methods were 
initially validated using a combination of known antibiotics (penicillin-streptomycin) prior to 
testing the histones. 
 
7.2.1 Spectrophotometric analysis 
The turbidity and hence concentration of bacterial cultures can be assessed 
spectrophotometrically using absorbance at 600nm (or 630nm when using automated plate 
reader).  An advantage of this approach is that it can be performed at relatively high-
throughput using a small amount of reagents in a 96-well plate format.  In addition, bacterial 
growth can be assessed at multiple time points.  Two bacteria including S. mutans (ATCC 
25175) which has previously been reported to be susceptible to killing by histone H2A (Park 
et al. 1998b), in addition to E. faecalis (ATCC 29212) which has also been reported 
susceptible to histone H1 killing (Rose et al. 1998), were incubated with penicillin-
streptomycin overnight and absorbance at 600nm measured (Figure 76).  Optical density 
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readings displayed a dose-dependent reduction in detected bacterial growth as the 
concentration of penicillin-streptomycin was increased up to 0.5µg/ml.   
 
OD630nm after overnight incubation with pen-strep
0
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25175
Figure 76.  Spectrophotometric analysis of overnight growth of three bacteria in the 
presence of pen-strep (0-0.5 units penicillin and 0-0.5 µg streptomycin per ml). Bacteria 
(29212 E. faecalis, 10556 S. sanguis, 25175 S. mutans) were incubated anaerobically 
overnight prior to measurement of absorbance at 630nm. Results show analysis from a single 
preliminary experiment. 
 
However, when the test substance (mixed histone) was used in place of the positive control 
(pen-strep), a significant increase in turbidity was immediately observed and obscured any 
changes in bacterial growth which could be assayed using this approach.   The increased 
optical density of un-inoculated (negative control) bacterial broth upon the addition of histone 
is demonstrated in Figure 77 and displays a dose dependant increase, indicating that the 
turbidity was due to the histone proteins present. 
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Figure 77. Spectrophotometric analysis of histone (0-5000µg/ml) in un-inoculated bacterial 
broth incubated overnight.  Optical density measured at 630nm.  Results show analysis from a 
single preliminary experiment. 
 
7.2.2 Plating method (colony count) 
As the addition of histone caused significant increases in turbidity measurements, bacterial 
growth from overnight cultures in microtitre plates could not be determined by absorbance 
measurements.  Therefore a sample of overnight broth culture was obtained and serial 
dilutions were made for plating onto agar to enable colony counts for bacterial cell number 
determination.  Innoculated plates were incubated anaerobically prior to colony counts being 
performed. 
 
Incubation with penicillin-streptomycin and subsequent colony count analysis (Figure 78) of 
bacterial cultures used for spectrophotometric analysis (Figure 76) demonstrated a similar 
dose-dependent reduction in detected bacterial growth.  The highest concentration of 
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penicillin-streptomycin used (0.5 µg streptomycin and 0.5 units penicillin per ml) resulted in 
no detectable growth of the 3 test bacteria 
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Figure 78. Colony count analysis of overnight cultures of three bacteria exposed to pen-
strep (0-0.5units penicillin and 0-0.5µg streptomycin per ml).  Bacteria (29212 E. faecalis, 
10556 S. sanguis, 25175 S. mutans) were incubated anaerobically overnight in 96-well 
microtitre plates and a sample used to make 3 serial dilutions for plating onto agar.  Results 
are derived from a single preliminary experiment. 
 
As data indicated that a colony count approach was able to accurately determine the effect of 
antibiotics on bacterial growth (Figure 77), bacteria were subsequently grown in the presence 
of histones prior to plating.  As previous publications have analysed the antimicrobial effect 
of purified histone H2A at concentrations up to 30µg/ml (Brinkmann et al. 2004) and as 
multiple histones are associated with genomic DNA, mixed histone was used here comprising 
all 4 core histone nucleosome subunits (H2A, H2B, H3 and H4) at a concentration of 
100µg/ml.  The three bacteria previously analysed (S. mutans, E. faecalis and S. sanguis) 
were initially tested in this assay in addition to two further periodontal pathogens (F. 
nucleatum and S. oralis).  Results were expressed as a percentage of growth detected in the 
absence of the antimicrobial agent (Figure 79).  Data represents 7 independent experiments 
although data was only obtained on 2-5 occasions for each bacterial strain (Figure 79).  This 
 238 
relatively low success rate and large spread of data points (represented by the standard 
deviation) for certain bacteria was likely due to the variability in oxygen exposure incurred 
during processing. 
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Figure 79. Percentage growth of periodontal pathogens with mixed histone (100µg/ml) 
measured by plating out method.  A panel of 5 bacteria (29212 E. faecalis, 10953 F. 
nucleatum, 25175 S. mutans, 10556 S. sanguis, 35037 S. oralis) were incubated overnight 
with mixed histone in a 96 well plate before serial dilution and plating out.  Results expressed 
as percentage of growth in the absence of histone and represent mean of up to 5 independent 
experiments ± SD.   
 
 
7.2.3 Fluorometric quantification of bacterial growth 
The SYTOX
®
 green fluorescent nucleic acid stain (Invitrogen) can be used to indicate the 
presence of dead cells and can therefore be used in conjunction with fluorometric analysis to 
quantify the number of dead bacteria in a culture.  Bacteria were cultured in microtitre plates 
overnight and the plate was subsequently processed by freeze-thawing, which in addition to 
the exposure to oxygen, ensured bacterial killing.  Initially the sensitivity of this method for 
bacterial quantification was tested using a culture of a single strain of bacteria (F. nucleatum) 
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stained with 5µM SYTOX
®
 green (Figure 80).  Data demonstrated a dose-dependant increase 
in fluorescence as bacterial concentration increased.  A plateau phase within the graph was 
observed at concentrations above 5x10
5
 bacteria/ml indicating saturation of the assay system.  
Bacterial concentrations below this displayed a linear range of fluorescence and therefore this 
range was used in subsequent assays for antimicrobial activity (range is indicated by dashed 
box, Figure 80). 
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Figure 80. Standard curve of SYTOX
®
 detection of F. nucleatum subsp. polymorphum.  
Concentration of bacteria estimated by spectrophotometry and diluted to concentrations 
displayed on x-axis.  25µl sample then stained with SYTOX
®
 5µM in 200µl total volume, and 
fluorometer reading taken at 10mins.  Results show mean of experiment performed in 
triplicate ± SD.  Dashed box represents range of fluorescence in antimicrobial assay, Figure 
81. 
 
2x10
4
 bacteria per well were incubated overnight with no antimicrobial (negative control), 
10units/ml penicillin-streptomycin (positive control) or the test agent (mixed histone 
100µg/ml).  Subsequent fluorometric quantification of a 25µl sample was used to assess 
growth in the presence of the antimicrobial and test agents, and represented as a percentage of 
bacterial growth in the absence of any antimicrobial (Figure 81).  Two bacteria proved 
difficult to routinely culture in broth and therefore no data were obtained for 35308 P. 
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denticola and 51146 C. Showae, and only a single strain of P. acnes (11827) was assayed.  
The remaining 31 bacteria were successfully grown in broth culture and the majority appeared 
susceptible to killing by the positive control agent (penicillin-streptomycin) with the 
exception of 27824 G. morbillorum, 43037 T. forsythensis and 49456 S. mitis (Figure 81a).  
The addition of mixed histone also appeared to cause a reduction in the growth of 21 out of 
the 31 bacteria (Figure 81b).  Notably 13 of these bacteria exhibited ≤50% growth in the 
presence of mixed histone compared to normal bacterial growth.  However, a small selection 
of bacteria (6 out of 31) exhibited increased growth in the presence of histones.  This 
increased growth was most dramatic for 33277 P. gingivalis, 10558 S. gordonii and 33397 S. 
anginosus, followed by 10556 S. sanguis, 27823 S. constellatus and 27335 S. intermedius.  
The growth of a further 4 out of 31 bacteria appeared unaffected by the addition of histone.  
Interestingly, all 10 bacteria which appeared resistant to killing by histone (unaffected or 
increased growth) were from the red, orange and yellow microbial complexes associated with 
increased disease severity in periodontitis.  All bacteria tested from the green, purple or non-
colour coded complexes appeared susceptible to killing by histone.  
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b) mixed histone 
histone
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Figure 81. Fluorometric quantification of the antimicrobial activity of a) penicillin-streptomycin (10units penicillin and 10µg 
streptomycin per ml) and b) mixed histone (100µg/ml) against 33 periodontal pathogens grouped by colour complex (Socransky et al. 
1998).  Results show mean of 3 independent experiments performed in triplicate ± SD.  Fluorescence of wells not containing bacteria were 
subtracted and fluorescence expressed as percentage of normal overnight growth (i.e. in the absence of pen-strep).  Dashed line indicates 100% 
of normal growth i.e. no change. * P≤0.05, ** P≤0.01, *** P≤0.001 by paired T-test of non-transformed data. 
* * 
** ** 
** 
*** 
* 
* 
*
* 
* 
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Discussion 
 
Identification of bacteria 
When utilising a large panel of different bacterial strains it is appropriate to characterise them 
to provide evidence of their identity.  Combined the data presented here supported the identity 
of the majority of the bacteria used in this study (Table 12).  A variety of complementary tests 
were chosen which utilise diverse characteristics and properties of the bacteria.  For example 
the genotype of the bacteria were examined by species specific PCR (Figure 73) which was a 
preferred method for identification as this characteristic is highly conserved and therefore 
generally robust; however this approach was not available for all bacteria.  The phenotype of 
the bacteria was examined by the catalase test (Table 11) and Gram stain (Figure 74), 
although these characteristics are known to be variable, subject to change and can be 
influenced by factors such as the pH, temperature or nutrient availability of the growth 
conditions.  Indeed even aging of the bacterial culture can result in an alteration in phenotypic 
appearance (Holt 1994).  Although phenotypic characterisation is the most commonly used 
method in diagnostic laboratories for the identification of bacterial strains, this approach relies 
upon a range of tests specific to each bacteria (Duerden et al. 1998).  When screening a large 
panel of bacteria it is more practical to use tests which could be applied to the entire panel of 
bacteria.  The final mode of identification used here was morphological characterisation 
which, whilst being highly subjective, is useful for the discrimination of particular bacteria 
such as the black pigmented strains. 
 
 244 
Susceptibility to killing by histone 
The degranulation of neutrophils as an antimicrobial defence mechanism is well known, 
however, the more recently described phenomenon of NET release involves the release of not 
only antimicrobial proteins but also nuclear chromatin.  A proposed reason for the presence of 
chromatin within the NETs is to provide a scaffold on which the antimicrobial proteins can 
adhere along with the trapped microorganisms.  However, an antimicrobial activity of the 
chromatin core has been demonstrated based on the apparent increased survival of 
microorganisms in NETs treated with anti-histone antibodies (Brinkmann et al. 2004; 
Guimaraes-Costa et al. 2009).  Experiments here initially attempted to use a 
spectrophotometric approach to determine relative bacterial growth in the presence and 
absence of histone proteins.  However, when the histone protein was combined with the 
culture media a visible ‘cloudy’ precipitate was apparent even in the absence of bacteria.  The 
acid solubility of histones is commonly exploited for their extraction and therefore the 
precipitate may be due to a sub-optimal pH of the culture media (Shechter et al. 2007).  
Therefore, bacterial growth was subsequently quantified fluorometrically based on staining of 
total bacterial DNA which revealed a reduction in growth of 21 out of the 31 bacteria tested.  
It is hypothesised that histones function in a similar way to other cationic neutrophil-derived 
AMPs such as defensins, in that they permeabilise the bacterial membrane resulting in cell 
lysis (Birkemo et al. 2003).  Alternatively, it has been reported that a peptide related to 
histone H2A (Buforin I) exerts its effect by crossing the bacterial membrane and binding 
intracellularly to the bacterial DNA (Park et al. 1998a).  Significantly however, the data 
presented here also revealed the growth of 7 bacterial strains to be increased in the presence 
of mixed histone.  In addition, the positive control antimicrobials used did not inhibit the 
growth of all bacteria tested to the same degree, and appeared to have no effect on the growth 
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of 3 of the bacteria at the concentrations applied here.  This data is in concordance with 
widespread research indicating that every bacterial strain has a different minimal inhibitory 
concentration (MIC) when tested with the same antimicrobial (Al-Haroni et al. 2006).  
 
The findings presented here (Figure 81) and previously (Brinkmann et al. 2004) were 
obtained using purified histones which are proposed to exert their effect via the strong 
cationic charge of the proteins resulting from the relative abundance of lysine and arginine 
residues.  This positive charge is vital to its function in the packaging of negatively charged 
DNA, however, in NETs where the histone protein is found complexed with DNA, the 
opposing charges may neutralise each other casting doubt on the in vivo relevance of histone 
microbicidal activity.  Indeed, one of the earliest reports of the antimicrobial activity of 
histone described a reduction in the killing efficacy of histone in the presence of nucleic acid 
(Hirsch 1958).  An in vivo antimicrobial role within NETs was identified by the use of anti-
histone (H2A/H2B) antibodies which allowed increased survival of microorganisms 
(Brinkmann et al. 2004; Guimaraes-Costa et al. 2009), although whether this effect was due 
to neutralisation of direct antimicrobial activity of the histone proteins or due to physical 
obstruction of microorganism immobilisation and killing by the granule proteins instead, is 
unclear.  As the other core component of NETs is DNA, future work could examine the 
antimicrobial potential of this molecule.  Indeed, reports exist describing an antimicrobial 
action of extracellular DNA against P. aeruginosa, S. aureus and E. coli (Mulcahy et al. 
2008).  This is thought to function via chelation of oppositely charged ions (cations in this 
case) which removes LPS-associated Mg
2+
 from its stabilising role in the outer membrane of 
the bacteria.  When this membrane becomes unstable cell lysis occurs.  Furthermore, it is 
reported that certain bacteria such as P. aeruginosa possess virulence factors, triggered by low 
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Mg
2+
 concentrations resulting from chelation by DNA, to modify the LPS structure and 
protect against membrane disruption (Mulcahy et al. 2008). 
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CHAPTER 8 RESULTS                                                                                                   
DNase expression by periodontal pathogens and in dental plaque 
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8.1 DNase expression by periodontal pathogens 
The pathogenic microbial subgingival flora of periodontal disease is characterised by a 
predominance of Gram negative anaerobes which have also been reported to exhibit 
significant DNase activity (Porschen and Sonntag 1974).  As the function of NETs can be 
destroyed by bacterial DNases which leads to increased pathogenic activity of the bacteria in 
vivo (Beiter et al. 2006; Buchanan et al. 2006), 34 anaerobic and facultative anaerobic 
bacteria reported to be important in periodontal disease pathogenesis were screened for 
extracellular DNase expression using two complementary approaches, 
i) DNase test plates  
ii) Assay by agarose gel. 
DNase test plate analysis enabled detection of culminative DNase expression by bacteria 
grown in a solid biofilm state, i.e. on agar plates.  Assay of DNase activity by agarose gel 
electrophoresis analysis following broth culture enabled determination of DNase expression 
by bacteria grown planktonically, i.e. in broth culture. 
 
8.1.1 DNase test plate assay 
DNase test plates are commercially available agar plates supplemented with mammalian DNA 
as the substrate for the DNase enzyme.  Hydrolysis of the DNA is detected by flooding the 
plate with hydrochloric acid, or the metachromatic dye, toluidine blue O (TBO) as applied 
here.  DNase test plates are used diagnostically for the detection of pathogenic staphylococci 
and therefore Staphylococcus aureus was used as a positive control when screening the 34 
periodontal pathogens.  As each bacteria grows at a different rate which is also dependant on 
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the size of the initial spot innoculum, for comparison of activity the area of DNA hydrolysis 
was normalised to the area of bacterial growth (mm
2
 of hydrolysis per mm
2
 bacterial growth). 
 
8.1.1.1 Duration of incubation of test plates 
Previous reports using DNase test agar to grow and assay for DNase activity in anaerobic 
pathogens involved bacterial incubations for between 48 hours and 5 days prior to assay 
(Porschen et al. 1974; Rudek et al. 1976; Brailsford et al. 1999).  Therefore, initially a 
preliminary experiment was performed to determine the necessary incubation time for 
periodontal bacteria on the DNase test agar plates using a randomly selected panel of 6 
pathogens.  TBO staining was performed at days 2 to 6 post-inoculation (Figure 82).  Three of 
the bacteria demonstrated detectable DNase activity after 2 days growth (P. melaninogenica, 
S. anginosus and S. intermedius), however, S. sanguis and C. gingivalis only exhibited 
detectable activity from day 4 onwards, whilst S. constellatus exhibited DNase positivity at 
day 5.  The zone of DNA hydrolysis generated by S. intermedius continued to increase 
throughout the incubation period which may reflect increased DNase production or simply the 
radial diffusion of the DNase secreted at an earlier time-point during bacterial growth.  The 
zone of DNA hydrolysis produced by S. anginosus and P. melaninogenica peaked on days 4 
and 5 respectively, although levels appeared reduced on subsequent days.  This result was 
likely due to the increased spread of the bacterial colony which may be advancing at a greater 
rate than the area of DNA hydrolysis at this culture time-point.  As DNase expression was 
evident in all bacterial strains tested by day 5, this time-point was selected as the duration of 
incubation for all subsequent DNase test plate assays for the anaerobic pathogens. 
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Figure 82.  Time-course analysis of the DNase activity of 6 periodontal pathogens 
detected by DNase test agar plates.  Separate plates were incubated anaerobically for 2 to 6 
days prior to staining for DNA hydrolysis using TBO.  Results presented as mm
2
 hydrolysis 
per mm
2
 bacterial colony growth and are derived from a single preliminary experiment. 
 
8.1.1.2 Plate-based assay of periodontal pathogens 
Subsequently, the panel of 34 periodontal pathogens were incubated for a standard 5 day 
period on DNase test agar plates, which were stained and the zone of DNA hydrolysis 
quantified as described (Figure 83).  Thirteen of the 34 bacteria tested exhibited positive 
DNase activity.  Notably the majority of these DNase positive pathogens (10 out of 13) 
represented the colour-coded groups previously associated with periodontitis pathogenesis 
(Socransky et al. 1998). 
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Figure 83.  Zone ratio of DNA hydrolysis after 5 days growth on DNase test agar plates.  Thirty-four periodontal pathogens identified 
by ATCC number and grouped by colour complex (Socransky et al. 1998).  Digital photographs were analysed to provide the area of TBO 
stained hydrolysed DNA per area of bacterial growth.  Results show mean of 3 independent experiments ± SD. 
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8.1.2 ‘Gel-based assay’ of DNase activity in bacterial broth culture 
To assay DNase activity of planktonically grown bacteria a sample (supernatant or pellet; 
2.7.2.1) was incubated with mammalian DNA for 2 hours before visualisation on agarose gel 
to assess the extent of DNA degradation.   
 
8.1.2.1 Optimum duration of ‘gel-based assay’ 
To enable the comparison of DNase activity levels between bacterial species, the duration of 
incubation needed to be standardised so that DNA digestion was visibly detectable.  Therefore 
one DNase positive bacteria (P. intermedia ATCC 25611) and one DNase negative bacteria 
(C. gracilis ATCC 33236), as demonstrated by DNase test plate assay (Figure 83), were 
incubated with calf thymus DNA for between 30 minutes and 4 hours (Figure 84).  A control 
‘no DNase’ sample was also assayed to demonstrate intact DNA of a high molecular weight.  
The reaction containing the DNase negative bacteria, C. gracilis, indicated visible undigested 
high molecular weight DNA, demonstrating no DNase contamination of the bacterial broth.  
The resultant DNA from both of the DNase negative reactions (C. gracilis and blank) 
remained unchanged throughout the incubation period at 37°C.  The DNase positive bacteria 
displayed DNA degradation as early as 30 minutes and was visualised as smearing of the 
DNA on the gel.  After 1 hour incubation the DNA exhibited decreased intensity indicating 
partial DNA digestion, whilst after 2 hours DNA was not visible indicating complete 
digestion.  Therefore, a 2 hour incubation period was chosen to provide the greatest sensitivity 
to detect DNase activity in bacteria producing levels equivalent to, and lower than, P. 
intermedia. 
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Figure 84. Time-course analysis of DNA degradation visualised by ethidium bromide 
stained agarose gel electrophoresis.  DNase positive bacteria (ATCC 25611), DNase 
negative bacteria (ATCC 33236) and blank containing no bacterial sample. Ladder - PCR 
ranger 100bp DNA ladder (Bioline).  High molecular weight calf thymus genomic DNA was 
used for assay. 
 
8.1.2.2 DNase standards 
The 34 periodontal bacteria available were grown in broth cultures for 6 days and 
subsequently the bacteria were pelleted and washed whilst a sample of the broth culture 
supernatant was collected.  For this approach the pellet and supernatant were assayed 
separately to distinguish between membrane bound DNase and secreted DNase activity 
respectively.  For this assay the pellet was suspended in PBS whilst the supernatant was 
composed of bacterial broth.  To determine if the diluent affected the detected DNase activity, 
DNase standards (bovine pancreatic DNase) were suspended in either PBS or sterile tryptone 
soya broth and assayed. 
 
Bovine pancreatic DNase (Sigma) was used as positive control for this assay and by using a 
range of known concentrations a standard curve was generated based on the distance migrated 
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on gel electrophoresis by the DNA digestion front, to enable estimation of DNase 
concentration in test samples.  A range of between 0.5 and 250 Kunitz/L bovine pancreatic 
DNase was diluted in PBS (the diluent of bacterial pellet samples) and also diluted in media 
(the diluent of bacterial supernatant samples) (Figure 85).  DNase in media resulted in visibly 
increased digestion of the DNA within the 2 hour assay period as compared with the 
equivalent concentration diluted in PBS (Figure 85a).  Gel images were binarised using 
ImageJ and the distance the DNA migrated from the well was measured in pixels (Figure 85b) 
to enable the generation of a standard curve (Figure 85c), from which the DNase activity of 
test samples could be estimated.  As the composition of the bacterial media allowed more 
rapid DNase enzymatic activity compared with the PBS diluent, the DNase assay for bacterial 
supernatant samples was subsequently more sensitive than the assay of bacterial pellets.  For 
example, 4Kunitz/L DNase in PBS showed no detectable digestion of DNA in the 2 hour 
incubation period, however, 4Kunitz/L DNase diluted in sterile media demonstrated 
considerable degradation of the DNA as no fragments remained visibly intact. 
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Figure 85. DNA degradation by bovine pancreatic DNase standards (0.5-250 Kunitz/L) 
in PBS or culture media.  a) Visualisation of DNA degradation by ethidium bromide gel 
electrophoresis,  Kunitz/L values are shown above each lane, b) Binarised image of agarose 
gel (using ImageJ), red arrows show distance measured in pixels from well to front of DNA 
band c) Standard curve of distance migrated in pixels plotted against concentration of bovine 
pancreatic DNase. 
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8.1.2.3 Stability of DNase 
It is recommended that purified bovine pancreatic DNase (D4263 Sigma) is stored at -20°C as 
reportedly storage at 4°C at a concentration of 10mg/ml can result in a loss of ~20% activity 
per week (Sigma).  It was therefore hypothesised that if bacteria were cultured in broth for 6 
days at 37°C, DNase that was secreted early in the culture period may have lost significant 
activity prior to time of assay.  To investigate whether the gel-based assay of broth cultures of 
bacteria was likely to detect only DNase produced immediately prior to harvest or detect 
cumulative DNase expression throughout bacterial growth, bovine pancreatic DNase was 
diluted into sterile culture media, incubated anaerobically at 37°C and an aliquot taken daily 
for gel-based assay of DNase activity (Figure 86).  No reduction in the potency of DNase 
degradation of DNA was detectable between DNase at day 0 compared to DNase following 8 
days incubation at 37°C.  This data therefore indicated that it was reasonable to culture 
bacteria for 6 days prior to harvest and subsequently assay of DNase. 
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Figure 86. Degradation of bovine pancreatic DNase at 37°C anaerobic incubation in 
sterile media.  a) 10 Kunitz/ml DNase in media b) no DNase (negative control), c) Image 
analysis of DNase positive gel, and d) graphical data showing distance migrated.  Samples of 
DNase were collected daily for 8 days (time points shown above gel images a-c) and assayed 
by gel-based DNase assay.  DNA end products were visualised following electrophoresis on 
ethidium bromide stained agarose gel. L = PCR ranger 100bp DNA ladder (Bioline). 
 
8.1.2.4 Gel-based assay of periodontal pathogen DNase activity 
Gel-based assay of DNase activity in the bacterial pellet (Figure 87) and supernatant (Figure 
88) samples from 34 periodontal pathogens demonstrated that a high number of strains (21 
out of 34) exhibited significant activity.  All samples were previously adjusted by dilution to 
1x10
9
 bacteria per ml and supernatants were diluted by the same factor prior to assay of a 
10µl aliquot, and subsequently enzymatic activity was expressed in Kunitz per bacteria.  The 
positive control bacterial strain, S. aureus, displayed the highest detected DNase activity in 
both the pellet and supernatant, although the levels detected in the supernatant were 
L    0   +1  +2  +3  +4  +5 +6  +7  +8 
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significantly higher (232 Kunitz/bacteria) than those in the pellet (42 Kunitz/bacteria) 
potentially indicating that DNase is primarily secreted.  DNase activity was higher in the 
supernatant than the pellets for all DNase positive bacteria detected except three which were 
amongst the lowest producers (including C. rectus ATCC 33238, S. sanguis ATCC 10556 and 
C. sputigena ATCC 33612).  DNase activity in the bacterial pellet was particularly common 
amongst orange and yellow complex bacteria (Figure 87) (Socransky et al. 1998).  However, 
DNase activity of bacterial supernatants did not demonstrate such a clear pattern and the 
highest DNase producer, P. melaninogenica (ATCC 25845), was not from a reported colour 
complex (Figure 88).   
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Figure 87. Gel-based assay of membrane bound (bacterial pellet) DNase activity in 34 periodontal pathogens.    Bacteria are 
identified by ATCC number and grouped by colour complex (Socransky et al. 1998).  S. aureus is shown as a positive control for bacterial 
DNase activity.  Bovine pancreatic DNase standards were used to estimate DNase in enzymatic units and is expressed per bacteria.  Results 
show mean of 3 independent experiments ± SD. 
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Figure 88. Gel-based assay of secreted (supernatant) DNase expression in 34 periodontal pathogens.  Bacteria are identified by 
ATCC number and grouped by colour complex (Socransky et al. 1998).  S. aureus is shown as positive control for bacterial DNase activity.  
Bovine pancreatic DNase standards were used to estimate DNase activity in enzymatic units which is expressed per bacteria in the original 
bacterial culture prior to their removal for separate assay.  Results show mean of 3 independent experiments ± SD. 
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8.1.3 Summary of DNase expression by periodontal pathogens by both methods 
Bacterial DNase activity detected by the two assay methods is summarised in Table 13.  A 
threshold of DNase activity was nominally set at 1 Kunitz/bacteria for the bacterial pellet and 
5 Kunitz/bacteria for the supernatant to distinguish ‘DNase positive’ bacteria from ‘DNase 
negative’ bacteria. 
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Table 13. Summary of detected bacterial DNase expression 
  
Bacterial 
species 
Plate-
based 
assay 
Gel-based assay 
ATCC Pellet Supernatant 
RED COMPLEX 
33277 P. gingivalis + - - 
43037 T. forsythensis + - - 
ORANGE COMPLEX 
10953 F. nuc. poly. - ++ + 
25586 F. nuc. nuc. - ++ ++ 
25611 P. intermedia + ++ +++ 
27823 S. constellatus + ++ + 
33270 P. micros - ++ ++ 
33238 C. rectus - + - 
33563 P. nigrescens + + +++ 
51146 C. showae - - - 
33236 C. gracilis - - - 
YELLOW COMPLEX 
10556 S. sanguis + ++ - 
10558 S. gordonii ++ ++ ++ 
25175 S. mutans - + - 
27335 S. intermedius + + - 
33397 S. anginosus + - - 
35037 S. oralis - + ++ 
49456 S. mitis - + ++ 
GREEN COMPLEX 
33612 C. sputigena - + - 
29523 A. actino. a ++ + +++ 
33624 C. gingivalis + - - 
PURPLE COMPLEX 
10790 V. parvula - - - 
17929 A. odontolyticus - + - 
43718 A. actino. b - - - 
43146 A. viscosus - - + 
OTHER BACTERIA 
11827 P. acnes - - - 
11828 P. acnes - - - 
12102 A. israeliii - - - 
12104 A. naeslundii - - + 
14201 L. buccalis - + + 
19696 N. mucosa - - - 
25845 P. melanino. + + +++ 
27824 G. morbillorum - - + 
35308 P. denticola + - - 
 
Bacteria grouped by colour coded complex associated with periodontitis pathogenesis 
(Socransky et al. 1998).  For the plate-based assay of DNase: + 0-0.5 mm
2
/mm
2
, ++ >0.5 
mm
2
/mm
2
; for gel-based assay of bacterial pellets: + 1-4 Kunitz/bacteria, ++ >4 
Kunitz/bacteria; for gel-based assay of bacterial supernatant: + 5-10 Kunitz/bacteria, ++ 10-20 
Kunitz/bacteria, +++ >20 Kunitz/bacteria. 
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8.2 In vivo DNase activity in gingival inflammation 
Having established that DNase expression is a relatively common characteristic within a panel 
of 34 bacterial strains associated with periodontal disease, it was appropriate to investigate 
whether DNase was present in vivo in the plaque biofilm and in GCF.  This study was 
performed utilising a 21 day model of gingivitis in which 4 teeth were shielded during tooth 
brushing to allow for plaque accumulation and providing ‘test sites’ and non-guarded teeth on 
the opposite side of the mouth were brushed normally and providing ‘control sites’ (2.8).  
Plaque and GCF samples were collected and assayed for DNase activity. 
 
8.2.1 Clinical measure of inflammation  
To record successful induction of gingivitis during the 21 day study period 3 clinical 
parameters were measured (Figure 89).  These were i) the plaque index to record plaque 
accumulation, ii) the gingival index to record gingival inflammation and iii) GCF volume.  At 
baseline (day 0) there was no significant difference in plaque index, gingival index or GCF 
volume (P=0.7, 0.7 and 0.95, respectively) at test sites compared to control sites.  All 3 
parameters significantly increased as expected in test sites compared to control sites in the 
first 7 days (P=0.002, 0.002 and 0.007, respectively) and remained elevated when compared 
to control sites throughout the 21 day study period.  No increase was observed in any 
parameter at control sites over the study period indicating the maintenance of gingival health. 
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Figure 89.  Clinical measures of inflammation during the 21 day experimental model of 
gingivitis. a) Plaque index, b) gingival index, and c) GCF volume.  Results show mean 
measures from test and control sites in 10 individuals ± SEM.  **P≤0.01 **P≤0.001 by 
Wilcoxon test for plaque and gingival index or by paired T-test for GCF volume. 
** 
** 
** 
** 
** 
** 
** 
** 
*** 
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8.2.2 DNase activity within biological samples 
Samples of plaque and GCF were collected on days 0, 7, 14 and 21 of the study period and 
stored until assay by gel-based assay.  GCF samples were diluted according to GCF flow rate 
(volume collected per unit time) so that any increased DNase activity did not simply reflect 
increased volume but was due to increased concentration or activity.  It was not possible to 
quantify the plaque collected at each sample site so plaque samples were not normalised.  
GCF samples were diluted in PBS-BSA and plaque samples were suspended in PBS, 
therefore standard curves were generated using bovine pancreatic DNase suspended in PBS-
BSA and PBS separately for estimation of DNase activity in Kunitz/ml.  The addition of BSA 
was found to cause the DNase-dependant degradation of DNA to progress further in the 2 
hour assay period, and therefore the assay of DNase activity in GCF samples was more 
sensitive than that used for the assay of plaque samples.  No detectable DNase activity was 
found in plaque samples from test sites on days 0 or +7, and only 1 individual out of 10 
displayed detectable DNase activity on day +14 (Figure 90a).  By day +21 the majority of 
individuals (8 out of 10) demonstrated DNase activity in plaque samples from test sites.  
Plaque samples from control sites demonstrated no detectable DNase activity throughout the 
study period, with only a single individual on each day exhibiting any DNase activity.  The 
difference in DNase activity on day +21 between test and control sites was statistically 
significant by paired T-test (P=0.04).  DNase assay of normalised GCF samples found no 
detectable DNase activity in the majority of samples from control sites throughout the study 
period (Figure 90b) and also no detectable activity in samples from test sites on day 0 i.e. 
before any inflammation had developed.  However, on days +7, +14 and +21 DNase activity 
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was seen in the majority of individuals and was significantly elevated in comparison to 
samples from control sites (P=0.05, 0.04 and 0.03 respectively by paired T-test). 
a)   DNase activity in plaque samples 
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b)   DNase activity in GCF samples 
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Figure 90.  Gel-based assay of DNase activity in samples collected on days 0, 7, 14 and 
21.  a) assay of plaque samples, and b) assay of normalised GCF samples.  Results show 
mean of DNase activty in samples from test and control sites of 10 individuals ± SEM.  
*P≤0.05 by paired T-test.  Tables indicate the number of individuls testing DNase positive 
(n=10). 
 * 
 * 
* * 
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Discussion 
 
Bacterial DNase detection 
DNase diluted in media resulted in more complete DNA digestion in the 2 hour incubation 
period compared with DNase diluted in PBS (Figure 85).  This may be due to the high 
availability of divalent cations within the media which are known to be necessary for the 
activity of DNase (Pan et al. 1999).  Collation of bacterial DNase expression data (Table 13) 
indicated that detection of DNase activity varied depending on the assay type.  The gel-based 
assay likely detected both secreted and membrane bound DNase activity whereas the plate-
based assay was only able to effectively detect secreted DNase able to diffuse through the 
agar from the bacterial colony.  Subsequently, the positive control strain (S. aureus) displayed 
greater levels of DNase activity in the supernatant than the pellet when assayed by gel-based 
method (Figures 87 and 88) and moderate levels by the plate-based assay (Figure 83), 
indicating a primarily secreted DNase as previously reported (Cunningham et al. 1956).  Of 
particular interest are the test bacteria that were found to be DNase negative by DNase test 
plate but positive by gel-based assay of the bacterial pellet such as C. rectus, S. mutans, C. 
sputigena and A. odontolyticus, indicating that the DNase may be membrane bound in these 
organisms.  Also of interest are the bacteria that were found to be DNase positive by plate-
based assay but negative by gel-based assay of broth cultures and this group included several 
streptococci spp. (S. constellatus, S. sanguis, S. gordonii and S. intermedius).  It is 
conceivable that this phenomenon could be due to DNase test agar containing the DNA 
substrate which may induce DNase expression over the 6 days of bacterial growth.  In 
contrast, in broth culture bacteria are not exposed to DNA until after harvest and freezing of 
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the samples.  The two assays applied also utilised bacteria cultured in different states (solid 
state on agar or planktonic in broth), a factor which is known to affect gene transcription and 
phenotype (Donlan et al. 2002; Mikkelsen et al. 2007).  Differences in DNase expression 
depending upon the growth state would be consistent with previous findings in which P. 
acnes and F. nucleatum were found to be DNase positive when grown on test agar but DNase 
negative when grown in broth culture prior to transfer to the test agar, which may also relate 
to the inducibility of DNase activity (Dahlen et al. 1983).  Alternative theories to explain the 
occurrence of DNase expression in the panel of periodontal pathogens are that subgingival 
bacteria may have a greater necessity for DNase expression and NET evasion than 
supragingival pathogens due to the closer proximity to host tissues and host defences.  Indeed, 
it has been reported that co-incubation of S. pyogenes with human pharyngeal cells induces 
the expression of an extracellular DNase (Broudy et al. 2002).  Another agent found to induce 
the gene expression of an extracellular DNase in GAS was hydrogen peroxide (Banks et al. 
2003), a membrane permeable ROS produced by neutrophil NADPH oxidase.  It has been 
demonstrated that functional NADPH oxidase is present in NETs but inactivated by DNase 
treatment (Munafo et al. 2009) and therefore bacterial DNase expression may protect against 
killing by extracellular ROS.  However, no such pattern in DNase expression based on 
localisation of the bacteria to the sub- or supragingival plaque (Ximénez-Fyvie et al. 2000) 
was observed in the panel of pathogens assayed here.  This may be attributable to the reported 
inconsistency of DNase expression amongst bacteria of a given species, as only a single strain 
of each bacterial species was tested here.  Indeed previous publications have assayed multiple 
strains of the same bacteria and found for example 8 out of 10 strains of P. melaninogenica to 
be DNase positive (Whaley et al. 1995), 3 out of 6 strains of S. intermedius to be DNase 
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positive (Marshall et al. 1981), and 28 out of 31 strains of A. naeslundii to be DNase positive 
(Whaley et al. 1995). 
 
In vivo DNase detection 
Recently it has been hypothesised that the increased flow of GCF in periodontal disease 
functions to remove bacterially produced DNase leaving NETs intact (Vitkov et al. 2009).  
Therefore the increased concentration of DNase detected in GCF may represent a host 
response that is successfully ‘rinsing’ bacterial DNase out of the gingival crevice.  
Conversely, as GCF is derived from plasma, the DNase detected may originate from host cells 
and tissues.  In a similar way that host production of serpins functions to limit the 
inappropriate destruction of host tissue by serine proteinases released from neutrophils 
(Henson et al. 1987), or glutathione acts as an antioxidant to neutralise ROS (Iwasaki et al. 
2009), it could be expected that a similar mechanism exists to terminate the function of NETs.  
This would be necessary to prevent immobilisation of host immune cells and also prevent 
possible autoimmune reactions triggered by an accumulation of extracellular neutrophil 
components comprising the NETs.  Alternatively it is possible that DNase expression is a 
physiological antimicrobial response by the host as DNase I has been demonstrated to 
strongly inhibit biofilm formation by P. aeroginosa (Whitchurch et al. 2002).  Evidence in 
support of this host derived DNase is given by the fact that activity was detectable in GCF 
earlier (day +7) than in plaque samples (day +21).  Alternatively, detection of DNase activity 
in GCF prior to plaque may indicate that the majority of DNase produced by the plaque 
bacteria is secreted rather than membrane bound.  If secreted DNase is removed by increased 
GCF flow during the development of inflammation, those bacteria expressing membrane 
bound DNase may display more virulence and comprise a greater proportion of the dental 
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plaque later in the development of inflammation.  This may explain why DNase activity 
retained within the dental plaque samples was only detectable on day 21 (Figure 90a) and 
GCF-DNase activity had reached a plateau by day 21 in this study (Figure 90b).  
Additionally, the difference in the detection pattern of DNase activity in GCF and plaque 
samples may have been influenced by the fact that the assay for GCF-DNase was more 
sensitive than plaque-DNase due to the diluent used, and in addition, GCF samples were 
normalised and this approach was not possible for plaque samples, therefore direct 
comparisons between the two sample types cannot easily be made.  Regardless of the origins 
of the DNase, levels were significantly increased in test sites compared to healthy sites by the 
end of the study period indicating a role for DNase activity in the inflamed tissue, possibly in 
the regulation of NETs.  As to whether regulation of DNase activity is to the advantage of the 
host or the bacteria remains to be elucidated, and future work should aim to identify the origin 
of the detected DNase within the GCF.  Indeed, discrimination between mammalian and 
bacterial DNase should be possible as bacterial and mammalian DNases are significantly 
different, for example the nuclease of S. aureus is approximately half the molecular weight 
(~16.9kDa) (Taniuchi et al. 1967) of mammalian DNase I (~31kDa) (Lindberg 1967). 
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9.1 Mechanism of NET release 
Described in this thesis are four NET detection methods, including SEM, fluorescent staining, 
fluorometric time course analysis and end point separation of the extracellular DNA by 
MNase digestion (Chapters 3 and 6).  The latter method, based on those previously reported 
(Fuchs et al. 2007; Ramos-Kichik et al. 2009; Wang et al. 2009), provided a high throughput 
and reproducible assay for comparison of NET responses under different experimental 
conditions.  Utilisation of this approach also enabled the application of a range of ROS 
pathway inhibitors and whilst it is established that NET release is associated with NADPH 
oxidase dependant hydrogen peroxide production (Fuchs et al. 2007), data presented here now 
indicates that the key step may lie downstream of hydrogen peroxide and implicates 
hypochlorous acid generated by myeloperoxidase activity (Chapter 4). 
 
HL60 cells were also utilised to study NET formation, and whilst they did not provide a 
robust model of neutrophil activity, they did add further to our understanding of the 
mechanisms involved in NET release.  Currently, only two publications exist documenting the 
analysis of NETs in HL60 cells (Munafo et al. 2009; Wang et al. 2009) in which 
combinations of stimuli e.g. IL-8 plus S. flexneri, or calcium ionophore stimulation resulted in 
only 3.2% and 8% NET release, respectively (Wang et al. 2009).  In this study, whilst 
calcium ionophore successfully induced NET release in dHL60 cells, only a short and 
relatively small burst of associated ROS production was detected.  In contrast, PMA 
stimulated dHL60 cells exhibited significant and sustained production of ROS, although no 
NET release was detected indicating that there may be other mechanisms, independent of 
NADPH oxidase, that result in NET release from dHL60 cells.  In further support of this 
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finding is the observation that although the NADPH oxidase inhibitor DPI, used both here 
(Chapters 4 and 6) and previously (Fuchs et al. 2007; von Kockritz-Blickwede et al. 2008; 
Yost et al. 2009), demonstrated the dependency of NET release on ROS production, DPI 
exposure did not result in complete NET inhibition and residual levels, thought to be NADPH 
oxidase-independent, were detectable.  Notably whilst DPI exposure caused a significant 
reduction in stimulated NET levels, in contrast where a stimulus was ineffective at evoking 
NET release (e.g. unstimulated primary neutrophils; or PMA stimulated, F. nucleatum 
stimulated or unstimulated dHL60 cells), exposure to DPI variably invoked an increase in 
NET release (Figures 40 and 42).  To further characterise the dependency of NET release on 
ROS production, attempts were made to correlate induced levels of these two responses.  
Notably a quantitative relationship has previously been demonstrated in murine neutrophils 
(Ermert et al. 2009) and the data presented here also indicated a positive correlation when 
neutrophils were stimulated with various periodontal pathogens (assuming exclusion of 
outliers; Figure 72).  Interestingly, this association was only detected when ROS production 
was measured by luminol detection, confirming that the key NET-associated ROS are 
intracellular molecules synthesised late in the ROS-metabolic pathway.  In addition, a weak 
correlation between luminol detected ROS and NET levels was also observed when 
neutrophils were stimulated with PMA (R
2
=0.24, P=0.007; 6.1.5).  It is notable that the data 
presented here was obtained using peripheral blood neutrophils which are exposed to a 
multitude of influencing factors prior to the point of assay.  In contrast, the previous report of 
a positive correlation between ROS and NET production utilised bone marrow derived 
neutrophils (Ermert et al. 2009) which are relatively naïve cells and potentially provide a 
‘cleaner’ assay of cellular responses to stimulation. 
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Previous studies have also demonstrated an important role for calcium in the synthesis of 
NETs, with evidence indicating that increasing intracellular calcium levels alone, induced 
through the use of a calcium ionophore, evokes NET release (Palic et al. 2007; Wang et al. 
2009).  Notably, of the 4 stimuli tested (Palic et al. 2007) this was the only one which 
displayed a dose dependant increase in NET release.  Combined, this data along with that 
presented here demonstrating that calcium ionophore was the only stimuli capable of evoking 
significant NET release in dHL60 cells (Figures 59 and 60), suggests that calcium levels 
activate a direct and essential step in the process of NET release, likely a calcium dependant 
enzyme.  Further support for the role of calcium in the NET process is derived from results 
demonstrating: i) activation of a calcium dependant protein kinase (i.e. PMA) is the most 
effective stimulus of NET release in primary neutrophils and ii) that histone citrullination by 
calcium dependant PAD is necessary for NET release (Wang et al. 2009).   
 
9.2 Microbial interactions with NETs 
For the first time, a sub-panel of periodontal pathogens were demonstrated as being capable of 
stimulating the release of, and interacting with, NETs (Chapter 6).  In addition, an extensive 
panel of periodontal pathogens were screened for potential virulence traits which may confer 
a survival advantage when challenged with NETs, namely resistance to killing by histones 
(Chapter 7) and DNase expression (Chapter 8).  Both the antimicrobial action of histones and 
bacterial DNase expression have been documented, since 1958 (Hirsch) and 1974 (Porschen 
and Sonntag), respectively, although their in vivo relevance was then not realised.  Now 
however, the role of host derived NETs may go some way to explaining a role for both these 
bacterial properties.   
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Histones reportedly represent 70% of NET associated proteins (Urban et al. 2009) therefore 
the previously demonstrated antimicrobial role of NETs may, at least in part, be attributed to 
histone molecules.  Antimicrobial susceptibility to histone proteins has recently been 
described in several types of bacteria with regard to NETs (Brinkmann et al. 2004), however, 
the yeast C. albicans has been demonstrated to be resistant to killing by histone, although it is 
effectively killed by complete NETs (Urban et al. 2006b).  The variability in susceptibility of 
the 32 different bacteria tested here to the antimicrobial activity of histones is therefore 
consistent with the current literature.  Interestingly, all 10 bacteria which appeared resistant to 
killing by mixed histone (Figure 81b) were derived from the red, orange and yellow colour 
complexes associated with more severe periodontitis (Socransky et al. 1998).  This could 
potentially result in their survival within periodontal tissues and the development of a more 
chronic and dysregulated inflammation. 
 
Bacterial DNase expression has previously been demonstrated to be directly linked to both 
bacterial survival in vitro and in vivo when challenged with NETs, and this property 
associates with increased disease severity (Beiter et al. 2006).  Therefore the panel of 
periodontal pathogens were also assayed for DNase activity by two independent methods and 
a large proportion (76% of strains tested) were found to exhibit some degree of activity (Table 
13).  In order to examine any relationship that may exist between DNase expression and 
disease severity in periodontitis, the test bacteria were grouped according to colour coded 
complexes (Socransky et al. 1998).  A higher proportion of the bacteria from the colour 
complexes (55% on average) were DNase positive compared with bacteria not associated with 
a complex (33% on average) when tested using all three methods (plate-based assay, gel-
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based assay of the pellet and gel-based assay of the supernatant).  This data potentially 
indicates the importance of DNase expression as a bacterial virulence determinant associated 
with periodontitis.  As these bacteria exist within a biofilm in vivo DNase expression by 
members of this complex will therefore likely contribute to a mutually beneficial environment 
whereby other non-DNase producing bacteria are afforded survival advantages. 
 
It is interesting to speculate that there may be a necessary association between the two 
virulence factors examined here, as following DNase digestion of NETs, histones may 
subsequently be liberated thereby creating a requirement for resistance to killing by these 
molecules.  Comparison of DNase activity detected in the bacterial pellet and resistance to 
histones lends support to this hypothesis as both appear to be a more common characteristic 
amongst bacteria of the orange and yellow colour complexes with 8 out of the 10 bacteria 
exhibiting resistant to killing by histone (Figure 81b) also producing significant membrane 
bound DNase activity (Figure 87).   
 
In addition to the virulence traits examined here, it has been hypothesised that bacterially 
produced catalase may be able to modulate the NET response of host neutrophils as in vitro 
addition of exogenous catalase decreases NET release (Fuchs et al. 2007).  Therefore future 
work could also examine the constitutive and inducible catalase production by periodontal 
pathogens as an anti-NET strategy.  Whilst catalase production by bacteria was assessed in a 
small panel of the bacteria for identification purposes (Table 11), this assay was a relatively 
insensitive visual test and was only performed for those bacteria for which catalase production 
was considered a key characteristic.  In addition, investigations could assess whether the 
levels produced were sufficient to play a patho-physiological role.  Bacterial PAD expression 
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is another bacterial property which may influence NET release as histone H3 citrullination by 
the endogenous PAD enzyme has been shown to be essential for NET release (Wang et al. 
2009).  The only bacterium currently known to express this enzyme is P. ginigvalis 
(Rodríguez et al. 2009) which is one of the most pathogenic periodontal organisms, and also 
an intracellular pathogen (Lamont et al. 1995), implicating P. gingivalis derived PAD 
enzymatic activity a possible modulator of NET release.  Further investigations could 
examine bacterial PAD regulation of NET release and determine whether other periodontal 
bacteria also possess this property. 
 
9.3 NETs in periodontitis 
Research into the phenomenon of NET release has increased significantly since they were 
first reported in 2004 (Brinkmann et al.).  Although at the outset of this work a role in 
periodontitis was only hypothesised based on its neutrophil driven pathology, a recent 
publication has now identified NETs in pus derived from the gingival crevice and gingival 
pocket surface (Vitkov et al. 2009).  The data presented here comparing NET responses from 
the peripheral blood neutrophils of periodontitis patients and age and gender matched healthy 
controls suggests a relationship may exist between periodontitis and elevated NET release 
(Chapter 6).  In addition to investigating the NET production associated with periodontitis, 
DNase activity in the disease state was also examined in a 21-day model of gingivitis.  This 
revealed a significant increase in DNase activity during the development of gingival 
inflammation potentially indicating an in vivo role for the previously described bacterial 
DNase expression (Table 13) and is in concordance with previous reports that bacterial DNase 
expression affects disease severity (Beiter et al. 2006).  It is however interesting to note that 
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pure cultures of 3 of the most pathogenic periodontal bacteria (P. gingivalis, T. forsythensis 
and A. actinomycetemcomitans serotype b) whilst able to stimulate NET release (Figure 70), 
exhibited a low occurrence of detectable DNase activity (Table 13), suggesting that a high 
presence of NETs may be detrimental to the host in periodontitis.  It is also conceivable that 
the in vivo increases in DNase activity may be of host origin rather than being bacterially 
derived, as activity was detectable in plaque at a later stage of clinical inflammation compared 
to levels detected in GCF samples (Figure 90).  Therefore host DNase expression may be a 
physiological rather than pathological response to increased NETs as a result of disease 
progression.  Indeed the presence of DNase has previously been demonstrated to be an 
essential counter-NET mechanism present in equine semen to enable effective fertilisation 
(Alghamdi et al. 2005).  DNase may be functioning to not only prevent trapping of host 
immune cells required to combat infiltrating bacteria but also prevent generation of auto-
antigens due to the presence of extracellular neutrophil components.  Indeed, it is known that 
circulating levels of self-nucleosomes are associated with the autoimmune disease, systemic 
lupus erythmatosus (Amoura et al. 1997), and it has been demonstrated in small vessel 
vasculitis that circulating DNA-MPO complexes proposed to be NET fragments are also 
elevated in active disease but not in remission (Kessenbrock et al. 2009).  Therefore effective 
removal of NETs may be essential to prevent the triggering of an autoimmune response due to 
excessive and prolonged accumulation of NETs within the tissues.  Conversely, if this does 
not occur efficiently NET release may contribute to propagation of the local inflammatory 
reaction and subsequently contribute to the association of periodontitis with other systemic 
diseases which exhibit an autoimmune component.  Therefore it is proposed that a strict 
balance between the presence of NETs and host-derived DNase activity exists to effectively 
combat bacterial infiltration and also bring about NET removal at the appropriate time thereby 
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maintaining a state of health within the tissues (Figure 91).  This dynamic may be subverted 
by excess DNase production by bacteria, which may confer survival advantages on those 
species, or excess host DNase production, although data on the latter in relation to disease 
pathogenesis is absent in the literature.  Moreover, excess NET production within tissues is 
likely to have pathogenic consequences by inhibiting immune surveillance mechanisms, and 
inadequate NET formation is also likely to have pathogenic consequences by facilitating 
pathogen survival.   
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Figure 91. Schematic of relationship that may exist between NET production and DNase 
production in inflammation such as periodontitis. 
 
To further characterise the role of NETs in the pathogenesis of periodontitis a study of 
peripheral neutrophil NET responses should be carried out in more strictly phenotyped 
patients and matched controls.  The use of antibodies to citrullinated histone H3 could also be 
utilised as this histone modification has been demonstrated to be an early and necessary step 
in NET activation and may indicate the level of peripheral neutrophils in a primed state for 
heightened NET release.  Similarly the expression levels of the PAD enzyme responsible for 
this citrullination may also be examined.  As inhibition of PAD suppresses NET release 
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(Wang et al. 2009), it is hypothesised that increased levels of PAD may promote NET release.  
Preliminary microarray data obtained in our laboratory indicates that PAD levels in patient 
neutrophils may be 1.5 times those of healthy controls (Personal communication, Dr H 
Wright) and this too could be further investigated in a patient group with appropriately 
matched healthy controls.  Future experiments could also harvest neutrophils directly from the 
gingival crevice to assess the effect the local environment within the periodontal tissues has 
on their capacity for NET release. 
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Figure 92. Gene alignments for design of primers: a) L. buccalis (16s rRNA; accession number X90831).  83% sequence match to F. 
nucleatum subsp. nucleatum 16s rRNA and 83% sequence match to F. nucleatum subsp. vincetii 16s rRNA. 
forward primer site 
reverse primer site 
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Figure 92. Gene alignments for design of primer: b) A. odontolyticus (16s rRNA; accession umber AJ234054). 90% sequence match 
to A. viscosus 16s rRNA, 91% sequence match to A. urogenitalis, 90% sequence match to M. curtitiis.  
forward primer site 
reverse primer site 
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Figure 92. Gene alignments for design of primer: c) N. mucosa (penicillin binding protein A; accession number X59635). 93% 
sequence match to N. sicca. 
forward primer site 
reverse primer site 
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Figure 92. Gene alignments for design of primer: d) P. denticola (16s rRNA; accession number L16467).  91% sequence match to P. 
melaninogenica, 87% sequence match to P. intermedia.
forward primer site 
reverse primer site 
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Figure 93. Effect of low PMA concentrations (0-1.6nM) on NET release measured by real-
time fluorescence.  Results show mean of experiment preformed in triplicate. 
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a) Dead cell stain 
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b) Live cell stain 
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Figure 94. Time course analysis of the effect of DPI (25µM) on cell viability using the 
protease dependant MultiTox-Fluor Multiplex Cytotoxicity assay (Promega).  a) dead 
cell stain read using filter 485/535nm,  b) live cell stain read at 355/460nm.  Cells stimulated 
using bacteria (F. nucleatum subsp. polymorphum and opsonised S. aureus MOI 1:150). 
Results show mean of experiment performed in triplicate. 
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Figure 95. Effect of DPI (25µM) on cell viability detected by SYTOX
®
 fluorescence over 
3 hours incubation using bacterial stimuli (F. nucleatum subsp. polymorphum and opsonised 
S. aureus MOI 1:150).  Results show mean of experiment performed in triplicate. 
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Figure 96. Kinetics of ROS production in primary neutrophils stimulated with PMA 
50nM.  Results show mean of experiment performed in triplicate. 
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a) A. naeslundii (fimbrial protein; accession number AF106034)  product size 999bp. 
 
     5581 cttcgtcgtc accctgccga tgaccaaccc ggagaagacc accgagtgga actacaacgt 
     5641 ccacgtctac cccaagaaca ccgtctccgg tgttgacaag caggtctccg acaagcaggt 
     5701 ctccggatcc ggtaacgaca tcacctacac gatcacgacc tccatcccga aggtcgacta 
     5761 cgccggcggt gccaggatca agcgctacga ggttgtcgac cagctcgaca agcgcatcaa 
     5821 gaaggaccag ctgacgccgg ttgtcaagat catcggcgcc gcaggcggga atccggagat 
     5881 caccctggtg gatggaacgg actacaccgt catcactgct gacggggcga accacaactg 
     5941 ggcgacgatc cagctcaccg aggaggggcg caggaaggcc gctgaggccc gtgccaacgg 
     6001 caccggtgag accaaggttc aggtgactct caccgccaag ttcgactctg acgtcgatct 
     6061 ggagggaacg ctgtccaaca ccgctggtct cattccctcc gacagtccca acttcgactg 
     6121 ggacccgagc aaccccggta cggatgtccc cggtattccc accaccccaa cgatctccaa 
     6181 gtacggcaag gtgaatctga ccaagaccgg taccgacaac ctcgccgaca agaccaagta 
     6241 caacggtgct gagttccagg tctacgagtg caccaagacc gccacgggcg ccactctcaa 
     6301 ggacgctgac gcctcgaccg ctgacaaggt agaccctctg accatcggtg gtaagcagac 
     6361 cttcacgact gagggccagg gcatggtctc gatcgcgact ctgcgcgcca acgactacgt 
     6421 caatggtgct gagaagcagc tcaccgacga tgactactac tgcctcgtcg agaccaaggc 
     6481 ccctgaggga tacaccctcc aggccgaccc gatccccttc cgagtcctgg ccgctgatgc 
     6541 tgagaagaag atcccgactg aggtgaccgt caccgacgtc ccgaagaacg caggtttccg 
     6601 cctgccgctc accggcgcca acggcgtcat cttcctcacc atcgccggcg ccctgctcgt 
     6661 ggccggtggc gcggtcgcgg cctacgccaa caagcgtcgc aacgccgcca agcgctgagc 
 
b) A. viscosus (fimbrial protein; accession number M32067)  product size 993bp. 
 
      541 gcctacctcg tcagcgagac gcgcaccccc gacaaggtca tcccggccga ggacttcgtc 
      601 gtcaccctgc cgatgaccaa cccgcaggac accgccaagt ggaactacaa cgtccacgtc 
      661 taccccaaga acaccctctc cggtgtggac aagcaggtga ccgacaagcc ggcccccggc 
      721 tccgggcgcg acatcaccta caccatcacc acctccatcc cgaaggtgga ctaccccggc 
      781 ggtgcgcgca tcaagcgcta cgaggtcgtt gaccgcctcg acaagcgcat caagaaggaa 
      841 gccctgaccc cggtcgtcaa gatcgtcggt cagaacgagg tgaccctggc ggagaccacc 
      901 gactacaccc tcatcactgc cgagggtaag gaccacaact gggccaccat ccagctcacc 
      961 gaggagggcc gccgcaaggc ctccgaggcg cgctacaacg gcaacggcga gaccaagctc 
     1021 caggtgaccc tgaacgccaa gttcgacgcc gccgtcaacc tcgagggcga cctgtccaac 
     1081 accgcgggcc tcatccccaa cgacagcccc aacttcacct gggacccgaa caaccccggc 
     1141 accaccacgg acatccccgg catccccacc acccccgtgc tctccaagta cggcaaggtg 
     1201 gttctcacca agaccggtac ggacgacctg gccgacaaga ccaagtacaa cggcgcccag 
     1261 ttccaggtct acgagtgcac caagaccgcc agcggtgcca cgctgcgtga ctccgacccc 
     1321 agcacccaga ccgtcgaccc gctgaccatc ggtggggaga agaccttcac caccgccggc 
     1381 cagggcaccg tggagatcaa ctacctgcgc gccaacgact acgtcaacgg tgcgaagaag 
     1441 gaccagctga ccgacgagga ctactactgc ctcgtggaga ccaaggcccc cgagggctac 
     1501 aacctccagg ccgacccgct ccccttccgg gtcctggctg agaaggccga gaagaaggcc 
     1561 gcgaccgagg tgaccgtcac cgacatcccg aagaacgccg gcttccgcct gccgctgacc 
     1621 ggtgccaacg gcgtcatctt cctgaccatc gccggcgccc tgctggtggc cggtggcgcg 
     1681 gtggtcgcct acgccaacaa gcgccgtcac gttgccaagc actgacagcc tctggcagcc 
 
Figure 97. Primer specificity for a) A. naeslundii (target species) and b) A. viscosus 
(cross-reactive species).  Red nucleotides indicate matches to forward and reverse primers. 
 
